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I N D E X
1.  TOTAL MOTHERS ATTENDING Totals 2014
Mothers who have delivered babies weighing >500 grams 8787
Mothers who have delivered babies weighing <500 grams {including
miscarriages} 1805  
Hydatidiform Moles * 35  
Ectopic Pregnancies 87  
Total Mothers Delivered 10814
*This figure includes complete & Partial Hydatidform Moles 
2.  MATERNAL DEATHS Totals 2014 
Maternal Deaths 2
3.  BIRTHS Totals 2014 
Singletons 8598 
Twins                                                                                          (183 sets)*  365 
Triplets                                                                                           (3 sets)  9 
Quadruplets                                                                                  (2 sets)  8 
Total Babies Delivered weighing> 500 grams 8980
* 1 less than 500g
4.  OBSTETRIC OUTCOME Totals 2014
Spontaneous Vaginal Delivery 51% 4515 
Forceps 5% 471
Ventouse 12% 1048
Caesarean Section 31% 2753
Induction of Labour 30% 2631
Breech Deliveries included in spontaneaous vaginal delivery
5.  PERINATAL DEATHS Totals 2014
Antepartum Deaths 45    
Intrapartum Deaths 0    
Stillbirths 45  
Early Neonatal Deaths 25
Late Neonatal Deaths 10
Congenital Anomalies 29 3
D U B L I N M AT E R N I T Y H O S P I TA L S
C O M B I N E D  C L I N I CA L  D ATA
6.  PERINATAL MORTALITY RATES                                                      Totals 2014
Overall Perinatal Mortality Rate per 1,000 Births 7.8  
Perinatal Mortality Rate Corrected For Lethal Congenital Anomalies 4.5
Perinatal Mortality Rate Including Late Neonatal Deaths 8.9       
Perinatal Mortality Rate Excluding Unbooked Cases 7.6
Corrected Perinatal Mortality Rate Excluding Unbooked Cases 4.3   
7.  AGE OF WOMEN
Nullips Multips             Total Mothers  Delivered>500g 
<20 yrs 197 25 22
20-24 yrs 549 339 888
25-29 yrs 902 922 1824
30-34 yrs 1306 1775 3081
35-39 yrs 670 1533 2203
40+ yrs 166 403 569
Total 3790 4997 8787
8.  PARITY
Totals 2014   % from Total Mothers  Delivered >500g 
Para 0 3790 43.1%
Para 1 3015 34.3%
Para 2-4 1862 21.2%
Para 5+ 120 1.4%
Total 8787 100% 
9. COUNTRY OF BIRTH & NATIONALITY AT DELIVERY - 2014
2013 % 2014 %
Irish 6,128 70.86% 5,451 62.03%
EU 1,535 17.75% 1,613 18.36%
NonEU 972 11.24% 1,106 12.59%
Unknown /Unrecorded 13 0.15% 617 7.02%
Total 8,648 100.00% 8,787 100.00%
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10. SOCIO-ECONOMIC GROUP - 2014
Socio-Group 2013 % 2014 %
1 622 7.03% 559 6.46% 636 7.24%
2 2,018 22.81% 1,989 23.00% 1,891 21.52%
3 1,498 16.93% 1,384 16.00% 1,270 14.45%
4 506 5.72% 437 5.05% 400 4.55%
5 603 6.82% 528 6.11% 468 5.33%
6 344 3.89% 317 3.67% 314 3.57%
7 2,334 26.38% 2,476 28.63% 1,782 20.28%
8 1 0.01% 0 0.00% 0 0.00%
9 2 0.02% 0 0.00% 2 0.02%
10 918 10.38% 958 11.08% 2,024 23.03%
TOTAL 8,846 100.00% 8,648 100.00% 8,787 100.00%
11. BIRTH WEIGHT  
Weights Totals 2014      
500 - 999 gms 57
1,000 - 1,499 75
1,500 - 1,999 139
2,000 - 2,499 337
2,500 - 2,999 1175
3,000 - 3,499 2997
3,500 - 3,999 2950
4,000 - 4,499 1080
4,500 - 4,999 159
>5,000 11
Total 8980
12. GESTATIONAL AGE   
Nullips Multips Totals 2014 
<26 weeks 11 18 29
26 - 29 weeks + 6 days 31 21 52
30 - 33 weeks + 6 days 59 61 120
34 - 36 weeks + 6 days 204 227 431
37 - 41 weeks + 6 days 3478 4665 8143
42 + weeks 7 5 12
Total 3790 4997 8787
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13. PERINEAL TRAUMA AFTER ALL VAGINAL DELIVERIES (Numbers & Percentages)
Nullips Multips  Totals 2014
Episiotomy & Extended Episiotomy 1245 319 1564
First Degree Laceration 177 502 679
Second Degree Laceration 655 1172 1827
Third Degree Anal Sphincter/Mucosa 118 41 159
Fourth Degree 4 1 5
Other { Lacerations/Grazes not 198 516 714
requiring sutures}
Intact 122 964 1086
Totals 2519 3515 6034
CS Deliveries not included in the above.
14.  THIRD DEGREE TEARS *  
Nullips Multips Totals 2014 
Occurring Spontaneously 49 38 87
Associated with Episiotomy 2 1 3
Associated with Forceps 27 2 29
Associated with Ventouse 28 0 28
Associated with Ventouse & Forceps 18 2 20
Associated with O.P. position 6 0 6
*Total 3rd Degree not listed as some women have a 3rd degree Tear with Both Episiotomy &
Instrumental Delivery.Table 13 has totals listed.
15.  PERINATAL MORTALITY IN ANTEPARTUM NORMALLY FORMED 
STILLBORN INFANTS
Nullips Multips Totals
Placental 0 8 8
Cord Accident 2 4 6
Extreme Prematurity 0 5 5    
Feto Maternal Haemorhage 1 0 1
Infection 1 1 2
Unexplained 3 4 7 
Total 7 22 29
Autopsy Totals
Autopsy Rate  21/29 72.4%
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16.  PERINATAL MORTALITY IN CONGENITALLY MALFORMED INFANTS
Nullips Multips      Totals 2014
CNS Lesions 2 0 2
Cardiac 1 2 3
Renal 1 2 3
Chromosomal 3 12 15           
Diaphragmatic Hernia 0 1 1
Other 0 5 5  
Totals 7 22 29
17.  EARLY NEONATAL DEATHS
Nullips Multips Totals 
Congenital 1 11 12
Prematurity / Infection 2 11 13
Placental 0 0 0
Unexpected 0 0 0
Totals 3 22 25
Full Autopsy 7/25
Autopsy Rate (inc 2 limited) 28%
Overall Full Autopsy total for all Perinatal Deaths    27
Overall Autopsy Rate 38.6%
18.  HYPOXIC ISCHAEMIC ENCEPHALOPATHY
Grades Grade 1   Grade 2             Grade 3  
13 5 3
19.  SEVERE MATERNAL MORBIDITY
Nullips Multips Totals 
Massive Obstetric Haemorrhage     4 3 7
Emergency Hysterectomy 1 0 1    
Transfer To ICU/CCU 9 4 13
Uterine Rupture 0 0 0    
Eclampsia 0 0 0
Pulmonary Embolus 1 6 7
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20.  FINANCIAL INFORMATION: Non-capital income and expenditure account
For the year ended 31 December 2014
2014 2013
€'000 €'000
Cumulative non-capital deficit/(surplus) 
brought forward from previous year 80 1,035
Pay
Salaries 46,535 46,691
Superannuation and gratuities 3,394 3,636
Total Pay 49,929 50,327
Non-Pay
Direct patient care 5,679 5,126
Support services 4,858 4,977
Financial and administrative 3,485 3,430
Total Non Pay 14,022 13,533
Gross expenditure for the year 64,031 64,895
Income (18,862) (19,464)
Net expenditure for the year 45,169 45,431
HSE Funding notified for the year (44,987) (45,351)
Deficit for the year carried forward 
to following year 182 80
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20. BODY MASS INDEX
Body Mass Index 2011 2012 2013 2014
Underweight: <18.5 197 (2.2%) 224 (2.5%) 215 (2.5%) 168 (1.9%)
Healthy: 18.5 - 24.9 4402 (48.3%) 4661 (52.7%) 4619 (53.4%) 4762 (54.2%)
Overweight: 25 - 29.9 2204 (24.2%) 2259 (25.5%) 2283 (26.4%) 2342 (26.7%)
Obese class 1: 30 - 34.9 730 (8.0%) 790 (8.9%) 804 (9.3%) 890 (10.1%)
Obese class 2: 35 - 39.9 227 (2.5%) 261 (3.0%) 267 (3.1%) 288 (3.3%)
Obese class 3: >40 95 (1.0%) 84 (1.0%) 83 (1.0%) 117 (1.3%)
Unrecorded 1261 (13.8%) 567 (6.4%) 377 (4.4%) 220 (2.5%)
Total Deliveries 9116 8846 8648 8787
91
Introduction
by the master
2014
The Master
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I N T R O D U C T I O N
was another difficult year for maternity services in Ireland,
with ongoing concerns in relation to quality and safety of
services and continued public and media interest in a small
number of high profile cases from various units around the
country.  We have being pushing very hard at every opportunity to highlight
issues around maternity services and the quality of care that we can provide for
our patients in the hope that we can secure investment for improvements in
infrastructure and to get the HSE and Department of Health to recognise that
staffing levels for our hospital is way below acceptable international norms.
2014 saw a continuation in the recent trend of high activity levels and while
obstetric activity levels in hospitals around the country seems to have fallen away,
the Rotunda’s position within the North East region where the population of
young couples has increased over the last number of years has ensured that our
activity levels remain high.  There were 10,954 patients registered for antenatal
care which was 1.5% less than in 2013.  We delivered 8,787 women of 8,980 babies
greater than or equal to 500 grams.  The corrected perinatal mortality rate for the
year was 4.4 per 1,000, in line with recent years.  There were 2 maternal deaths in
2014, both due to indirect cause.  Despite extreme activity levels, the hospital
continues to provide a safe service for its patients.
The other ongoing significant issue we faced in 2014 was the demand for
gynaecology out-patient clinic appointments. This demand far outstripped our
ability to provide new appointments for these patients.  This has again been
caused by the increase in the population we serve but is also due to the fact that
the general hospitals have been unable to process gynae patients due to activity
levels within their own Emergency Departments and the associated competition
for elective beds.  Allied to this, the Mater Hospital, which in the past would have
provided a significant amount of benign gynae services, now concentrates most of
its activity on gynae oncology.  A combination of all of these factors, in addition to
the huge demand led obstetric workload, has meant that gynae services have been
squeezed significantly.  During 2014 the Board recognised the risk associate with a
long wait to be seen in gynae out-patients for some patients and agreed to
institute a waiting list initiative in conjunction with the Mater Private Hospital.
Over the course of the year 476 patients were taken from the Rotunda public
waiting list, seen by Rotunda consultants and investigated and 87 required day
case treatment in the Mater Private Hospital.  This initiative in addition to
revalidation of the current gynae waiting list has successfully reduced the number
of women waiting to be seen in gynae out-patients significantly.  It is anticipated
that this waiting list initiative will run into 2015, but should ultimately be replaced
by expansion of gynae services within the group model.  This will of course
depend on additional consultant posts being appointed to allow us to expand the
service to match the demand.
2014
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There have been significant changes within the administration of Health Service
in Ireland over the last year, both nationally and at regional level.  We continue to
work with the RCSI Hospital Group and with hospitals within our group, however
there has been a frustrating lack of progress due to the fact that there has been so
many changes in personnel at HSE level within the region.  We are working with
the Group and with the HSE to ensure that as a voluntary hospital we are able to
maintain our own unique governance arrangements and to find a way in which
this can fit within the current group model. 
There were some welcome initiatives at regional level, with agreement on a
regional perinatal pathology post and agreement from the HSE and the Group to
expand post-mortem facilities on the Rotunda site to assist with regional post-
mortem and perinatal pathology services.  There was also a welcome development
of a joint Fetal Medicine post between Our Lady of Lourdes Hospital Drogheda and
the Rotunda.  However unfortunately there were no applicants for this post.  We
are currently restructuring the job to try and make it more attractive.
The Bartholomew Mosse Charter Day lecture was delivered by Dr. Ruth Barrington.
Her lecture entitled ‘Health Care Reform and the Voluntary Hospital - the Case for
Hastening Slowly’ provided great insight into the evolution of the Irish Health
Service and stressed the importance the voluntary hospital sector has played in
the delivery of quality health care to the Irish system.  
The Friends of the Rotunda continue to work extremely hard to support research
within the hospital.  The annual Rotunda Masters Golf Classic was held in
Milltown and was a great success.  Again my sincere thanks go to Sheila
Thompson and the Friends for all of the work that they put in to support research
within the hospital.
The Rotunda was delighted to partner up with the RCSI in the Institute of
Leadership during 2014.   Fifteen of our staff completed a leadership training
programme with RCSI.  They worked on three projects which were particularly
relevant to our Strategic Plan.  These included a project on the consent process, a
project on progressing a thrombocalc risk assessment for thrombo-embolism in
pregnancy and a project which looked at the flow of patients through our out-
patients department.  Each project team was multi-disciplinary in nature.  The
output of the process was extremely impressive with all three projects leading to
significant quality initiatives.  It is envisaged that the relationship with the
Institute of Leadership Faculty in RCSI will continue, with further programmes to
be held in the future.
The Clinical Audit Department continues to work extremely well, generating a
regular stream of important audit information concentrating on high risk and
high cost.  The Research Department led by Dr. Joanna Griffin continues to go from
strength to strength with close links developed, not only with our principal
academic partner the RCSI, but also with other third level institutions.  This is a
really valuable asset to the hospital and all of its staff.  
2014 also saw the sale of the HARI Unit, the Hospital’s infertility unit to Virtus, an
Australian company with an international interest in fertility services.  Virtus had
recently acquired a majority ownership of the SIMS Clinic.  
Over the course of 2014 we had been working towards the development of a plan
to expand along the west side of Parnell Square to deal with our demand led
activity.  We had planned to have an application ready for submission to Dublin
City Council in early 2015, however meetings in early 2015 indicated that there
would be a Ministerial announcement in relation to relocation of the Rotunda and
therefore this plan was put on hold pending the Minister’s announcement.  There
is absolutely no doubt that the current level of activity within the Parnell Square
site cannot be sustained.  A re-developed and re-located Rotunda on the site of a
suitable funded and equipped adult hospital site is urgently required.
As a country we have failed to recognise over the last couple of years that failure to
invest in our Health Service, failure to invest in our Hospitals, our infrastructure
and our staff has allowed a situation to arise where many of our young graduate
doctors and nurses and midwives are leaving the country. This situation is
generating large numbers of vacant posts, not only in our hospitals but also in our
general practice and community service. This must be addressed urgently if
further escalation of an already challenging situation is to be avoided.
I would like to take this opportunity to thank all of those who contribute to the
support and provision of services to our patients.  The hospital, despite
submissions to the HSE and the Department of Health, remains understaffed from
a medical, midwifery and administrative point of view.  It is a tribute to the skill
and dedication of our front line staff who continue to maintain the quality of
services in increasingly difficult circumstances.  To all of those who stay late, miss
breaks and come in to do additional shifts when requested, I am eternally grateful.
The hospital administrative and management team led by Ms. Pauline Treanor our
Secretary General Manager have worked incredibly hard to keep the hospital as
lean as possible and bringing us in close to budget.  Their efforts are hugely
appreciated and they do a wonderful job.
To our midwifery colleagues ably led by Ms. Margaret Philbin, our Director of
Midwifery, I would like to express my gratitude for the unparalleled commitment
that they bring to their jobs in extremely difficult circumstances.  Without their
hard work and dedication the hospital could never deliver such high quality
services.
I N T R O D U C T I O N
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I N T R O D U C T I O N
I would also like to thank all of the Heads of Departments for the enormous work
that they contribute to the life and the running of the hospital.
I am deeply indebted to all of my consultant colleagues for the extraordinary
effort that everyone puts in to the delivery of a quality service in each of their
areas.  To all of the NCHDs who work extremely hard to keep the hospital as safe
as they do and for all of the added value that they bring to the hospital and its
social life I am extremely grateful. 
Dr. Peter McKenna as Clinical Director has taken over a number roles to support
the office of the Master and for this I am extremely grateful.
The Rotunda Hospital as a voluntary institution is overseen by a Board of
Governors, ably led by the Chairman Ms. Hilary Prentice.  The General Board and
its various Sub-Committees provide their services free of charge and do an
enormous amount of work in overseeing the governance system for the hospital.
A great deal of credit goes to the governors for all of the hard work that they put
in to ensure that the hospital is maintained and run as safely as possible and for
this I would like to extend my thanks.
Dr. Sam Coulter-Smith.
Master.
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Y E A R S 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Babies
Born 6804 7325 8456 8799 8912 8792 9319 9041 8841 8980
Perinatal
Deaths 61 
+ 10* 50 + 13 * 66 + 10 * 64 + 7* 56+ 5* 69+5* 59+2* 66+2* 63+6* 68+2*
Perinatal
Mortality
Rate
9.8 8.6 9.0 8.1 6.8 8.4 6.5 7.5 7.8 7.8
Mothers
Attending 7,518 8,036 9,290 9,655 9,709 9,594 10,547 10,397 10,314 10,814
Maternal
Deaths 0 0 0 1 2 3 3 2 3 2
Caesarean
Section
%
25.6 27.7 27.1 26.2 28.5 27.9 29 29 31 31
Forceps/
Ventouse
%
15.3 16.8 17 20 19.8 20.5 19.4 18 17 17
Epidural
% 46.7 47 47 49 49.2 46.6 46 48 47 47
Induction
% 19 20 20 21 23.27 27 29 28 29 30
* Unbooked
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C O M PA R A T I V E  R E S U L T S  F O R
1 0  Y E A R S
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S T A T I S T I C A L  S U M M A R I E S
1.  TOTAL MOTHERS ATTENDING Totals 2014
Mothers who have delivered babies weighing >500 grams 8787
Mothers who have delivered babies weighing <500 grams {including
miscarriages} 1805  
Hydatidiform Moles * 35  
Ectopic Pregnancies 187  
Total Mothers Delivered 10814
*This figure includes complete & Partial Hydatidform Moles 
2.  MATERNAL DEATHS Totals 2014
Maternal Deaths 2
3.  BIRTHS Totals 2014
Singletons 8598 
Twins                                                                                               (183 sets)*      365 
Triplets                                                                                                (3 sets) 9 
Quadruplets                                                                                       (2 sets) 8 
Total Babies Delivered weighing> 500 grams 8980
* 1 Less than 500g
4.  OBSTETRIC OUTCOME Totals 2014
Spontaneous Vaginal Delivery 51% 4515 
Forceps 5% 471
Ventouse 12% 1048
Caesarean Section 31% 2753
Induction of Labour 30% 2631
Breech Deliveries included in spontaneaous vaginal delivery
5.  PERINATAL DEATHS Totals 2014
Antepartum Deaths 45    
Intrapartum Deaths 0    
Stillbirths 45  
Early Neonatal Deaths 25
Late Neonatal Deaths 10
Congenital Anomalies 29          
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6.  PERINATAL MORTALITY RATES                                                      Totals 2014
Overall Perinatal Mortality Rate per 1,000 Births 7.8  
Perinatal Mortality Rate Corrected For Lethal Congenital Anomalies 4.5 
Perinatal Mortality Rate Including Late Neonatal Deaths 8.9      
Perinatal Mortality Rate Excluding Unbooked Cases 7.6
Corrected Perinatal Mortality Rate Excluding Unbooked Cases 4.3  
7.  STATISTICAL ANALYSIS OF HOSPITAL POPULATION
AGE AT DELIVERY 2008 2009 2010 2011 2012 2013 2014
<20 4.7% 3.8% 3.5% 3.0% 2.8% 2.5% 2.5%
20-24 14.8% 14.6% 13.1% 12.4% 11.6% 11.0% 10.1%
25-29 25.7% 24.7% 24.6% 23.6% 23.2% 21.5% 20.8%
30-34 30.2% 31.6% 31.6% 33.6% 34.8% 34.8% 35.1%
35-39 20.5% 21.3% 22.2% 22.5% 22.0% 24.3% 25.1%
>=40 4.1% 4.0% 5.0% 4.9% 5.5% 5.9% 6.5%
PARITY 2008 2009 2010 2011 2012 2013 2014
0 48.9% 47.3% 45.5% 45.5% 44.4% 42.6% 43.1%
1 29.3% 31.2% 32.3% 32.8% 34.1% 34.1% 34.3%
2-4 20.8% 20.4% 21.1% 20.7% 20.3% 22.1% 21.2%
5+ 1.0% 1.1% 1.1% 1.0% 1.2% 1.2% 1.4%
BIRTHWEIGHT 2008 2009 2010 2011 2012 2013 2014
(grams)
500-999 0.6% 0.5% 0.6% 0.5% 0.7% 0.8% 0.6%
1000-1499 1.1% 0.9% 0.7% 0.8% 1.0% 0.9% 0.8%
1500-1999 1.6% 1.6% 1.4% 1.6% 1.5% 1.7% 1.5%
2000-2499 3.7% 3.4% 4.0% 3.8% 4.0% 4.1% 3.8%
2500-2999 13.4% 13.6% 13.1% 13.8% 12.9% 13.0% 13.1%
3000-3499 33.0% 33.5% 32.1% 32.4% 31.5% 32.6% 33.4%
3500-3999 32.3% 34.4% 32.9% 33.0% 34.1% 32.4% 32.9%
4000-4499 12.2% 10.0% 12.7% 11.8% 12.2% 12.2% 12.0%
4500-4999 2.0% 1.9% 2.3% 2.1% 2.0% 2.2% 1.8%
>5000 0.3% 0.2% 0.2% 0.2% 0.1% 0.1% 0.1%
GESTATION 2008 2009 2010 2011 2012 2013 2014
(Weeks) 
<26 weeks 0.3% 0.2% 0.3% 0.2% 0.3% 0.3% 0.3%
26 - 29 weeks + 6 days 0.6% 0.6% 0.6% 0.8% 0.7% 0.7% 0.6%
30 - 33 weeks + 6 days 1.5% 1.4% 1.4% 1.3% 1.5% 1.5% 1.4%
34 - 36 weeks + 6 days 4.1% 4.1% 4.3% 4.4% 4.4% 4.4% 4.9%
37 - 41 weeks + 6 days 90.9% 92.6% 92.8% 93.2% 93.0% 93.0% 92.6%
42 + weeks 2.5% 1.1% 0.6% 0.2% 0.2% 0.1% 0.1%
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NOTES ON PERINATAL MORTALITY
• The overall rate applies to all babies weighing greater than or equal to 
500g who were stillborn or died in the first seven days of life (70).
• The uncorrected perinatal mortality rate is calculated when unbooked or 
transferred in labour cases (2) are excluded.  Late bookers are not excluded.
• The corrected perinatal mortality rate is the uncorrected perinatal deaths
(68) less the number of congenital malformations (29) equals 39.  This 
gives an uncorrected rate of 7.6 and a corrected rate of 4.3.
STILLBIRTHS
Stillbirths 45
Congenital Malformations 16
Placental 8
Cord 6
Extreme Prematurity & Infection 5
Infection 2
Feto Maternal Haemorrhage 1
Unexplained 7
F E T A L  L O S S
T h e  M a s t e r
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Congenital (16)
1. Age 37. Para 1.  Previous SVD at 38 weeks.  Previous manual removal of
placenta.  Booked at 11 weeks.  Anatomy scan at 20 weeks showed an
abnormal four chamber view with suspected VSD.  Amniocentesis
performed.  Reviewed by paediatric cardiology.  Diagnosis Phelan McDermid
syndrome.  Review by Clinical Genetics.  IUD in another jurisdiction at 28
weeks.  Spontaneous vaginal delivery, female infant, 1.1 kilograms.  No PM.
Cause of death chromosomal abnormality Phelan McDermid syndrome
deletion in the long arm of chromosome 22. 
2. Age 21. Nulliparous.  Booked at 12 weeks.  BMI 22.4.  Anatomy scan at 20
weeks negative for malformations.  Regular attendance at antenatal clinic.
Attended Emergency Room at 33 weeks with lower abdominal pain and
reduced fetal movements.  Scan confirmed FHND.  Spontaneous labour. SVD
male infant 2.19 kilograms.  Post-mortem confirmed the presence of
congenital anomaly, a dural AV fistula with secondary microcephaly and
congestive cardiac failure.  Placental examination was unremarkable. 
3. Age 32.  Para 1.  Booked at 12 weeks. BMI 25.3.  Previous obstetric history of
forceps delivery at term.  Uneventful antenatal care.  Anatomy scan at 21
weeks negative for malformations.  Presented in spontaneous labour at 38
weeks gestation.  Fully dilated on admission to the Emergency Room.
Twenty minutes later on admission to the labour ward the fetal heart not
detected.  Spontaneous vaginal delivery of a stillborn female infant
weighing 3.3 kilos.  Post-mortem examination confirmed a congenital
malformation Trisomy 21.  In addition there was a placental abnormality
with extensive fetal thrombotic vasculopathy and the cord was tightly
coiled with non-occlusive thrombus present.
4. Age 29. Booked at 19 weeks. BMI 22.5.  Para 2.  Previous ventouse and
spontaneous vaginal delivery at term.  Anatomy scan at 22 weeks revealed
bilateral choroid plexus cysts and exomphalos.  Amniocentesis revealed
Trisomy 18.  Intrauterine fetal demise diagnosed at 26 weeks.  Assisted
breech delivery.  Stillborn male infant, 0.8 kilograms.  Cause of death
Trisomy 18 with associated multiple congenital malformations.  
5. Age 34. Nulliparous.  BMI 20.6.  History of hypothyroidism.  Booked at 12
weeks.  Anatomy scan at 20 weeks showed sub-optimal views of the fetal
heart.  Scan repeated at 24 weeks revealed a small outlet VSD with a
possibility of a overriding aorta.  Cardiology review confirmed presence of
VSD.  Follow-up in Fetal Medicine Clinic.  NIPT showed high risk for Trisomy
21.  Confirmed following amnion PCR.  Further follow-up in Fetal Medicine
Department at 30 weeks, FHND.  Induction of labour, stillborn male infant
1.76 kilograms.  Placental histology hypercoiled cord with non-occlusive
thrombus.  Cause of death Trisomy 21 with cardiac abnormality.
6. Age 43. BMI 24.6.  Nulliparous.  Booked at 14 weeks.  Anatomy scan at 20
weeks revealed normal anatomy but evidence of echogenic bowel.
Amniocentesis performed at 24 weeks. Diagnosis confirmed Trisomy 21.  21
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Further follow-up showed reduced growth velocity.  IUD diagnosed at 27
weeks.  Induction of labour.  Stillborn male infant, assisted breech, 0.93
kilograms.  No PM.  Cause of death Trisomy 21.  Placental histology revealed
hypercoiled cord.  Patients postnatal course complicated by a DVT. 
7. Age 22. Para 1.  Previous ventouse at term for a 2.5 kilo infant with known
cardiac anomaly.  Booked at 20 weeks.  Fetal anatomy scan at 22 weeks
revealed abnormal cardiac views.  Fetal Medicine and Fetal Cardiology
review revealed suspected congenital cardio-myopathy and reduced bi-
ventricular function, similar to previous pregnancy.  IUD diagnosed at 30
weeks.  Induction of labour, stillborn male infant, 1.18 kilograms.  Placental
histology revealed a hyper-coiled cord.  Post-mortem examination was
negative for structural congenital malformations, but examination of the
heart was consistent with congenital cardio-myopathy.  Cause of death
congenital cardio-myopathy.
8. Age 25. Nulliparous.  Transferred from another hospital with a suspected
significant fetal anomaly.  Ultrasound confirmed presence of a large
encephalocoele.  FHND following visit abroad.  Induction of labour at 24
weeks.  Stillborn female infant, 0.82 kilograms.  No PM. 
9. Age 28. BMI 22.3.  Para 1.  Previous stillbirth at 28 weeks.  Diagnosis
congenital Arthrogryposis Multiplex.  Booked at 8 weeks.  Follow-up in Fetal
Medicine Clinic.  First trimester screening declined.  Follow-up scan at 16
weeks showed evidence of scalp oedema.  Further scans confirmed skin
oedema plus bilateral pleural effusions suggestive of recurrence of
diagnosis in first pregnancy.  Amniocentesis performed at 17 weeks.  Genetic
counselling organised.  Further scans confirmed worsening hydrops. FHND
at 25 weeks.  Induction of labour.  Assisted breech delivery of stillborn female
infant 0.96 kg.  Fresh muscle biopsy taken at delivery. Karyotype 46 XX.
Specific test for spinal muscular atrophy were negative.  Placental histology
revealed hydropic placenta with multifocal fetal thrombotic vasculopathy.
Post-mortem examination confirmed recurrence of congenital myopathy.
10. Age 38. Para 1.  Previous spontaneous vaginal delivery at term.  History of
primary infertility.  ICCSI pregnancy.  Booked at 13 weeks.  Anatomy scan at
20 weeks, repeated because of poor cardiac views.  Repeat scan at 24 weeks
confirmed likely VSD with sub-optimal views of the aortic arch, subsequent
review with paediatric cardiology confirmed aortic coarctation.
Amniocentesis confirmed Trisomy 21.  FHND following visit abroad.
Induction of labour at 27 weeks.  Male infant stillborn, 1.18 kilograms.  Cause
of death Trisomy 21 with complex cardiac abnormality.  No PM.
11. Age 37. Nulliparous.  History of primary infertility and asthma.  Booked at 12
weeks.  Anatomy scan at 21 weeks negative for malformations.  Further scan
at 26 weeks showed absent nasal bone.  NIPT performed, suggestive of
Trisomy 21.  Amniocentesis at 28 weeks positive for Trisomy 21.  FHND
following visit abroad.  Induction of labour at 29 weeks.  Spontaneous
vaginal delivery, stillborn male infant 1.53 kilograms.  No PM.  Placental
examination – hypercoiled cord.  Cause of death Trisomy 21 with cardiac
abnormality.
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12. Age 39. Para 2.  Two previous vaginal deliveries at term.  Booked at 12 weeks.
Scan at 20 weeks negative for malformations, however patient concerned
about fetal anomaly.  Amniocentesis confirmed Trisomy 21.  FHND following
visit abroad.  Induction of labour, assisted breech delivery, female infant,
0.59 kilograms.  Cause of death Chromosomal Trisomy 21.
13. Age 39. BMI 30.23.  Para 1.  Previous emergency section at term.  Previous
LLETZ.  Booked at 13 weeks.  Anatomy screening scan at 20 weeks revealed
short femur.  Estimated fetal weight less than 5th centile.  Follow-up in Fetal
Medicine Clinic.  Amniocentesis performed at 28 weeks, following suspected
Trisomy 18 on NIPT.  Diagnosis of Trisomy 18 confirmed.  IUD confirmed at
30 weeks.  Induction of labour.  Spontaneous vaginal delivery, male stillborn,
1.19 kilograms.  PM declined.  Placental histology showed early acute
chorioamniotis with some recent retro placental haemorrhage.  Cause of
death chromosomal Trisomy 18.
14. Age 41. BMI 30.54.  Para 1.  Previous elective section for poly-hydramnios
complicated by PPH.  Known fibroids.  History of DVT.  Booked at 14 weeks.
Anatomy scan at 21 weeks revealed bilateral choriod plexus cysts, two vessel
cord, estimated weight less than 10th centile.  Follow-up in Fetal Medicine
Department.  Amniocentesis performed at 22 weeks.  Confirmed Trisomy 18.
Planned VBAC.  Attended with spontaneous rupture of membranes at 42
weeks.  Spontaneous labour.  Assisted breech, stillborn female, 2.19
kilograms.  No PM.  Cause of death Trisomy 18.  Placental histology evidence
of ascending infection, two vessel cord, acute suppurative chorioamnionitis
and accelerated villous maturation. 
15. Age 20. Para 1.  Late booker at 34 weeks.  Past history of previous
spontaneous vaginal delivery at term.  Past history hypertension.  Anatomy
scan at booking visit confirmed 34 weeks, polyhydramnios, brain
holoproscencephaly alobar spine thoracic hemi vertebra, long bones all less
than the 5th centile.  Amniocentesis performed.  Prenatal MRI performed in
Temple Street.  Appearances suggestive of compete infarction of the hind
brain.  Fetal Medicine follow-up.  Induction of labour at 39 weeks.  Stillborn
male infant 2.69 kg.  Karyotyping from amniocentesis failed with no
growth.  Placental cytogenetics revealed abnormal male karyotype.
Trisomy 8.  Cause of death Trisomy 8 plus CNS congenital anomaly.
16. Age 33. Para 1.  One previous vaginal delivery at term.  Previous pregnancy
associated with pre-eclampsia and PPH.  Booked at 11 weeks.  Anatomy scan
at 21 weeks negative for malformations.  Low lying placenta.  Repeat
ultrasound at 34 weeks for placental localisation identified possible cardiac
anomaly.  Fetal Medicine follow-up at 37 weeks showed oligohydramnios
and FHND.  Induction of labour.  Spontaneous vaginal delivery of stillborn
female infant weighing 3.08 kg.  PM confirmed major congenital cardiac
malformation with a VSD with preductal coarctation/tubular hyperplasia of
the aorta.  Facial features were suggestive of Trisomy 21, but cytogenetics
failed to grow from both placenta and fetal skin samples.  Cause of death
major congenital cardiac malformation.
Placental  (8 )
1. Age 29. Para 1.  Previous ventouse at 41 weeks.  BMI 30.27. Booked at 15 weeks.
Booking bloods normal.  Anatomy scan negative for malformations.
Irregular attender.  Glucosuria at 35 weeks, poor follow-up and multiple
DNAs.  Scan at 35 weeks, normal growth and biophysical score.  Attended
Emergency Room at term +5 with reduced fetal movements.  FHND.
Induction of labour.  Spontaneous vaginal delivery of a female infant
weighing 3.16 kilograms.  Mec III.  Placental examination revealed normal
coiling index.  Placenta was below the 3rd centile for gestational age.
Evidence of placental hypoplasia, but there was evidence of multi-focal
moderate to severe chronic villitis with an increase in nucleated red blood
cells.  Post-mortem declined.  Cause of death placental.
2. Age 25. Para 3.  Three previous vaginal deliveries at 32, 36 and term.
Multiple attendances at ultrasound unit for cervical length.  Anatomy
scan negative for malformations.  Attended Emergency Room at 25 weeks
with abdominal pain.  FHND.  Induction of labour.  Spontaneous vaginal
delivery, female infant, 1.1 kilograms.  PM revealed no evidence of
congenital malformation.  There was a large retro-placental clot
confirming a diagnosis of placental abruption.
3. Age 36. Para 3.  BMI 31.23.  Previous classical caesarean section at 25 weeks
followed by emergency caesarean section at 25 and 26 weeks.  Pre-
eclampsia in all three pregnancies.  Booked at 13 weeks.  Regular attender.
Anatomy scan at 20 weeks negative for malformation.  Regular review in
Fetal Assessment with serial growth and Doppler.  Regular attender in the
Day Care Unit for PET monitoring.  Hypertension treated with Labetalol
and Methyldopa.  Required addition of Nifedipine to control blood
pressure from 20 weeks.  Admitted at 24 weeks for monitoring.  At 25+3 no
FH picked up on routine auscultation.  Confirmed on scan.  Stillborn male
infant weighing 0.8 kilograms delivered by elective caesarean section.  PM
declined.  Placental histology revealed significant retroplacental
haemorrhage.  Cause of death placental abruption, less than 5% infarction
with evidence of nucleated red cells in the fetal circulation.
4. Age 26. Para 1.  Previous SVD.  BMI 31.6.  Booked at 13 weeks.  Anatomy scan
at 20 weeks negative for malformations.  Irregular attender at clinic
Gestational diabetes diagnosed following GTT.  Diet controlled.  Attended
Emergency Room by ambulance at 36 weeks with abdominal pain.  FHND.
Induction of labour.  Female infant weighing 2.2 kilograms, stillborn.
Placental histology revealed a hyper-coiled cord, coiling index 0.5.
Placental histology revealed significant delayed villous maturation.  Post-
mortem examination was negative for malformations.  Cause of death
delay villous maturation/maturation defect.  
5. Age 33. Para 1.  Previous PPROM at 25 weeks and vaginal delivery of female
infant 0.68 kilograms.  Neonatal death at 16 days from prematurity and
sepsis.  Past history of depression, unexplained seizures as a child.  Booked
at 14 weeks.  Early pregnancy scan at 16 weeks.  Anatomy scan at 20 weeks
negative for congenital malformations.  Growth scan at 32 weeks showed24
reduced growth velocity, Doppler and biophysical score normal.  Estimated
fetal weight on the 19th centile.  Planned for induction of labour at term.
However IUD diagnosed following attendance with reduced fetal
movements at 38 weeks.  Induction of labour, spontaneous vaginal
delivery, female infant, stillborn, 2.24 kilograms.  Post-mortem
examination negative for congenital malformations.  Growth restricted
infant on the 3rd centile for gestational age.  Small placenta, third centile.
Increased peri-villous fibre and deposition affecting 40% of the placenta.
Evidence of fetal thrombotic vasculopathy.
6. Age 36. Para 1.  One previous emergency section at term.  Booked at 14
weeks.  Scan at 21 weeks negative for congenital malformations.  Regular
attender at clinic.  Booked for planned elective repeat caesarean section in
view of breech presentation at 39+5.  On admission routine fetal heart
check revealed fetal heart not detected.  Induction of labour.  Stillborn
female infant, 2.49 kilograms.  Post-mortem examination confirmed
normal karyotype.  No evidence of congenital malformation or ascending
infection.  Fetal demise was caused by delayed villious maturation leading
to fetal hypoxia. 
7. Age 29. BMI 33.7.  Poor obstetric history.  Para 2+2.  Emergency caesarean
section at 31 weeks in first pregnancy for HELLP syndrome; twenty week
late miscarriage; followed by emergency section at 24 weeks; neonatal
death followed by late miscarriage at 18 weeks in last pregnancy.  Later
booker at 22 weeks.  Anatomy scan negative for congenital malformations
at 22 weeks.  Developed proteinuria and hypertension at 23 weeks.
Admitted for observation and treatment of hypertension.  Placental
abruption at 24 weeks.  Emergency caesarean section.  Female infant,
stillborn, 0.6 kg.  Placental examination confirmed massive placental
abruption, in addition evidence of chronic utero-placental insufficiency
was noted.  No PM.  Cause of death massive placental abruption on a
background of pre-eclampsia and previous HELLP syndrome.
8. Age 39. Para 0+1.  BMI 27.6.  Medical history – insulin dependent diabetes,
hyperthyroid.  Booked at 12 weeks.  Anatomy scan at 20 weeks showed
polyhydramnios.  View of great vessels not completely reassuring.  Fetal
echo booked with subtle disproportion of the great artery.  Fumur length
was also short.  Amniocentesis at 25 weeks.  Fetal Medicine follow-up.
Suspected pulmonary stenosis. Query Noonan Syndrome.  Fetal cardiac
echo normal.  Scan at 31 weeks, FHND.  Induction of labour.  Spontaneous
vaginal delivery, male infant, 1.71 kg, stillborn.  Karyotype 46XY normal.
PM examination revealed evidence of dual pathology, pleural effusions
and enlarged liver consequent upon congestive cardiac failure leading to a
widely patent foreamen ovale and may have accounted for the difference
between widths or the aorta and pulmonary artery.  This is likely to have
developed as a result of placental pathology which suggested placenta
chorangiomas.  There was also partly occlusive thrombus within the
umbilical vein with extensive fetal thrombotic vasculopathy.  No definite
evidence of congenital malformation. Cause of death placental
chorangiomas leading to congestive cardiac failure. 25
Cord  (6 )
1. Age 18. BMI 23.5.  Para 1.  Previous emergency caesarean section.  Booked
at 18 weeks.  Negative anatomy scan at 22 weeks.  Attended Emergency
Room at 31 weeks with lower abdominal pain.  FHND.  Induction of labour,
male infant, 1.57 kilograms, stillborn.  PM declined.  Placental histology
revealed evidence of increased nucleated red blood cells in keeping with
acute hypoxia.  There was a partly occlusive thrombus in the cord.  Cause
of death probable cord accident.
2. Age 25. Nulliparous.  BMI 28.7.  Late booker at 19 weeks.  Anatomy scan at
22 weeks negative for malformations.  Regular attender at clinic.  Attended
Emergency Room at 38 weeks with back and lower abdominal pain.
Assessment normal.  Allowed home.  Re-attended at 40 weeks with pains,
query labour.  FHND, scan confirmed IUD.  Induction of labour.  Stillborn
male infant, 3.58 kilograms.  PM negative for congenital malformations.
Placental examination revealed a very long cord, 1.25 metres in length.
Cord was wrapped around the neck, the body and the leg.  There was a
complete occlusive thrombus in the umbilical cord artery.  Cause of death
cord accident.
3. Age 25. Para 2+3. Two previous caesarean sections at term and 3 early
miscarriages.  BMI 29.4.  Past history CIN II, irritable bowel, panic attacks,
recurrent UTIs.  Booked at 14 weeks.  Anatomy scan performed late at 30
weeks due to multiple DNAs.  Negative for malformations.  Attended at 37
weeks with reduced fetal movements.  Scan confirmed FHND.  Delivered
by caesarean section in view of two previous sections.  Stillborn female
infant, 2.65 kilograms.  PM declined.  Placental histology revealed a tight
true knot in the umbilical cord.  Cause of death cord accident.
4. Age 28. Para 2.  Two previous spontaneous vaginal deliveries at term.  BMI
34.  Booked at 16 weeks. Regular attender.   Anatomy scan negative for
malformations at 20 weeks.  GTT at 28 weeks. Attended Emergency Room
at 39+5 weeks, query labour.  FHND.  Spontaneous onset of labour.  SVD
stillborn female infant, 4.02 kg.  Post-mortem examination negative for
congenital malformations.  Placental examination revealed long
umbilical cord 94.5 centimetres, hyper-coiled with true knot, mural fibrin
thrombi in the chorionic plate vessels with downstream obstruction in
the fetal circulation, indicating probably cord accident.  Cause of death
probably cord accident.
5. Age 26. Nulliparous.  BMI 20.  Past history of PCO.  Booked at 13 weeks.
Anatomy scan at 20 weeks negative for malformations.  Regular
attendance at clinic.  Attended with reduced fetal movements at 36 weeks.
Reassuring fetal wellbeing investigations.  Attended emergency room at
term with a SHOW, query early labour, FHND.  Induction of labour,
spontaneous vaginal delivery, female infant, stillborn, 2.71 kg.  Coroners
PM.  Placental examination revealed partly compressed umbilical cord
with a partly occlusive thrombus present in the umbilical vein.  There was
probable evidence of ascending infection with maternal inflammatory 26
response, but no fetal response.  Chorionic villi showed diffuse delayed
villous maturation and incidental chorioanginomas 1 per cent of the
volume was noted.
6. Age 40. Para 1+2.  Two late miscarriages at 19 weeks followed by a
spontaneous vaginal delivery at term.  History of gestation diabetes.  BMI
37.6.  Booked at 11 weeks.  Anatomy scan at 20 weeks, incomplete.  Planned
re-scan at 24 weeks.  Attended Emergency Room at 23+ weeks with
reduced fetal movements.  Scan – FHND.  Induction of labour.  Assisted
breech delivery, stillborn male infant, 0.72 kg.  True knots X 2 in cord.
Umbilical cord 49 centimetres long.  Two tight knots identified. The cord
was noted to be hypocoiled, with a coiling index of 0.06, non-occlusive
thrombus was noted in the umbilical vessels.  There was some fresh retro-
membranes haemorrhage.  PM declined.  Cause of death probable cord
accident.
Extreme Prematur ity  &  Infect ion  (5 )
1. Age 36. Para 0+1.  BMI 37.  Booked at 11 weeks.  Past history of PCO.  Primary
infertility.  Anatomy scan at 21 weeks negative for malformations.
Attended Emergency Room at 22 weeks with PPROM and abdominal pain.
Fetus BBA.  Female stillborn infant, 0.58 kg.  PM negative for congenital
malformations.  Congenital broncho pneumonia.  Placental examination
revealed evidence of ascending infection with maternal and fetal
inflammatory response.  Cause of death extreme prematurity, with
evidence of ascending infection.
2. Age 36. Para 1+1.  Previous Ventouse delivery at term.  Third degree tear.
Booked at 15 weeks.  Known fibroid uterus.  Anatomy scan at 20 weeks
negative for malformations.  Attended at 23+ weeks with PPROM and
irregular pains, cervix 6 centimetres dilated, ultrasound, FHND.  Assisted
breech delivery, stillborn, male infant, 0.56 kilos.  PM negative for
congenital malformations.  Diffuse congenital pneumonia.  Placental
examination showed evidence of ascending infection with maternal and
fetal response.  Cause of death extreme prematurity and infection.
3. Age 32. Para 2.  BMI 24.4.  Previous emergency caesarean section at term,
followed by spontaneous vaginal delivery at term.  Multiple early
miscarriages.  Previous CIN II and LLETZ.  History of mental health issues,
gestational diabetes and anaemia.  Congenital renal anomaly diagnosis as
a child.  Smoker 10 per day.  Mild asthma.  Late booker at 25 weeks.  Anatomy
scan negative for malformations.  Poor attender at clinic.  Admitted at 34
weeks gestation with PPROM.  Two days following admission routine CTG
showed deep decelerations.  Vaginal examination revealed cord prolapse.
Emergency caesarean section, female infant, 2.05 kilograms, no sign of life
at delivery.  Coroners PM negative for congenital malformation.  Placental
examination showed acute supprative chorioamnionitis and vasculitis
with mild accelerated villous maturation.  Cause of death premature
rupture of membranes leading to cord prolapse and ascending infection.
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4. Age 35. Para 1.  Previous emergency caesarean section at term for failure to
advance in second stage.  Transfer from another hospital at 24 weeks
gestation with a dichorioniac diamniotic twins with bulging fore-waters.
Admitted for observation, antibiotic and steroids.  Two weeks later at 26+4
FHND twin I, decision taken to proceed to deliver twin II by classical
caesarean section.  Magnesium sulphate given.  Twin I stillborn male infant,
1.1 kilograms.  Twin II, male infant, live born 0.85 kilograms.  Admitted to
NICU.  Placental culture pseudomonas.  Twin II RIP at two days old
secondary to pseudomonas infection and extreme prematurity.     Placental
histology confirmed DCDA twins.  Evidence of ascending infection with
maternal and fetal response in both twins.  Membranes showed acute
supprative chorioamnionitis with positive culture of pseudomonas
aeruginosa.  No PM.  Cause of death, twin I stillborn secondary to infection
and extreme prematurity.  Twin II, neonatal death infection secondary to
extremely prematurity.
5. Age 39. Para 1.  BMI 22.6.  Past history endometriosis.  Booked at 11 weeks.
Diagnosed MCDA twins.  Followed up in Fetal Medicine twin clinic with
regular scans.  Screening for the TTTS.  Attended with PPROM at 23+1 weeks.
Scan confirmed diagnosis also suggestive of low lying placenta, possibly
covering the cervix. 25 weeks and 5 days, FHND twin 1.  During routine CTG,
fetal bradycardia in twin II decision made perform emergency caesarean
section.  Delivery at 25+ weeks.  Twin I stillborn male infant, 0.77 kilograms.
Twin II live born male infant 0.68 kilograms.  Poor Apgar scores,
resuscitation discontinued.  NND day 1.  Placental examination confirmed
evidence of significant ascending infection in both twins.  No PM.  Cause of
death sepsis and extreme prematurity.
Infect ion  (2 )
1. Age 29. Para 1.  Previous spontaneous vaginal delivery. BMI 22.2.  Booked at
17 weeks.  Normal booking bloods.  Anatomy scan negative for
malformations.  Low lying placenta.  Regular antenatal care.  Repeat scan
for localisation at 34 weeks showed polyhydramnios. GTT normal.
Attended at 39 weeks with abdominal pain and antepartum haemorrhage.
FHND.  Spontaneous labour, SVD, female 3.29 kilograms.  Velamentous cord
insertion.  Limited PM negative for external congenital malformations.
Placental cytogenetic 46XX.  Placental examination revealed evidence of
ascending infection with maternal and fetal response and velamentous
cord insertion.  Likely cause of the fetal demise ascending infection.
Subsequent maternal death by suicide just over six months later.
2. Age 22. Nulliparous.  BMI 21.1.  Booked at 12 weeks.  Anatomy scan at 22
weeks negative for malformations.  Presented with spontaneous PPROM at
30 weeks gestation.  Antibiotics and steroids given routinely.  On day two
following admission patients temperature was noted to be increased, 38
degrees centigrade, white cell count was raised.  Magnesium sulphate was
given and a plan was made for delivery by caesarean section due to
suspected to evolving chorioamnionitis.  The patient was taken to theatre.
An emergency caesarean section was carried out.  A stillborn male infant
weighing 1.62 kilograms was delivered.  A Coroners post-mortem was 
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performed.  PM negative for congenital malformations.  Cause of death
ascending infection secondary to acute suppurative chorioamnionitis with
fetal and maternal response.  Strep pneumonia isolated.  Cause of death
infection.
Feto  Maternal  Haemorrhage  ( 1 )
1. Age 41. Nulliparous.  BMI 24.  Booked 14 weeks.  Past history of hypothyroid.
Regular attender at antenatal clinic and endocrine clinic.  Anatomy
negative for malformations at 20 weeks.  Repeat scan for placental
localisation at 34 weeks. Normal biophysical score and growth.  Seen at
term +5, induction of labour planned.  Attended at 41 weeks gestation with
reduced fetal movements. FHND.  Induction of labour.  Spontaneous
vaginal delivery of male infant, stillborn, 3.44 kilograms.  Placental
histology negative.  PM examination negative for congenital
malformations.  Kleihauer test strongly positive indicating feto-maternal
haemorrhage of 224 mls.  Cause of death large feto-maternal haemorrhage.
Unexplained  (7 )
1. Age 25. Nulliparous.  BMI 26.9.  Past history PCO.  Booked at 8 weeks.
Regular attender.  Anatomy scan at 22 weeks negative for malformations.
GTT at 28 weeks negative.  Attended Emergency Room at 34+ weeks with
reduced fetal movements.  FHND.  Induction of labour.  Spontaneous
vaginal delivery, male infant 2.34 kilograms.  PM declined.  Placental
examination revealed non occlusive thrombus in the umbilical cord but no
downstream effect.  Negative for ascending infection or retroplacental
haemorrhage.   Unexplained IUD.
2. Age 35. Para 2.  Previous elective sections x 2 at 37 and 38 weeks.  BMI 22.5.
Booked at 10 weeks.  Anatomy scan at 21 weeks negative for malformations.
Presented to the Emergency Room at 24 weeks with no fetal movements.
Scan - no fetal heart detected.  Induction of labour.  Assisted breech delivery,
male infant, 0.72 kilograms.  Placental examination negative for infection,
negative for cord accident, cytogenetics normal.  Post-mortem revealed
evidence of mild hydrops but no evidence of congenital malformation.
Cause of death unexplained.
3. Age 24. Nulliparous.  BMI 26.8.  Booked at 13 weeks.  Anatomy scan at 21 weeks
negative for malformations.  Regular attender at clinic.  Attended Emergency
Room at 38 weeks with reduced fetal movements for three days.  Fetal
assessment normal.  Re-attended at 39+4 with pains but not in labour.  FHND.
Induction of labour, spontaneous vaginal delivery, stillborn female infant,
2.78 kilograms.  PM declined.  Placental examination revealed a hypercoiled
cord but no evidence of ascending infection.  Cause of death unexplained.
4. Age 38. Para 2.  BMI 33.5.  One previous elective caesarean section at term,
followed by a forceps delivery at term.  Booked at 12 weeks.  Anatomy scan
at 21 weeks negative for malformations.  Regular attender at clinic.  Minor
RTA at 28 weeks.  Growth scan at 26 and 28 weeks normal.  Scan at 38 weeks
normal biophysical score, normal Dopplers.  She also attended the 
endocrine clinic and was on Eltroxin for hypothyroidism.  Attended
Emergency Room at 39 weeks with reduced fetal movements.  Admitted
for observation and monitoring over night.  Allowed home but returned
later that day with reduced fetal movements and FHND.  Induction of
labour, stillborn female infant, 2.97 kilos. Placental histology revealed a
placenta with a weight on the 5th centile.  There was some evidence of
some mild delayed villous maturation.  There was pseudo knot in the
umbilical cord.  No evidence of ascending infection, retroplacental
haemorrhage or villitis.  Karyotype normal.  PM negative for congenital
malformations.  Cause of death unexplained.
5. Age 30. Nulliparous.  BMI 22.4.  Booked at 11 weeks.  Anatomy scan at 20
weeks negative for malformation.  Right sided 5 centimetre ovarian cyst
seen.  Placenta low lying.  Attended Emergency Room at 24 weeks with
reduced fetal movements.  Ultrasound scan confirmed FHND.  Induction of
labour at 24+4.  Spontaneous vaginal delivery stillborn male infant 0.7 kg.
Placental examination revealed increased coiling index 0.49, no evidence
of thrombosis in the cord.  There was significant recent retro-placental
haemorrhage with secondary inflammation, negative for fetal and
maternal inflammatory response.  Post-mortem examination limited to
external examination.  Placental cytogenetics normal.  Cause of death
unexplained.
6. Age 33. Para 1.  One previous SVD at term.  BMI 19.7.  History of IBS,
depression, asthma.  Booked at 11 weeks.  Anatomy scan 21 weeks negative
for malformations.  Attended the Emergency Room at 29 weeks having
fainted.  Assessment normal and allowed to go home.  Attended
Emergency Room at 34 weeks with reduced fetal movements, scan FHND.
Induction of labour.  Spontaneous vaginal delivery of male infant,
stillborn, 2.12 kg.  Placental histology negative.  Post-mortem examination
negative for congenital malformation.  Cause of death unexplained. 
7. Age 17. Para 0+2.  BMI 29.  Unsure of dates.  Anatomy scan at 22 weeks,
negative for malformations.  Attended the hospital at 26 weeks with
reduced movements.  Scan confirmed FHND.  Induction of labour.
Spontaneous vaginal delivery stillborn female infant, 0.9 kg.  PM declined.
Placental histology revealed a hypercoiled cord but no evidence of
thrombus within the cord vessels.  Cause of death unexplained.
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EARLY  NEONATAL  DEATH
Early Neonatal Deaths 25(27 reported on, including 2 < 500g born alive)
Prematurity & Infection 12 (+2 less < 500g)
Congenital 13
Prematur ity  &  Infect ion  ( 14 )
1.  Age 34. Para 2+1.  Previous twin delivery at 34 weeks and miscarriage at
17 weeks.  Past history hypothyroid and anaemia.  Booked at 15 weeks
having had cervical cerclage inserted in another jurisdiction at 10 weeks
gestation.  Attended at PPROM at 24 weeks.  Admitted for observation,
antiobiotics, steroids.  Cervical cerclage removed.  Developed
chorioamnionitis.  Emergency caesarean section performed at 24 weeks 5
days, following fetal tachycardia and deterioration of maternal condition.
Female infant 0.7 kg, live born.  Apgars 1 at 1, 1 at 5 and 5 at 10.  Cultures
pseudomonas ? negative.  Chorioamnionitis.  Baby RIP day 4 post delivery.
Mother discharged day 11 post delivery.  PM declined.  Placental histology
ascending infection.  Cause of death infection and extreme prematurity. 
2. Age 37. Para 1+4.  One forceps delivery at term followed by three early
miscarriages and a late miscarriage at 19 weeks.  Booked at 6 week.
Regular follow-up in ultrasound.  Cervical cerclage at 12 weeks.  Regular
follow-up in ultrasound to assess cervical length.  Anatomy scan at 19
weeks negative for malformations.  Scan at 22 weeks, picked up
asymptomatic cervical funnelling.  Admitted for observation.  Laboured
at 24 weeks.  Suture removed.  Assisted breech delivery.  Female infant.
0.59 kilograms.  Apgars 2 at 1, 0 at 5.  Paediatric review.  Not for
resuscitation.  No PM.  Placental histology evidence of ascending
infection.  Cause of death infection and extreme prematurity.
3. Age 22. Para 1. Previous spontaneous vaginal delivery at term.  BMI 22.
Moderate smoker 10 to 20 per day.  Booked at 13 weeks.  Booking scan
revealed anhydramnios.  Followed up in Fetal Medicine Unit.  History
suggestive of PPROM.  Anatomy scan at 22 weeks confirmed
anhydramnios.  Limited structural survey, due to poor view, but no
congenital malformations identified.  Regular weekly follow-up.  Patient
aware of poor prognosis.  Attended Emergency Room at 24 weeks with
heavy vaginal bleeding.  Attended Emergency Room at 31 weeks with
pains.  CTG non- reassuring.  Emergency caesarean section performed,
live born female infant, 1.17 kilograms.  Apgars 2 at 1, 2 at 5 and 2 at 10.  RIP
shortly after delivery.  No PM.  Placental histology revealed evidence of
ascending infection, with maternal and fetal response.  Cause of death
pulmonary hypoplasia secondary to prolonged PPROM.
4. Age 35. Para 1.  Previous emergency caesarean section at term for failure to
advance in second stage.  Transfer from another hospital at 24 weeks gestation
with a dichorioniac diamniotic twins with bulging fore-waters.  Admitted for
observation, antibiotic and steroids.  Two weeks later at 26+4 FHND twin I, 
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decision taken to proceed to deliver twin II by classical caesarean section.
Magnesium sulphate given.  Twin I stillborn male infant, 1.1 kilograms.  Twin II,
male infant, live born 0.85 kilograms.  Admitted to NICU.  Placental culture
pseudomonas.  Twin II RIP at two days old secondary to pseudomonas infection
and extreme prematurity.     Placental histology confirmed DCDA twins.
Evidence of ascending infection with maternal and fetal response in both
twins.  Membranes showed acute supprative chorioamnionitis with positive
culture of pseudomonas aeruginosa.  No PM.  Cause of death, twin I stillborn
secondary to infection and extreme prematurity.  Twin II, neonatal death
infection secondary to extremely prematurity.
5. Age 39. Para 1.  BMI 22.6.  Past history endometriosis.  Booked at 11 weeks.
Diagnosed MCDA twins.  Followed up in Fetal Medicine twin clinic with regular
scans.  Screening for the TTTS.  Attended with PPROM at 23+1 weeks.  Scan
confirmed diagnosis also suggestive of low lying placenta, possibly covering
the cervix. 25 weeks and 5 days, FHND twin 1.  During routine CTG, fetal
bradycardia in twin II decision made perform emergency caesarean section.
Delivery at 25+ weeks.  Twin I stillborn male infant, 0.77 kilograms.  Twin II live
born male infant 0.68 kilograms.  Poor Apgar scores, resuscitation
discontinued.  NND day 1.  Placental examination confirmed evidence of
significant ascending infection in both twins.  No PM.  Cause of death sepsis
and extreme prematurity.
6. Age 32. Para 2.  Two previous emergency sections.  Booked at 9 weeks.  Past
history of gestational diabetes.  BMI 26.6.  Attended Emergency Room at 19
weeks with vaginal bleeding.  Spontaneously settled.  Anatomy scan at 20
weeks negative for malformations.  A further episode of vaginal bleeding at 22
weeks with associated lower abdominal pain.  Laboured spontaneously at 22+
weeks gestation.  Spontaneous vaginal delivery, female infant, 0.61 kilograms.
Active resuscitation not performed.  RIP one hour.  PM negative for
malformations.  Cause of death extreme prematurity.
7. Age 40. Para 4.  Unbooked.  History of all vaginal deliveries, last baby born at
28 weeks.  Brought in by ambulance at 23+ weeks gestation with PPROM.
Admitted for steroids and antibiotics.  Proceeded to spontaneously labour.
Spontaneous vaginal delivery, live born female infant, 0.6 kilograms.  Baby died
shortly after delivery.  Placental histology negative for ascending infection.
Cause of death extreme prematurity.
8. Age 30. Para 0+1, previous late miscarriage at 20 weeks.  BMI 32.  Booked at 12
weeks.  Cervical cerclage at 12 weeks.  Regular cervical length assessments.  Mild
funnelling noted at 16 weeks.  Rescue suture inserted.  Previous histology on
first pregnancy suggestive of infective aetiology. Further scan at 18 weeks; no
change.  Anatomy scan at 20 weeks incomplete structural survey.  Planned for
review in four weeks.  Admitted at 22 weeks with bulging membranes.  Cervical
suture removed in theatre.  Proceeded to spontaneous vaginal delivery of
female infant, 0.53 kilograms.  Resuscitation not indicated due to extreme
premature gestation.  No PM.  Placental histology showed evidence of
ascending infection with maternal inflammatory response noted.  There
was no evidence of fetal inflammatory response.  Cause of death extreme
prematurity secondary to incompetent cervix.
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9. Age 25. BMI 20.6.  Para 0+4.  Two early and two late miscarriages at 16 and
17 weeks.  Past medical history – factor XI deficiency.  Booked at 13 weeks.
Booked for cervical cerclage the following week.  Regular follow-up with
serial cervical lengths.  Anatomy scan at 22 weeks negative for
malformations.  Presented at 23 weeks with PPROM.  Cervical cerclage
removed.  Laboured at 23+4 weeks.  Live born, male infant, 0.59 kg, Apgars 1
at 1 and 1 at 5.  No resuscitation undertaken.  No PM.  Placental examination
revealed evidence of extensive ascending infection with maternal and fetal
response.  Cause of death extreme prematurity and infection.
10. Age 27. Nulliparous.  BMI 27.4.  Booked at 13 weeks.  Past history – non
insulin dependent diabetes, primary infertility.  IVF pregnancy.  Triplet
pregnancy with demise of twin 1 diagnosed at booking visit at 11 weeks.
Followed up in Fetal Medicine Twin Clinic.  Anatomy scan at 20 weeks
negative for malformations.  Attended Emergency Room at 22 weeks with
PPROM.  On examination twin I had progressed through the cervix into the
vagina.  Twin I spontaneous vaginal delivery, female infant 0.45 kilograms.
Apgars 1 at 1, 0 at 5.  Twin II spontaneous vaginal delivery of male infant, 0.5
kg, 3 at 1, 2 at 5.   RIP day 1.  PM declined.  Placental examination showed
evidence of ascending infection.  There was some old retro-membranous
haemorrhage.  Cause of death extreme prematurity.
11. Age 26. Para 0+2.  BMI 27.  Booked at 13 weeks.  Attended Emergency Room at
19 weeks with threatened miscarriage.  Query UTI.  Anatomy scan at 21 weeks
negative for malformations.  Attended Emergency Room at 23 weeks.
Speculum examination, bulging forewaters. Proceeded to deliver
spontaneously.  Female infant, assisted breech, 0.59 kg at 23+ weeks gestation.
Apgars 1 at 1 and 1 at 5.  No active resuscitation.  RIP at 1 hour.  PM declined.
Placental histology showed evidence of extensive ascending infection with
maternal and fetal response.  There was some fresh retroplacental
haemorrhage.  Cause of death extreme prematurity and infection.
12. Age 32.  Booked at another hospital. Transferred at 26+2 weeks.  Para 4+4.
Four previous caesarean sections.  On admission palpable abdominal
contractions with abdominal tenderness.  Suspected scar rupture.
Emergency caesarean section performed.  Male infant 1.06 kg, Apgars
scores 5 at 1 and 8 at 5.  Neonatal death day 1 post delivery.  PM declined.  No
evidence of uterine rupture or abruption at delivery, cause of death
iatrogenic prematurity. Placental histology negative.
13/14.  Age 38. Nulliparous.  BMI 22.3.  Booked at 14 weeks.  IVF pregnancy.
Dichorionic diamniotic twins.  Anatomy scan at 20 weeks, incomplete
structural survey due to poor views.  Attended the Emergency Room at 22
weeks gestation with increasing vaginal discharge.  Speculum examination
showed bulging membranes.  Admitted for observation.  Laboured
spontaneously at 22 weeks gestation.  Twin I assisted breech female 0.46 kg,
Apgars 1 at 1 and 1 at 5.  Twin II male infant assisted breech 0.47 kg, Apgars
3 at 1 and 1 at 5.  Resuscitation discontinued.  Placental histology evidence of
ascending infection in both twins. 
Congenital  ( 12 )
1.  Age 28. Par 1+1.  BMI 31.6.  Previous Ventouse delivery at term.  History of
PCOS.  Pregnancy induced hypertension in first pregnancy.  IBS, group B strep
in first pregnancy.  History of dermoid cyst.  Attended Early Pregnancy Unit
with threatened miscarriage.  Scan at 12 weeks revealed increased nuchal
translucency.  Anatomy scan at 20 weeks negative for malformations.  Scan
at 28 weeks revealed an-hydramnios with enlarged echogenic kidneys
suggestive of polycystic kidney disease.  Followed up in Fetal Medicine Clinic
with serial ultrasound scans.  Spontaneous labour at 37 weeks gestation.
Male infant 3.19 kilograms.  Apgars 3 at 1, 7 at 5 and 9 at 10.  Transferred to
NICU.  Baby RIP day 5 postnatally.  Post-mortem revealed auto-recessive
polycystic kidney disease.  Congenital hepathic fibrosis.  Extensive
pulmonary haemorrhage.  Cause of death congenital renal anomaly. 
2. Age 32. Para +1.  Previous vaginal deliveries x 2 at term. Referred from
another hospital at 23 weeks with suspected cardiac anomaly.
Amniocentesis normal male karyotype.  Admitted with PPROM at 36
weeks.  Induction of labour for prolonged PPROM.  Live born male infant
1.86 kilograms, Apgars 9 at 1, 9 at 5. Transferred to Crumlin Hospital for
cardiac review.  Additional anomaly tracheal oesophageal fistula and
imperforated anus diagnosed.  This additional features were suggestive of
Vacteral Syndrome.  Placental histology diffuse moderate accelerative
villious maturation with retroplacental haemorrhage.  Baby died day 3.
3. Age 25. Nulliparous.  BMI 29.7.  Booked at 11 weeks.  Regular attender.  Initial
booking scan suggested abdominal wall herniation.  Subsequent follow-up
in Fetal Medicine Department revealed bladder outlet obstruction with
bilateral dilated renal pelvis and marked megacystis.  Amniocentesis normal
karyotype 46XY.  Two vessel cord noted.  Gross polyhydramnios developed.
At 36 weeks bilateral drainage of fetal kidneys performed in theatre under
ultrasound guidance.  Induction of labour arranged for following day.
Ventouse delivery male infant, 3.52 kilograms.  Baby transferred to NICU,
then to Crumlin.  RIP day 1.  Post-mortem examination revealed multiple
congenital malformations.  Trachea oesophageal fistula, anal atresia,
ambiguous external genitalia and marked bilateral renal dysplasia.  Cause of
death renal and GI congenital malformations. 
4. Age 29. Para 1.  Previous forceps delivery at term.  Later booker at 29 week.
Booking anatomy screening scan revealed an abnormal four chamber view,
abnormal vessels.  Hypoplasia of the left ventricle and echogenic bowel.
Lumber and/sacral spinal bifida.  Arnold Chiari malformation and banana
shaped cerebellum.  Amniocentesis performed at 29 weeks.  Laboured
spontaneously at 31 weeks.  Spontaneous vaginal delivery female infant 1.33
kilograms.  Primary PPH.  Apgars 5 at 1, 8 at 5.  Baby RIP day 2 post delivery.  
Cytogenetics returned 69XXX.  Placental histology true knot in cord but no
thrombosis.  No PM.  Cause of death.  Chromosomal Triploidy with multiple
congenital malformations.
5. Age 36. Para 0+1.  Transferred from another hospital with suspected fetal
anomaly at 22 weeks gestation.  Ventricolomegaly and suspected absence of 34
corpus callosum noted on scan.  Fetal Medicine follow-up.  Antenatal MRI
performed.  Confirmed mild ventricular enlargement and absent septum
pellucidum.  Patient had incidental finding of large pelvic mass.
Amniocentesis suggestive of single chromosome 13.  Patient delivery by
elective caesarean section at 30+1 weeks, male infant, 0.88 kilograms.  Apgar
score 3 at 1.  Baby died shortly after delivery.  Large righted ovarian mass
removed at the time of caesarean section.  Ovarian histology pseudo
myxoma peritonei.  No PM.  Placental histology, placenta hypoplasia.  No
other pathology noted.  Cause of death chromosomal anomaly absent
chromosome 13.
6. Age 27. Nulliparous.  Transferred from another hospital at 34 weeks
gestation with suspected cardiac anomaly and polyhydramnios.
Amniocentesis performed.  Fetal medicine follow-up revealed abnormal
four chamber view of the heart.  Enlarged left atria and ventricle with mitral
regurgitation.  Out flow tracks were poorly visualised.  Also possible
abdominal wall defect.  Follow-up in combined cardiac clinic between the
Rotunda and the Coombe.  Scan confirmed hypoplastic left heart variant
with mitral stenosis and aortic atresia (Shone complex).  Poor prognosis
explained to patient.  Spontaneous labour at 35 weeks.  Ventouse delivery,
male infant, 2.76 kilograms, Apgars 4 at 1 and 4 at 5.  Comfort care given.
Baby RIP at 1 hour.  Karyotype 46XY.  PM confirmed prenatal cardiac findings
in keeping with Shone complex.  Cause of death cardiac anomaly.
7. Age 30. Para 2.  Two previous caesarean sections at term.  BMI 26.3.  Booked
at 12 weeks.  DCDA twins diagnosed.  Anatomy scan at 22 weeks negative for
malformations.  Followed up in Twin Fetal Medicine Clinic.  Discordant
growth identified at 24 weeks.  Twin I IUGR with associated
polyhydramnios, VSD, fixed flexion deformities of both wrists.  Further
follow-up confirmed discordant growth with symmetrical growth
retardation in twin I.  Amniocentesis confirmed Trisomy 18 twin I. Elective
caesarean section at 35+ weeks.  Twin I male infant, 1.59 kilograms, Apgars 3
at 1, 6 at 5 and 6 at 10.  Twin II male infant, 2.59 kilos, Apgars 8 at 1 and 10 at
5.  Twin I transferred to NICU.  Primary PPH.  Twin I RIP day 3.  No PM.
Placental histology unremarkable.  Cause of death.  Trisomy 18.
8. Age 28.  BMI 25.  Para 0+1.  Booked at 13 weeks.  Anatomy scan at 21 weeks
negative for malformations.  Regular attender at clinic.  Diagnosed breech
and large for dates at 30 weeks.  Scan confirmed polyhydramnios.  Glucose
tolerance test revealed gestational diabetes.  Controlled with diet.
Spontaneous labour at 37 weeks.  Live born male infant weight 2.7 kg.  Baby
floppy and unresponsive with no FH at birth.  Resuscitation discontinued.
Coroners PM with input from neuropathology. Karyotype 46XY.  Post-
mortem was negative for structural congenital malformations.  There was 
evidence of growth restriction.  There was wide spread neo cortical and
brain stem neuro necrosis with old long standing IVH.  Muscle biopsies
revealed evidence of mitochondrial respiratory chain defect, which
explained the abnormal CNS findings.  Placental examination showed a
minor retroplacental haemorrhage which would not have been sufficient to
cause fetal demise.  Cause of death mitochondrial respiratory chain defect.
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9. Age 29. Para 1.  One previous spontaneous vaginal delivery at term.  No
past medical history of note.  Transferred from another hospital for
suspected fetal anomaly at 24 weeks.  Short long bones, small thorax,
suspected skeletal dysplasia.  Fetal Medicine follow-up.  Polyhydramnios
identified at 29 weeks.  Multiple rib fractures and long bone fractures
noted.  Amnio reduction at 33 weeks, uncomplicated.  Induction of labour at
36 weeks.  Female infant, 3.38 kg.  Neonatal death at 1 hour.  Post-mortem –
lethal skeletal dysplasia.
10. Age 31. Para 2+1.  Previous vaginal delivery of twins at 38 weeks.  BMI 24.
Past history of LLETZ for CIN, laser eye surgery, varicose veins, depression.
Booked at 13 weeks.  Anatomy scan at 21 weeks showed evidence of
ventriculomegaly bilaterally.  Absent nasal bone, possibility of septal
cardiac defect.  Fetal Medicine follow-up.  IUGR, bilateral choroid plexus
cysts, short femur and humerus.  Amniocentesis performed.  Confirmed
Trisomy 18.  Followed up in Fetal Medicine department.  Induction of labour
at 39 weeks.  Spontaneous vaginal delivery, male infant 2.37 kg.  Apgars 4 at
1, 7 at 5, 7 at 10.  Comfort care provided.  NND day 2.  Placental histology
showed placental hyoplasia otherwise unremarkable.  No PM.  Cause of
death Trisomy 18.
11. Age 34. Para 1+1.  BMI 27.7.  Previous history Ventouse forceps delivery with
third degree tear.  Past medical history of PCO.  Booked at 10 weeks.
Anatomy scan at 20 weeks revealed short long bones, fractured humerus,
IUGR.  Referred to fetal medicine.  Confirmed likely skeletal dysplasia.  Fetal
echo normal.  Spontaneous onset of labour at 35 weeks.  Assisted breech
delivery, female, 2.1 kg, Apgars 2 at 1 and 1 at 5.  RIP day 1. Genetics consistent
with oestogenesis imperfecta.  Placental histology showed placental
omegaly, hypercoilded umbilical cord. Cause of death lethal skeletal
dysplasia.
12. Age 24. Para 1.  Previous vaginal delivery at term.  BMI 25.9.  Past history of
hypothyroidism and depression.  Booked at 13 weeks.  Anatomy scan
showed anhydramnios. Follow-up in Fetal Medicine Clinic confirmed
anhydramnios, IUGR.  History suggestive of PPROM.  Poor prognosis
outlined.  Spontaneous labour at 32 weeks.  SVD male infant.  Live born 1.34
kg.  Apars 5 at 1, 5 at 5.  Comfort care provided.  Baby RIP shortly after
delivery. PM declined.  Placental histology revealed evidence of early
ascending infection.  Negative for fetal inflammatory response.  PPROM
although suspected was never confirmed.  Cause of death suspected renal
agenesis. Congenital malformation not absolutely confirmed.
13. Age 23. Para 0+1.  BMI 20.18.  Smoker 10 per day.  Booked at 24 weeks.
Anatomy screening scan revealed a right sided cystic mass restricting cardiac
views.  Followed up in the Fetal Medicine Clinic.  Diagnosed congenital
diaphragmatic hernia.  Amniocentesis performed.  Induction of labour at 39
weeks.  Spontaneous vaginal delivery, female infant, 3.05 kg.  Apgars 6 at 1
and 7 at 5.  Transferred to Crumlin.  Developed invasive group B strep
infection in PICU in Crumlin.  PM performed.  Karyotype 46XX normal.
Placental examination showed evidence of early ascending infection.
.  
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MATERNAL MORTALITY 2
M a t e r n a l  M o r t a l i t y  
T h e  M a s t e r
There are two indirect maternal deaths reported on below. There were no direct
maternal mortalities.
1.  Age 27. para 0+1, previous early miscarriage, later booker at 30 weeks.  BMI
26.9.  Large for dates at booking.  GTT one abnormal value at 2 hours,
ultrasound scan – polyhydramnios, small for dates fetus, suspected multi-
cystic kidneys.  Spontaneous rupture of membranes at 35 weeks.  Non-
reassuring CTG.  Emergency caesarean section.  Female infant, 2.19 kg.  Good
Apgar scores.  Transferred to NICU.  Baby RIP – multi-cystic kidneys.  Mother
discharged day 4 post caesarean section.  Re-attended day 16 feel unwell
with headache, maternal collapse, transferred to the Mater, RIP.  Coroners
case.  Cause of death a large astrocytoma.  
2. Age 30. Para 1.  The patient died by suicide just over six months following an
intrauterine death at term.  
The second is included in the maternal death section for the record.  The case does
not strictly fit the criteria of Maternal Death according to the WHO definition
maternal death is with 42 days of delivery, however the Confidential Maternal
Death Enquiry in Ireland has requested that deaths be recorded up to one year after
delivery.
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WHO Definitions:  
Direct obstetric deaths are those resulting from obstetric complications of the
pregnant state {pregnancy, labour and the puerperium} from interventions,
omissions, incorrect treatment or from a chain of events resulting from the
above.  
Indirect obstetric deaths are those resulting from previous existing disease or
disease that developed during pregnancy and which are not due to direct
obstetric causes, but are aggravated by the Physiologic effects of pregnancy.  
Maternal Mortality   
Year Total Total Number of Mothers Attending      
2005 0 7518
2006 0 8036
2007 0 9290
2008 1 9655
2009 2 9709
2010 3 9594
2011 3 10547
2012 2 10397
2013 3 10314
2014 2 10814
Total 16 95874
Maternal Mortality Rate       16.7/100,000
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The Rotunda continued to prospectively monitor severe maternal morbidity
during 2014.
In total there are 57 patients reported on with 70 events. The incidence of severe
morbidity for 2014 was 0.6%.  The incidence of severe maternal morbidity events
was 0.79%.
The number of major morbidity events in the hospital has increased since 2013,
reflecting the complexity of the cases attending the hospital.
Similar to 2013 there were no episodes of eclamptic seizure. Our number of cases
with major obstetric haemorrhage remained the same at 25. There were one
caesarean hysterectomy in 2014.
Our number of cases requiring transfer for intensive care or coronary care
management or delivery increased to 16 in 2014 from 10 in 2013. 
In line with previous years we report “near-miss” cases for prompt identification
of learning points for all providing maternity care in Ireland.
Major Maternal Morbidity Number Number
of cases 2013 of cases 2014
Major Obstetric Haemorrhage 25 25
Uterine rupture 1 0
Peripartum hysterectomy 3 1
Eclampsia 0 0
Renal or liver dysfunction 3 14
Acute respiratory dysfunction 3 4
Pulmonary embolism 4 1
Cardiac arrest 1 0
Coma 1 0
Cerebrovascular accident 0 0
Status epilepticus 1 1
Septicaemic shock 0 4
Anaesthetic issue 1 2
Transferred for ICU/CCU/ 
/Delivery in another unit 10 16
Maternal deaths 3 2*
*both indirect
S E V E R E  M A T E R N A L  M O R B I D I T Y
D r .  S h a r o n  C o o l e y
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Major  Obstetr ic  Haemorrhage  (25 )
1.  28 year old, para 0+ 1, booked at 15 week gestation. Combined antenatal care,
diet controlled gestational diabetic. Spontaneous vaginal delivery at term of
a live born male infant weighing 3.33 kg, Apgars 9 at 1, 10 at 5. Placenta
retained. Primary post partum haemorrhage, transfer to theatre for
examination under anaesthetic. Manual removal of placenta followed by an
atonic uterus. Third degree tear noted. In total 4 litres of blood loss requiring
4 units of packed red cells, 2 units of FFP and 2 Fibrinogen. Well postnatally
and discharged home on day 3, 6 weeks later hospital postnatal check up
with consultant input.
2. 35 year, para 1, previous term delivery in another hospital, of an appropriate
grown infant.  Medical history of hyperthyroidism, booked for hospital led
multidisciplinary antenatal care. Medications at booking: Neomercazole 20
mg 3 times a day and Propanolol 40mg daily.  Dichorionic diamniotic
pregnancy. Tachycardia in early pregnancy with associated tremor
requiring medication adjustment, hyperemesis gravidarum. Antenatal
anaemia, with poor response to oral iron. Haemoglobin 7 prior to delivery.
Discordant growth noted at 35 weeks gestation with a 40% growth
discrepancy and absent end diastolic flow in twin 2.  Nonreassuring CTG.
Emergency Caesarean section of a live born female infant weighing 2.37 kg
and a liveborn female infant weighing 1.73 kg.  Transfused 4 units packed red
cells and 1 unit octoplas.  High Dependency Unit admission for observation
in the immediate postnatal period.  Discharged home well on Day 5.
3. 39 year old, primip.  No significant medical history, booked at 13 weeks
gestation with certain dates. Combined antenatal care; spontaneous onset
of labour at 41 weeks gestation, forceps delivery with retained placenta and
vaginal lacerations, 3.5 litre blood loss, 3 units of blood transfused. High
dependency care for 48 hours postnatally. Discharged home well day 3.
4. 27 year old, para 1 – previous Caesarean section for fetal distress. No
significant medical history, non-smoker, booked at 13 weeks gestation,
estimated date of delivery confirmed and consistent with dates. Requesting
VBAC, combined antenatal care, spontaneous onset of labour at 40 weeks
gestation. Emergency Caesarean section for fetal distress at 5 cm dilatation.
Live born female infant delivered weighing 3.78 kg, Apgars 9 at 1 and 10 at 5.
1 litre blood loss inter-operatively, subsequent hypotension and tachycardia
within the 24 hours post operatively, necessitating a return to theatre.
Bleeding from the right ovarian pedicle identified necessitating right
oophorectomy.  Abdomen packed and patient transferred to the Mater
Hospital. Transferred back for removal of the packs 48 hours later.  In total
8.5 litre blood loss. Discharged home day 9 days post operatively. 18 units of
blood transfused with 3 grams of Fibrinogen, 3 units of platelets and 8 units
of octoplas. Subsequent postnatal review 6 weeks following delivery. 
5. 33 year old, para 4.  Booked at 12 weeks gestation, non-Irish, limited
English.  Dates confirmed by ultrasound. 4 previous term deliveries, non-
smoker, no significant medical history, Group B Streptococcus isolated 
antenatally. Combined antenatal care, went into spontaneous labour at 40
41
weeks gestation.  Live born delivery of a female infant weighing 4.48 kg -
Apgars 9 at 1 and 10 at 5.  Massive post partum haemorrhage, 3.5 litre loss,
retained placental tissue removed from the uterine cavity, Bakri balloon
inserted for haemostasis. High Dependency care for 48 hours post delivery.
Discharged home well day 4. Transfused in total 3 units of packed red cells.
6. 33 year old, primip.   Booked at 11 weeks gestation, estimated date of
delivery confirmed by ultrasound, singleton pregnancy, no significant
medical history, combined consultant led care.  Presented in spontaneous
labour at 40 weeks gestation. Non reassuring CTG at 4 cm, necessitating an
emergency Caesarean section, placental abruption identified, live born
male infant delivered weighing 3.35 kg, Apgars 8 at 1 and 9 at 5.
Intraoperative blood loss 3 litres, necessitating transfusion of 1 unit of
emergency O negative blood, cross matched with 5 units, 1 unit transfused
and 1 pool of platelets.  High dependency care for 48 hours post operatively.
Discharged home well on day 5. 
7. 34 year old, primip.   Booked at 12 weeks gestation, past medical history of
hypertension, normotensive at booking. Shared antenatal care.
Hypertension noted at 37 weeks gestation referred to the Day Care Unit,
induction of labour at 40 weeks gestation for hypertension. Emergency
Caesarean section at full dilatation for brow presentation, subsequent
return to theatre with an atonic uterus. Examination under anaesthetic
and a Bakri balloon insertion. Total blood loss 2.9 litres, transfused 2 units
of cross matched blood. HDU care, 48 hours post operatively.  Discharged
home well day 5 post Caesarean section.
8. 40 year old, primip.  History of detached retina and Bipolar Disorder. Booked
with spontaneous pregnancy at 11 weeks gestation and dichorionic
diamniotic twins confirmed. Non-smoker, normal BMI. Hospital based care.
Pre-eclampsia developed at 34 weeks gestation with selective intrauterine
growth restriction of twin 2. Elective Caesarean section at 36 weeks gestation
due to increased resistance in the blood flow of twin 2 and deterioration in
the maternal condition. Live born male infant delivered weighing 2.97 kg,
Apgars 9 and 10 and live born female infant weighing 1.98 kg, Apgars 9 and
10.  Massive post partum haemorrhage, necessitating a return to theatre and
insertion of Bakri balloon. 4 litres blood loss, 4 units of cross matched blood
transfused, 2 grams of Fibrinogen, 1 pool of platelets and 4 units of octoplas.
HDU care for 4 days post operatively. Discharged home well day 6 post
operatively. On oral antihypertensive with arrangements made for a 6 week
post natal check up. DNA for 6 week check up.
9. 30 year old, primip.  Booked for Consultant led care at 12 weeks gestation,
certain dates, spontaneous labour at 40 weeks gestation, assisted vaginal
delivery of a live born female infant weighing 3.59 kg, Apgars 8 at 1 and 10 at
5. Subsequent post partum haemorrhage 3.5 litres. Transferred to theatre for
examination under anaesthetic.  Cotyledons removed. 4 units of blood cross-
matched and transfused, 2 units of octoplas transfused, transferred to HDU
for 24 hours post natally. Transferred to the ward day 2 postnatally.
Discharged home day 4.   At 6 week follow up full recovery.
10. 38 year old, para 1 – previous forceps delivery and PPH. No significant
medical history, booked at 10 weeks gestation, ultrasound confirmed
estimated date of delivery, combined antenatal care. Placenta noted to be
low lying at the anatomy scan with arrangements for rescan at 34 weeks
gestation. Placenta persistently posterior and low lying at 34 weeks
gestation, admitted at 36 weeks gestation, sectioned at 38 weeks gestation.
Live born female infant weighing 3.75 kg, 3.5 litre inter-operative loss. Bakri
balloon inserted. 2 units of blood transfused and 2 grams of Fibrinogen,
transferred to HDU unit for post operative care. Uneventful post natal
period.  Bakri balloon removed day 1 postnatally. Discharged home day 4
post section.
11. 33 year old, para 5 – 5 previous Caesarean sections, 3 previous post partum
haemorrhages.  Booked at 13 weeks gestation.  Estimated date of delivery
assigned based on ultrasound.  Previous echo for a heart murmur reported
as normal.  Booked for caesarean section at 39 weeks gestation and a
bilateral tubal ligation.  Patient declined tubal ligation on admission.  Blood
cross matched on admission in view of previous postpartum haemorrhage.
Caesarean section undertaken by consultant in theatre.  Limited access to
the uterus with dense adhesions between the uterus and abdominal wall.
J shaped incision undertaken and a difficult breech extraction.  Live born
male infant weighing 3.48 kilograms, Apgars 8 at 1 and 10 at 3.  Three litre
blood loss, necessitating 3 units of packed red cells, two grams of fibrinogen
and two units of octoplas.  High dependency admission.  Bakri balloon
inserted.  Redivac drain.  Transferred to the Mater for imaging day 3
postnatally due to increase in abdominal distension.  CT showed intra
abdominal fluid with normal bladder and urinary tract.  Discharged home
well day 5 post section following discussion of contraception.  Reviewed six
weeks postnatally.  
12. Emergency admission of a 37 year old lady, para 3.   Two previous term
deliveries and one emergency caesarean section.  Medical History of HIV.
Attended at 7 weeks gestation with abdominal pain.  Ultrasound showed
free fluid in the pelvis and a right sided ectopic pregnancy.  Laparoscopic
salpingectomy undertaken.  Extensive dense adhesions within pelvis
requiring dissection to access the ectopic at the time of surgery.  Total blood
loss 2.5 litres.  Four units of cross matched blood transfused, one gram of
fibrinogen and two units of octoplas.  High dependency care for 24 hours
post operatively.  Discharged home well on day 3 post laparoscopic right
salpingectomy.  
13. 30 year old, para 0+1, booked at 14 weeks gestation.  Combined antenatal
care.  No significant medical history.  Non-smoker.  Presented in
spontaneous labour at 40 weeks gestation.  Failure to advance in labour and
emergency caesarean section undertaken.  Atonic uterus at the time of
surgery with 2.5 litre blood loss.  Uterotonics administered.  Two units of
blood transfused and two grams of fibrinogen.  Subsequent secondary
postpartum haemorrhage necessitating return to theatre from the recovery
room and a laparotomy.  Persistent atony with clots removed from the
uterus.  B-Lynch suture and Bakri balloon inserted and transferred to the
High Dependency Unit.  Discharged home well day 5 postnatally.  42
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14. 33 year old, primip.  BMI 31.  Non-smoker.  Family history of haemophilia.
Booked at 13 weeks gestation.  Dichorionic diamniotic twin pregnancy.
Hospital based care with regular ultrasound.  Antenatal review with
haematologist.  Plan for delivery recorded.  Appropriately grown infants.
Spontaneous rupture of membranes at 35 weeks gestation.  Fetal tachycardia
and assumed ascending chorioamnionitis necessitating emergency
caesarean section.  Two live born female infants were delivered weighing 3.14
and 2.79 kilograms.  Both infants transferred to NICU for septic work up.
Haematology input obtained at the offset of surgery, with urgent factor IX
levels requested in view of the family history of haemophilia.  Four litre intra-
operative loss in total with a subsequent return to theatre for re-laparotomy
B-Lynch suture and Bakri balloon in the immediate post-operative period due
to ongoing postpartum haemorrhage.  Transferred to HDU post-operatively.
Discharged home well day 7 post caesarean section.  
15. 39 year old, para 0+3, booked at 11 weeks gestation.  Ultrasound confirmed
gestation.  Consultant led antenatal care.  Medical history of anaemia.
Haemoglobin normal at booking.  Non-national.  History of back surgery.
Non-smoker.  Labour induced at 40 weeks gestation in view of maternal age.
Spontaneous vaginal delivery of a liveborn female infant, weighing 3.54
kilograms.  Post-partum haemorrhage necessitating transfer to the operating
theatre for examination under anaesthetic.  Placental cotyledons removed
from the uterine cavity. In total 2.5 litre postpartum haemorrhage. Transfused
5 units of packed red cells.  Four units of octoplas and two grams of
fibrinogen.  High dependency care postnatally.  Transferred to the ward day 2
post delivery.  Discharged home day 4 post delivery. 
16. 29 year old, para 2+2.  Two previous second trimester losses and a previous
caesarean section at 24 weeks for severe early onset pre-eclampsia,
subsequent neonatal death; and another caesarean section at 31 weeks for
severe early onset pre-eclampsia. Non-national, non smoker.  History of
essential hypertension.  Booked at 22 weeks gestation.  BMI 33.  Hospital based
care with weekly review.  Admitted with hypertension two weeks following
booking at 24+1 weeks gestation.  Intrauterine fetal demise at 24 weeks.
Progressive HELLP syndrome.  Cause of intrauterine demise placental
abruption.  Caesarean section undertaken following correction of
coagulopathy in the maternal interest, 850 ml blood loss.  Two units of blood
transfused, 7 grams of fibrinogen and 2 pools of platelets.  High dependency
care post operatively.  Patient remained anuric 48 hours post operatively,
necessitating transfer to the Mater Misericordiae Hospital for dialysis.
17. 33 year old, para 1.  One previous caesarean section at term.  Rheumatoid
arthritis.  BMI 47.  Booked at 12 weeks gestation with dichorionic diamniotic
twins.  Hospital led care.  Admitted at 36 weeks gestation with a non-
substantial antepartum haemorrhage and decision for caesarean section.
Five litres intra-operative blood loss secondary to an atonic uterus post
caesarean section.  In total 2 units of uncrossed blood transfused, 7 units of
cross matched blood, 4 units of fresh frozen plasma and 2 grams of octoplas.
High dependence care post operatively for 6 days.  Discharged home day 7,
with arrangements for postnatal follow-up.
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18. 34 year old, para 2.  Two previous term deliveries.  First delivery complicated
by pre-eclampsia at term, necessitating induction of labour.  Second
pregnancy uncomplicated.  Booked at 15 weeks gestation for midwifery led
care.  Spontaneous onset of labour at 39 weeks gestation after an
uncomplicated pregnancy.  Keillands forceps delivery in theatre for failure
to advance in the second stage. 4.01 kilogram, live born, female infant
delivered.  Apgars 9 at 1 and 10 at 5.  Maternal collapse three hours following
delivery with a massive postpartum haemorrhage, 2.5 litres blood loss.
Transferred to theatre for examination under anaesthetic.  Lateral wall
vaginal tear sutured.  Bakri balloon inserted.  Postnatal care in the High
Dependency unit.  Discharged home day 4 post delivery.  In total three units
of cross matched blood transfused and two units of octoplas.
19. 20 year old, primip. No medical history.  Booked for midwifery led care at 18
weeks gestation. Non-smoker.  BMI 24.   Uncomplicated obstetric antenatal
history.  Spontaneous labour at 39 weeks gestation and spontaneous
vaginal delivery of a male infant weighting 3.2 kilograms.  Apgars 9 at 1 and
10 at 5.  Vaginal wall laceration with a 2.9 litre blood loss.  Transferred to
theatre for suturing.  Four units of blood transfused.  Transferred to high
dependency unit postnatally.  Discharged home well day 2 post delivery.
20. 26 year old, primip.  IVF pregnancy.  Booked at 14 weeks gestation.
Singleton pregnancy.  Uncomplicated antenatal care.  Non-smoker.  Pre-
eclampsia at 40 weeks gestation necessitating magnesium sulphate and
labetalol infusion, induction of labour.  Forceps delivery of a male infant
weighing 3.97 kilograms.  Apgars 9 at 1 and 10 at 5.  Subsequent secondary
postpartum haemorrhage, 2.5 litre blood loss, necessitating examination
under anaesthetic and uterine balloon insertion.  Three units of cross
matched blood transfused.  Strict fluid input and output.  Balloon removed
day 1 postnatally.  Discharged home well day 4 postnatally on labetalol 200
mg twice daily and arrangements for postnatal follow-up. 
21. 23 year old, para 1, previous term caesarean section for failure to advance.
Booked at 12 weeks gestation.  Estimated date of delivery confirmed.
Medical history of anaemia and laryngeal malformation.  Combined
antenatal care.  Non-smoker.  Presented to the Emergency Room at 38
weeks gestation with bleeding.  Revealed abruption diagnosed, Category 1
emergency caesarean section under general anaesthetic.  Live born male
infant delivered weighing 3.11 kilograms.  Apgars 1 at 1 and 5 at 5.  Stabilised
and transferred to the Neonatal Intensive Care Unit.  Estimated blood loss,
2000 mls.  Two units of cross matched blood transfused and 5 grams of
fibrinogen.  HDU admission.  Discharged from HDU day 2 postnatally.
Discharged home well day 5 postnatally with arrangements for postnatal
follow-up.    Suspected cause of abruption pre-eclampsia.  Labetalol
commenced in the postnatal period.  Did not attend for postnatal follow up.
22. 30 year old, para 2. Two previous elective caesarean sections for
oligohydramnios at term.   Hepatitis B.  Booked at 20 weeks gestation.  Twin
pregnancy. Hospital based antenatal care.  Anomalies identified in twin 1 at
23 weeks gestation suggestive of aneuploidy.  Non smoker, non-national.
Elective caesarean section at 35 weeks gestation due to progressive
polyhydramnios 
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for twin 1 and impending labour.  Twin 1 1.59 kilograms, Apgars 3 at 1 and 6 at
5.  Twin II 2.59 kilograms, Apgars 8 at 1 and 10 at 5.  Subsequent atonic uterus.
Twin I neonatal death at day 3 of age, suspected Trisomy 18.  Primary
postpartum haemorrhage necessitating return to theatre and examination
under anaesthetic. Bakri balloon inserted.  Balloon removed day 2 post-
operatively.  Endometritis day 7 postoperative necessitating IV antibiotics.
Discharged home day 9 post-operatively well with arrangements for follow-
up.  In total 5 units of bloods transfused, two grams of fibrinogen and four
units of octoplas.
23. 33 year old, primip.  Booked for consultant led care at 12 weeks gestation,
medical history of polycystic ovaries, white coat hypertension and renal
calculi.   Uncomplicated pregnancy.  Presented with spontaneous rupture of
membranes at 39 weeks gestation.  Augmentation of labour in view of a
background history of Group B strep.  Assisted vaginal delivery of live born
male infant weighing 3.9 kilograms.  Primary postpartum haemorrhage,
secondary to uterine atony.  Total blood loss six litres.  Six units of cross
matched blood transfused, 6 grams fibrinogen, 1 pool of platelets and six units
of octoplas.  Coagulopathy at the time of haemorrhage.  Acute renal failure in
the immediate postnatal period necessitating stabilisation and transfer to
Beaumont Hospital for dialysis. 
24. 26 year old, primip.  Booked at 20 weeks gestation.  Non-smoker.  Normal body
mass index.  Planned for midwifery led care.  Elevated blood pressure and
cholestasis at 40 weeks gestation.  Induction of labour.  Spontaneous vaginal
delivery of a live born male infant weighing 4.02 kilograms.  Apgars 9 at 1 and
10 at 5.  Primary postpartum haemorrhage.  Total estimated blood loss 5.8
litres.  Transferred to theatre.  Examination under anaesthetic Bakri balloon
inserted. Subsequent midline laparotomy. Unicornuate was identified with
the bleeding point on the posterior wall over sewn, modified B-Lynch suture
inserted.  Total 12 units of cross matched blood transfused, 4 grams of
fibrinogen, two units of platelets and four units of octoplas.  High
dependency care for three days postnatally.  Discharged home well day 7
postnatally.  Subsequent six week follow-up with consultant review.
25. 30 year old, primip.  Evacuation of the retained products of conception was
undertaken at 8 weeks gestation for a molar pregnancy.  Discharged home
well.  Subsequent emergency admission, transferred from Connolly Hospital
four weeks following surgery with heavy vaginal bleeding.  Emergency
laparotomy undertaken and uterine perforation identified and repaired.
Total blood loss three litres.  Four units of packed red cells and four units of
fresh frozen plasma transfused.  High dependency care post surgery.
Discharged home well day 5 post-operatively.
Transferred  for  ICU/CCU/  Del ivery  in  another  unit  ( 16 )
1. 38 year old, para 0.  Known history of severe endometriosis.  Assisted
fertility.  Developed gram negative septicaemia one week following embryo
transfer.  Drainage of a pelvic collection and systemic fungal infection
identified.  Subsequent miscarriage at 7 weeks gestation.
46
2. 30 year old, primip. Booked at 11 weeks gestation. Past history of depression
and urinary incontinence. Combined antenatal care. Presented at 38 weeks
gestation with pre-eclampsia. Admitted for stabilisation. Ultrasound
showed oligohydramnios and intrauterine growth restriction. Delivery by
caesarean section in the maternal and fetal interest. Liveborn female infant
weighing 2.25kgs. Apgars 9 at 1, 10 at 5. Maternal respiratory dysfunction in
the recovery room, with associated maternal collapse. Suspected high spinal
anaesthetic, possible anaphylaxis. Transferred to the Mater Hospital for
intubation. Transferred back 24 hours postnatally, with arrangements for
immunology follow up and cardiology follow up. Left ventricular
dysfunction noted on echocardiogram. Suspected drug reaction
precipitating maternal collapse. Normotensive in the postnatal period.
Discharged home day 5 post caesarean section on oral antihypertensive.
Arrangements for immunology, obstetric and cardiology follow up. 
3. 30 year old.   Booked in the National Maternity Hospital. Transferred from
the National Maternity Hospital to the Mater Hospital with Acute Cauda
Equina Syndrome at 36 weeks gestation for emergency caesarean section.
Transferred for postnatal care to the Rotunda Hospital. Liveborn female
infant weighing 2.74kgs delivered. Maternal condition stabilised in the 24
hours post-delivery and discharged home well day 3 postnatally.
4. 36 year old, para 2. One previous emergency and one previous elective
caesarean section. Smoker. Booked at 14 weeks gestation. Shared antenatal
care. Seizures secondary to benzodiazepine usage at 20 weeks gestation.
Brought by ambulance to the hospital for assessment. Recurrent seizures
on presentation to the hospital. History of substance abuse disclosed by
the carer. Stabilised and transferred to the Mater Hospital for further
management. Good recovery. Elective caesarean section with bilateral
tubal ligation undertaken at term. Liveborn male infant delivered
weighing 3.54kgs, Apgars 9 at 1, 10 at 5. Discharged home well postnatally.
5. 39 year old, para 0+1.  Booked at 15 weeks gestation for combined antenatal
care.  No significant medical history.  Non-smoker.  Attended for induction
of labour at 41 weeks gestation.  Maternal tachycardia noted.  Induction
deferred and maternal echocardiography undertaken.  Peripartum
cardiomyopathy identified.  Elective caesarean section undertaken.
Maternal care in the high dependency unit.  Subsequent deterioration in
maternal cardiac function necessitating stabilisation and transfer to the
Coronary Care Unit in the Mater Hospital. 
6. 35 year old, para 1.  Unbooked.  Presented at the hospital at 36 weeks
gestation with general malaise and fever.  Emergency caesarean section
undertaken and a live born male infant weighing 3.2 kilograms delivered.
Maternal malaria diagnosed.  Intensive care and ventilatory support
required.  Mother stabilised and transferred to the Mater Hospital for
intensive care. 
7. 23 year old. Unbooked.  Attended the emergency room at 22 weeks
gestation with urosepsis and systemic shock.  Admitted to HDU for further
management and joint microbiology anaesthetic and obstetric care.
Suspected pyelonephritis with associated renal failure.  Transferred to the 
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Mater Hospital due to deterioration in maternal condition day one following
admission.  Transferred back from the Mater Hospital day 4 following initial
review with a diagnosis of urosepsis, septic shock, acute renal injury and
acute pulmonary oedema.  E coli cultured from the urine, requiring 10 days
of antibiotics.  Discharged home ten days after initial review with
arrangements for follow-up with her booking hospital.
8. 26 year old, primip. Non-smoker. History of anxiety and depression. Booked
at 15 weeks gestation. Mental health referral. Shared antenatal care.
Emergency room attendance at 31 weeks gestation with hypertension and
decreased fetal movements. Hospital admission. Emergency caesarean
section for HELLP syndrome at 32 weeks gestation, and labile hypertension.
Liveborn female infant delivered at 32 weeks gestation, weighing 1.22kgs.
Apgars 8 at 1, 9 at 5. High dependency care. Deterioration in maternal hepatic
function over the following 48 hours, necessitating transfer to intensive care
in the Mater Hospital for plasmapheresis. Transferred back to the Rotunda
day 7 postnatally. Discharged home well day 9 postnatally with
arrangements for obstetric and haematology follow up.
9. 31 year old, para 0.  Care transferred from another hospital at 30 weeks
gestation.  Primary infertility.  Medical history of complete heart block.
Attending cardiology in the Mater Hospital.  Hospital based antenatal care.
Intermittent heart block during pregnancy.  Persistent heart block developed
at term.  Spontaneous onset of labour at 38 weeks gestation.  Assisted vaginal
delivery of a live born female infant weighing 3.21 kilograms.  Apgars 9 at 1
and 10 at 5.  Complete heart block worsening postnatally.  Transferred to the
Mater Misericordiae Hospital for Cardiology Intensive Care.  Transferred back
to the Rotunda day 1 postnatally.  Discharged home well day 3 post delivery.
10. 29 year old, para 2. Two previous caesarean sections for growth restricted
infants. Smoker. Booked at 13 weeks gestation. Combined antenatal care.
Presented at 37 weeks in early labour. Emergency caesarean section
undertaken and a liveborn male infant was delivered, weighing 2.6kgs.
Apgars 9 at 1, 10 at 5. Central chest pain in the immediate hours
postoperatively. High dependency care. Ileus on day 2/day 3 postoperatively.
Transferred to the Mater Hospital for CT. CT abdomen and pelvis negative.
CTPA showed multiple pulmonary emboli in the base of the lungs. Some free
air under the diaphragm. Suspicion of visceral damage. Laparotomy
undertaken to exclude the same. No damage identified. IVC filter inserted in
the Mater. Combined anaesthetic, radiology and haematology care.
Discharged day 18 following surgery. Arrangements for postnatal follow up
and haematology follow up.
11. See Maternal Death section of report.
12. See No. 4 Major Obstetric Haemorrhage.
13. See No. 16 Major Obstetric Haemorrhage.
14. See No. 23 Major Obstetric Haemorrhage.
15. 31 year old, para 0.  Known history of an AVSD and a tracheo oesophageal
fistula which was repaired.  Vaters syndrome. Hospital based care.  Booked
at 13 weeks gestation.  Planned for elective delivery in the Mater Hospital
with cardiac input.  Elective caesarean section at 35 weeks gestation.  Live
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born male infant delivered weighing 2.12 kilograms.  Apgars 9 at 1 and 10 at 5.
Coronary care in the Mater Hospital for the immediate post-operative period.
Transferred to the Rotunda Hospital day 2 post delivery for high dependency
care.  Postnatal period complicated by pneumonia.  Subsequent recovery and
discharge from the hospital on day 12 following delivery.  
16. 31 year old, para 2.  Two previous caesarean sections.  One preterm with
emergency admission with maternal bleeding and fetal demise and one
term delivery.  No other significant medical history.  Booked at 14 weeks
gestation.  Central low lying placenta identified at 21 weeks gestation.
Suspected placenta accreta.  MRI requested and confirmed that suspicion
of accreta.  Admitted from 31 weeks gestation.  Elective caesarean section in
the Mater Hospital at 36 weeks gestation.  Live born female infant delivered
weighing 2.76 kilograms.  Intra-operative blood loss 1.2 litres.  Placenta
accreta identified.  Placenta left insitu.  Transferred back to the Rotunda
Hospital day 1 postnatally for obstetric follow-up.  Discharged home well
one week post caesarean with arrangements for ongoing follow-up to
ensure dissolution of placental tissue.
Acute  Renal  or  L iver  Dysfunct ion  ( 14 )
1. See No. 23 Major Obs Haem. 
2. 35 year old, para 1. Known Gitelmans syndrome.  Previous elective
caesarean section at term for breech presentation.  Booked at 12 weeks
gestation for hospital led care.  Obstetric and renal input.  Elective
caesarean section at 40 weeks gestation of a live born male infant
weighing 3.29 kilograms.  Maternal care in the high dependency unit for 48
hours postnatally.  No postnatal complications and discharged home well
on day 4 with arrangements for renal and obstetric follow-up.
3. 30 year old, para 2+1. Two previous term deliveries. History of
hypertension. Booked on antihypertensives at 17 weeks gestation.
Hypertensive at booking. Referred to the medical clinic, diagnosed with
essential hypertension.  Anti-hypertensive medication adjusted.  Presented
to the emergency room at 30 weeks gestation with upper abdominal pain,
hypertension and proteinuria identified.  Admitted for stabilisation with
suspected HELLP syndrome. Maternal condition stabilised on IV
antihypertensives and induction of labour commenced in the maternal
interest.  Subsequent emergency caesarean section for a non-reassuring
CTG.  Live born female infant delivered weighing 1.13 kilograms, Apgars 9 at
1 and 10 at 5.  High dependency maternal care postnatally.   Labile
hypertension postnatally.  Discharged home well day 7 post caesarean
section.  Arrangements for day care and obstetric follow-up.
4. 20 year old, para 1. Previous assisted vaginal delivery of a liveborn male
infant weighing 2.9kgs in 2009. Past medical history of anxiety and
depression. Body mass index of 33. Booked at 13 weeks gestation for
combined antenatal care. Hypertension noted at 27 weeks. No associated
proteinuria. Pregnancy induced hypertension diagnosed. Regular day care
review. Presentation to the emergency room at 35 weeks with proteinuria
and blurred vision. Deterioration in the maternal condition at 36 weeks 
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gestation. Induction of labour. Liveborn male infant weighing 2.2kgs
delivered, Apgars 9 at 1, 10 at 5. Maternal high dependency care postnatally.
Blood pressure stabilised and discharged home well on day 4.
5. 34 year old, para 1.  Previous term uncomplicated normal delivery of a live
born male infant weighing 3.71 kilograms.  No significant medical history.
Booked for combined antenatal care.  Pre-eclampsia at 32 weeks and 4 days
gestation necessitating maternal admission, stabilisation and emergency
caesarean section of a live born male infant weighing 1.61 kilograms.  Infant
stabilised and transferred to the Neonatal Intensive Care Unit.  Mother
stabilised and transferred to the High Dependency Unit for two days
postnatally.  On labetalol and magnesium sulphate infusion.  Changed to
oral antihypertensives and discharged home well day 5 postnatally.
6. 37 year old, para 0+1.  No significant medical history.  Booked at 12 weeks
gestation for consultant led care.  Presented to the Emergency Room at 37
weeks gestation with hypertension and headache.  Diagnosis of HELLP
syndrome made, maternal condition stabilised and emergency caesarean
section undertaken.  Live born male infant delivered weighing 3.58
kilograms.  Apgars 9 at 1 and 10 at 5.  High dependency maternal care for 48
hours following delivery.  Gradual improvement in hepatic dysfunction.
Discharged home well on antihypertensives with arrangements for
obstetric follow-up.
7. 27 year old, para 1. Previous intrauterine fetal demise of a female infant at 27
weeks gestation. Booked at 13 weeks gestation, for consultant-led hospital-
based care. Emergency room admission at 32 weeks gestation. Presented
with vomiting for 12 hours and epigastric pain, with associated
hypertension and proteinuria. Retained in hospital. Commenced on
antihypertensives. Transferred to the high dependency unit at 34 weeks
gestation due to blood pressure refractory to oral medications. Emergency
caesarean section undertaken once the maternal condition was stabilised at
34 weeks gestation. Liveborn male infant delivered weighing 2.05kgs.
Apgars 9 at 1, 10 at 5. Continued high dependency care for 6 days postnatally.
Discharged home day 6 with arrangements for follow up.
8. 32 year old, primip. Booked at 11 weeks gestation for consultant-led care.
Uncomplicated pregnancy. Presented with abdominal pain and nausea at 37
weeks gestation. Atypical HELLP syndrome diagnosed. Emergency
caesarean section. Liveborn male infant weighing 3.04kgs delivered. Apgars
9 at 1, 10 at 5. High dependency maternal care for 48 hours postnatally. Blood
pressure and bloods stabilised in 72 hours postnatally. Discharged home
well day 5.
9. See No. 12. Transfer to Intensive Care.
10. See No. 21. Major Obstetric Haemorrhage.
11. 28 year old, para 1+1.  No significant medical history.  Previous term delivery.
Booked at 14 weeks gestation for combined antenatal care.  Noted to be
small for dates at 35 weeks gestation.  Ultrasound required.  Small baby with
reduced growth interval identified.  Admitted.  Normotensive on admission.
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Subsequent development of HELLP syndrome.  Emergency caesarean
section at 35 weeks gestation.  Delivered of a live born female infant
weighing 1.93 kilograms.  Apgars 9 at 1 and 10 at 5.  Admitted to the high
dependency unit post-operatively.  Discharged home well day 4.
12. See No. 16. Major Obstetric Haemorrhage.
13. 35 year old, para 0+2. Previous ectopic, previous miscarriage. Booked at 13
weeks gestation for consultant-led care. Uneventful pregnancy. Admitted at
38 weeks gestation from the day care unit with HELLP syndrome.
Emergency caesarean section. Liveborn male infant delivered weighing
3.1kgs, Apgars 9 at 1, 10 at 5. Admitted to HDU postnatally. Discharged to the
ward 48 hours following delivery. Normotensive on Labetalol. Bloods
stabilised and discharged home day 5 postnatally.
14. 39 year old, primip.  History of primary infertility.  White coat hypertension.
Booked at 12 weeks gestation for consultant led care.  Admitted at 27 weeks
gestation with severe pre-eclampsia and intrauterine growth restriction,
stabilised.  Emergency caesarean section at 27 weeks gestation.  Live born
female infant weighing 840 grams delivered.  Maternal care in the high
dependency unit following delivery.  Discharged home well on day 8.
Acute  Respiratory  Dysfunct ion  (4 )
1. 40 year old primip. IVF pregnancy. Dichorionic, diamniotic twins. Presented
in labour at 28 weeks gestation. Emergency caesarean section for a non-
reassuring CTG. Liveborn male infant weighing 1.25kgs, Apgars 6 at 1, 9 at 5,
and female infant weighing 1.16kgs, Apgars 7 at 1, 9 at 5. Stabilised and
transferred to the Neonatal Intensive Care Unit. Pulmonary oedema
postoperatively, necessitating admission of patient to the high dependency
unit. Gradual resolution of symptoms over the following 3 days, and good
response to diuretics. Discharged well day 4 postnatally.
2. 37 year old, primip. Booked for combined antenatal care at 13 weeks
gestation. Uneventful pregnancy. No significant medical history. Presented
with an antepartum haemorrhage at 37 weeks gestation, and non-
reassuring CTG. Suspected abruption. Emergency caesarean section.
Liveborn female infant delivered, weighing 3.15kgs. Apgars 9 at 1, 10 at 5.
Persistent maternal hypoxia post-section. Asymptomatic in relation to the
same. Subsequent diagnosis of low oxygen affinity haemoglobin, with
familial history of the same identified. Discharged home day 10 post-
operatively, with haematology follow up.
3. 21 year old, primip. Background history of asthma, current smoker, normal
body mass index. Booked at 18 weeks gestation for combined antenatal care.
Induced at 39 weeks gestation for intrauterine growth restriction.
Emergency caesarean section for fetal bradycardia in labour. Liveborn
female infant weighing 2.5kgs, Apgars 8 at 1, 9 at 5. Patient hypothermic
postoperatively, with dyspnoea. Suspected lower respiratory tract infection.
Admitted to the high dependency unit for 48 hours. Discharged home well
day 3 postoperatively.
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4. 38 year old, para 2.  Two previous term deliveries.  Medical history of
anaemia and asthma.  Booked in Cavan Hospital with monochorionic
diamniotic twins.  Referred to the Rotunda at 22 weeks gestation with
suspected twin to twin transfusion syndrome.  Transfer of care.  Bacterial
pneumonia at 22 weeks gestation complicating twin to twin transfusion
syndrome.  Fetoscopic laser ablation of placental vessels once maternal
condition was stabilised.  Fetal surveillance and follow-up over the duration
of the pregnancy with plan for elective caesarean section in the referring
hospital at 36 weeks gestation.
Pulmonary  Embol ism ( 1 )
1. No. 14.  Transfer to Intensive Care.
Sept ic  Shock  (4 )
1. 33 year old, para 1.  Previous emergency caesarean section for failure to
progress. Live born female infant.  No significant medical history.  Booked at
14 weeks gestation. Estimated date delivery confirmed.  Serology negative.
Combined antenatal care.  Planned for VBAC.  Presented in spontaneous
labour, vaginal delivery of a live born female infant weighing 3.4 kilograms
at 38 weeks gestation.  Apgars 6 at 1 and 8 at 10. Uncomplicated postnatal
care and discharged home well.  Reattended the hospital Day 5 postnatally
with abdominal distension.  Suspected endometritis.  Patient took self
discharge 48 hours later and subsequently re-presented 13 days postnatally
in septic shock.  Triple antibiotics.  Evacuation of retained tissue from the
uterine cavity.  High dependency care.  Appropriate antibiotics with
maternal response to same.  Eight days high dependency care.  Discharged
home on antibiotics for a further five days and arrangements for follow-up
in out-patients.  Failed to attend for follow-up.
2. 36 year old, para 0 +1.  Known hypothyroidism and insulin dependent
diabetes.  Booked at 5 weeks gestation for combined endocrine obstetric care.
History of recurrent urinary tract infections. Recurrent infections during the
course of the pregnancy.  Multiple admissions during the course of the
pregnancy.  Urosepsis at 30 weeks gestation necessitating three days in HDU.
Subsequent prophylactic antibiotics for the duration of the pregnancy.
Spontaneous rupture of membranes at 39 weeks gestation.  Non-reassuring
CTG, emergency caesarean section of a live born male infant weighing 2.62
kilograms.  Mum and baby discharged home well 5 days postnatally with
arrangements for urology, endocrine and obstetric follow-up.
3. See Transfer Out No. 6.
4. See Transfer Out No. 7
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Pulmonary  Embol ism ( 1 )
1. See Transferred Out No. 10.
Status  Epi lept icus  ( 1 )
1. 28 year old, para 0+2.  Known history of ectopic pregnancy.  Pregnancy
anxiety, obsessive compulsive disorder and epilepsy.  Booked at 12 weeks
gestation.  Hospital led care.  On anti-epileptic drugs at booking with
regular review.  Numerous attendances at the emergency room with PV
bleeding and abdominal pain.  Presented at 39 weeks gestation in early
labour.  Tonic clonic seizure on attendance.  Short and self limiting.   Labour
induced and a spontaneous vaginal delivery of a live born female infant
weighing 3.58 kilograms.  Apgars 9 at 1 and 9 at 5.  Uncomplicated postnatal
care and discharged home well on day 2 with arrangements for obstetric
and neurology follow-up.  
Per ipar tum Hysterectomy ( 1 )
1. 40 year old, para 0. Medical history of Turner Mosaicism, hypertension and
hypothyroidism.  IVF pregnancy. Booked at 11 weeks gestation.
Measurements consistent with dates.  Hospital led antenatal care.  Elevated
blood pressure at booking.  Cardiology review.  Subsequent admission at 33
weeks gestation with uncontrolled blood pressure. Blood pressure stabilised.
Elective caesarean at 36 weeks and 5 days in maternal interest.  Streak gonads
noted, morbidly adherent placenta, no evidence of separation.  Uterine
inversion on attempt to remove placenta.  Decision made for caesarean
hysterectomy.  Well postnatally.  Discharged home day 5. 
Maternal  Deaths  (2 )
See Maternal Deaths Section of report.
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C O M P L I C A T E D  P O S T N A T A L  C L I N I C
D r  M a e v e  E o g a n
This clinic offers postnatal review to women who sustain anal sphincter injury
at vaginal delivery. The Royal College of Obstetricians and Gynaecologists, the
HSE and the Institute of Obstetrics and Gynaecology recommend that such
patients are ideally seen in a dedicated Perineal Clinic in order to: 
•  Discuss delivery and associated events in further detail
•  Assess for symptoms of continence compromise
•  Arrange appropriate treatment / referral
•  Advise on future deliveries
Our clinic also reviews women who are pregnant again after a previous anal
sphincter injury in order to discuss options and risks in terms of mode of
delivery. It also provides care for women who have had other postnatal concerns,
including wound infection, perineal pain, dyspareunia and faecal incontinence. 
377 new patients were seen in the clinic in 2014 and the indications for their
attendances are tabulated below:
Indication for Attendance Number of Patients Seen
Postnatal Third Degree Tear 140
Postnatal Fourth Degree Tear 8
Postnatal Perineal Infection / Pain / Dyspareunia 64
Faecal Incontinence 7
Antenatal Assessment (next pregnancy) 134
Other (incl healing issues, history of FGM etc) 24
Total 377
The largest group of patients seen were those who attended after obstetric anal
sphincter injury. 164 patients sustained anal sphincter injury in the year 2014,
159 of whom had third degree tear, while 5 patients sustained fourth degree tear
(extending to involve anal mucosa). 
The modes of delivery of those who sustained anal sphincter injury are
tabulated below:
Mode of Delivery Third Degree Tear Fourth Degree Tear
SVD 82 3
Ventouse 27 1
Ventouse & Forceps 20 0
Forceps 28 1
Born before arrival 2 0
Total 159 5
Clinic review after anal sphincter injury takes place at 6 weeks postnatal. However,
all patients will have been offered physiotherapy follow-up prior to that and the
clinic works closely with Cinny Cusack and team at the Department of
Physiotherapy.  A history is taken, including continence score if there are symptom
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of faecal incontinence. Information regarding perineal healing and other
postnatal symptoms is also obtained. Appropriate treatment or referral is
initiated as required, and the clinic visit also provides an opportunity to answer
questions regarding the index delivery as well as to the potential impact on
future deliveries.
In the latter part of 2014, the Irish Family Planning Association (IFPA) in with
support from the HSE National Social Inclusion Unit and AkiDwA established
Ireland’s first Specialist Clinical Service for the Treatment of Female Genital
Mutilation (FGM). This clinic refers any women who require surgical treatment
to me for evaluation, and we anticipate that we will be seeing greater numbers
of women in this context over the coming years. 
45 patients who attended the clinic required treatment or ongoing referral (in
addition to physiotherapy, which is offered to all). The specific treatments
required are enumerated below:
Procedure/Referral Number of Patients
Removal of persistent suture material (OPD) 2
Treatment of granulation tissue (OPD) 17
Fenton’s procedure / perineal revision (day case) 13
Reversal of FGM 1
Perineal injection (day case) 6
Referral to colorectal service 6
Total 45
I am very grateful to my colleagues at the Department of Colorectal Surgery,
Mater Misericordiae University Hospital for both clinic and operative support
and also to all the team at the Physiotherapy Department for their holistic and
committed care of our combined patient cohort. 
Publ icat ion:
Ali A, Glennon K, Kirkham C, Yousif S, Eogan M. Delivery outcomes and events in
subsequent pregnancies after previous anal sphincter injury. European Journal
of Obstetrics, Gynaecology and Reproductive Biology 2014; 174:51-53  
Audit :
Doyle A, Horgan R, Eogan M. Re-Audit of compliance with current hospital
guidelines on the management of 3rd degree tears
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YEARS 2013 2014
Total number of cases 199 189
Booked 198 187
Unbooked 1 2
Incidence against delivery 2.3% 2.2%
Eclampsia % 0.50% 0.00%
Stillbirths 1 2
Neonatal Deaths 3 0
Multiple pregnancy 21 13
Par ity  of  Pat ients  at  Del ivery
0 125 126
1 49 38
2 14 10
3 6 10
4 plus 5 5
Total 199 189
Gestat ion  of  Pat ients  at  Del ivery
< 28 weeks 3 5
28 - 29 weeks 3 3
30 - 31 weeks 8 3
32 - 33 weeks 10 15
34 - 35 weeks 25 15
36 weeks plus 150 148
Total 199 189
H Y P E R T E N S I O N  W I T H  P R O T E I N U R I A
T h e  M a s t e r  
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In 2014, the induction rate was 30%. Of the 2631 inductions, the proportion of
nulliparous patients was 55% versus 45% multiparous patients; this is broadly in
keeping with previous years. The indications for induction were increased in the
prolonged rupture of membranes category, and also in the diabetes category.
Otherwise the indications for induction were similar to previous years. 
INDUCTIONS OVER 5 YEARS
Year Nullip       % Multip      %   Total        % 
2010 1326 57% 1008 43% 2334 27%
2011 1482 57% 1134 43% 2616 29%
2012 1414 57% 1064 43% 2478 28%
2013 1372 54% 1151 46% 2523 29%
2014 1436 55% 1195 45% 2631 30%
INDICATIONS FOR INDUCTIONS 2014
REASONS TOTAL %
Post Dates 858 32.6%
Prolonged SROM 499 19.0%
Reduced Fetal Movements 88 3.3%
Diabetes 137 5.2%
Hypertension 212 8.1%
Heart Disease 3 0.1%
IUD 30 1.1%
Anomaly 20 0.8%
Antibodies* 7 0.3%
Diminished Liquor 82 3.1%
IUGR 144 5.5%
Large Baby 48 1.8%
Medical/Social 232 8.8%
Multiple Births 27 1.0%
Other 192 7.3%
Poor Obstetric History 44 1.7%
Decreased Placental Function 1 0.03%
Poor Byphysical Score 7 0.3%
Total 2631 100%
* Anti D detected or Anti E
I N D U C T I O N O F L A B O U R
T h e  M a s t e r
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INDUCTION OF LABOUR
YEARS 2013 2014
Total No. of cases 2523 2631
Incidence against deliveries >500 29% 30%
No. of Caesarean sections for Inductions 537 614
Stillbirths 28 30
Neonatal Deaths 3 8
METHOD OF INDUCTION
YEARS 2013 2014
ARM 182 215
ARM + Synto 471 559
Prostin + ARM + Syntocinon 678 682
Prostin + ARM 410 375
Prostin 305 299
Cytotec 22 23
Prostin + Syntocinon 176 204
Syntocinon 279 274
Total 2523 2631
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In 2014, the caesarean section rate was 31.3%, just over half of one percent higher
than 2013. The primary caesarean section rate was slightly higher, at 62% versus
59%, while the repeat caesarean section rate was slightly lower at 37.8% versus
41.1%. There were an increased number of tubal ligations performed at caesarean
section, 132 versus 91, and the caesarean hysterectomy rate was reduced from
three cases in 2013 to one case in 2014. The total number of elective caesarean
sections was slightly down, while there were 127 more emergency caesarean
sections performed during the year. Looking at the Robson Criteria for 2014, the
only significant change was an increased section rate in nulliparous patients
induced at term, where the rate increased from 31.5% to 35.8%. Finding a more
successful method of inducing nulliparous patients remains a challenge.
In looking at the indication for primary caesarean sections, a higher number of
sections were performed for failure to progress in the first stage of labour. There
was a reduction in the number performed for failure to progress in the second
stage of labour, however there was a higher number of sections for failed
instrumental delivery and a higher number performed for multiple pregnancies.
Primary caesarean sections were reduced for patients with IUGR and increased
where the indication was maternal request.
YEARS 2013 2014
Total number of cases 2650 2753
Incidence against total deliveries > 500g 30.6% 31.3%
Primary C.S. 58.9% 62.2%
Repeat C.S. 41.1% 37.8%
Classical C.S 2 2
Tubal Ligation at C.S. 91 132
C/S Hysterectomy 3 1
C A E S A R E A N  S E C T I O N
T h e  M a s t e r
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CAESAREAN SECTION ANALYSIS
All Deliveries for 2014 8787
All Caesarean Sections 2753
Section Rate 31.3%
Group 1 - Nullip Single Ceph Term Spont Lab 220/1686
Section Rate 13.0%
Group 2 - Nullip Single Ceph Term Induced 497/1389
Section Rate 35.8%
Group 2a - Nullip Single Ceph Term CS Before Labour 207
Group 3 - Multip Single Ceph Term Spont Labour 57/2136
Section Rate 2.7%
Group 4 - Multip Single Ceph Term Induced 65/1065
Section Rate 6.1%
Group 4a - Multip Single Ceph Term CS before Labour 156
Group 5 - Prev Section Single Ceph Term 873/1139
Section Rate 76.6%
Group 6 - All Nullip Breeches 190/197
Section Rate 96.4%
Group 7 - All Multip Breeches 167/181
Section Rate 92.3%
Group 8 - All Multiple Pregnancies 141/189
Section Rate 74.6%
Group 9 - All Abnormal Lies 13/13
Section Rate 100.0%
Group 10 - All Preterm Single Ceph 167/429
Section Rate 38.9%
Elective Caesarean Section Total 1319
Emergency Caesarean Section Total 1434
Total Multips 5009
Total Primips 3748
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INDICATION FOR PRIMARY SECTIONS 2014
DELIVERY METHOD INDICATION 2013 2014
Fetal Distress {Antepartum & Intrapartum} 511 555
Failure to progress 1st stage 132 162
Failure to progress 2nd stage 46 31
Breech 218 267
Abruption/APH 23 18
P.E.T. 24 29
Transverse Lie/Oblique 16 17
Pyrexia 13 21
Placenta Praevia 30 28
Poor Obstetric History 27 16
Cord Prolapse/Presentation 6 7
Disproportion & Deep Transverse arrest 0 2
Failed Forceps/Ventouse 21 31
Face/Brow Presentation 5 4
Multiple Birth 39 60
Failed Induction 74 77
Prematurity 7 8
Hypertension 20 18
Emergency CS Scheduled for Elective CS 16 13
I.U.G.R. 25 14
Maternal Request 22 31
Medical Disorders 41 41
Poor Biophysical Profile 1 0
Other 174 181
Recurring indications 2 7
Rhesus Antibodies 0 0
Previous 3/4th degree tear 52 55
Malpresentaion in labour 15 20
Total 1560 1713
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INDICATION FOR REPEAT SECTIONS 2014
DELIVERY METHOD INDICATION Elective Emergency 
Failure to progress 1st stage       0 22
Failure to progress 2nd stage       0 0
Fetal distress                      2 57
Disproportion(Malpresentation in Labour) 0 1
Breech                              33 13
Hypertension                        3 5
Placenta praevia                    4 6
P.E.T.                              1 6
Poor obstetric history              3 1
Cord Prolapse/Presentation 0 1
Previous LSCS                       664 82
Previous classical CS               4 1
Multiple birth                      7 1
Abruption / APH 0 7
Failed induction                    0 4
Antepartum fetal distress           0 0
Emergency CS scheduled for elective CS 0 10
Failed forceps/ventouse             0 1
I.U.G.R.                            7 2
Medical disorders                   3 8
Transverse lie / Oblique lie 5 3
Other                               36 19
Recurring Indications 0 3
Maternal request 6 1
Prematurity 0 5
Previous 3/4th Degree tear 1 0
Pyrexia 0 2
TOTAL 779 261
** These reasons are the  First reason for  Caesarean Section 
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CLINIC New Return Total
Attendances Attendances
 Antenatal & Postnatal 11,678 37,887 49,565
Gynaecology 2,668 7,044 9,712
Paediatrics 5,466 3,283 8,749
Endocrinology 3,496 2,556 6,052
Gastroenterology 21 19 40
Haematology 304 397 701
Anaesthetics 477 22 499
Nephrology 239 660 899
Psychiatry 417 355 772
Dove Medical 115 136 251
Allied Health Clinics 3,101 3,410 6,511
Diagnostic Clinics 7,632 21,632 29,264
Total 35,614 77,401 113,015
*** Gynaecology includes Colposcopy & Smear Clinics
O U T PA T I E N T  A C T I V I T Y  D A T A  2 0 1 4
3
Departmental
Reports
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OPERATION CATEGORIES
2010 2011 2012 2013 2014
Obstetrical Majors 2469 2745 2604 2717 2821
Obstetrical Minors 1273 1287 1284 1259 1242
Vaginal  Surgery 677 626 610 609 592
Abdominal:Uterus 113 110 125 93 88
Abdominal:Tubes & Ovaries 360 336 317 311 295
Other procedures 2760 2615 2365 2245 2369
D E PA R T M E N T  O F  G Y N A E C O L O G Y
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THEATRE GYNAECOLOGIC  WORKLOAD 
VAGINAL SURGERY 2013 2014
Vaginal hysterectomy 13 10
Manchester repair 0 0
Pelvic Floor Repair 48 41
Vaginal Hysterectomy & AP Repair 35 31
Sacro Spinous Colpopexy 8 5
Removal of IUCD 134 146
Insertion of IUCD 357 344
Other 14 15
Total 609 592
ABDOMINAL OPERATIONS 
OF THE UTERUS 2013 2014  
Total Abdominal Hysterectomy 33 14
Myomectomy 17 16
TAH & Bilateral Salpingo-oophorectomy 23 31
Sub Total Hysterectomy 20 27
Total  93 88
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OTHER PROCEDURES 2013 2014  
Laparoscopy 297 259
Laparoscopy and Dye 216 218
Hysteroscopy 199 153
D&C/H&C 853 846
UBT 46 54
EUA 46 65
Cystoscopy 18 15
Laparotomy 48 59
Excision Bartholins Cyst 36 24
Fentons 4 13
Diathermy Vulval Warts 1 0
Operative Hysteroscopy 4 6
Endometrial Ablation {Rollerball} 14 47
Laparoscopic division of Adhesions 47 29
Laparoscopic Ablation of Endometriosis/Argan 124 138
Polypectomy 71 72
TVT 10 1
Punch Biopsy of Cervix 12 4
LLETZ 21 23
Other Gynae Surgery 136 307
Other Surgery - fetal/anaesthetic 42 36
Total 2245 2369
GRAND TOTAL
Gynae Grand Total Minors & Majors 3258 3344
THEATRE GYNAECOLOGIC  WORKLOAD 
ABDOMINAL: TUBES AND OVARIES 2013 2014   
Tubal Surgery 2 1
Laparoscopic Sterilisation 33 28
Tubal Ligation at Caesarean Section 91 92
Salpingectomy 73 68
Ovarian Cystectomy 73 69
Oophorectomy 17 9
Ovarian Biopsy 7 3
Salpingo-oophorectomy 15 25
Total 311 295
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MINORS 2013 2014  
SVD 7 2
Delivery Forceps 54 55
Delivery Vacuum 33 50
Episiotomy Resuturing 3 0
Episiotomy Repair 96 95
Evacuation of Uterus (AB) 571 544
Evacuation of Uterus (PPH) 11 8
Placenta  Manual Removal 111 113
Insert Shirodkar suture 12 31
Remove Shirodkar suture 13 20
Suturing 1st/2nd degree Tear 68 62
Suturing 3rd degree Tear 211 159
Suturing 4th degree Tear 7 5
Suturing Vaginal Wall Tear 19 16
Miscellaneous 43 82
Total 1259 1242
GRAND TOTAL
Grand Total  Obstetrics (Majors & Minors) 3976 4063
THEATRE OBSTETRIC WORKLOAD 2014
MAJORS 2013 2014   
Caesarean Hysterectomy 3 1
Classical Caesarean Section 2 2
Ectopic 67 68
Lower Segment Caesarean 2645 2750
Total 2717 2821
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DR. TOM WALSH
DR. YAHYA KAMAL (locum)
Lead Nurse Coordinator MS. SELINA IGOE
Nurses MS. ROSE THORNE
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Health Care Assistants MS. TRISH O’DONOVAN
MS. NICOLA BOYD
Colposcopy Team Leader MS. SUSAN DALY
Administrative Support MS. ÉILIS DALTON
MS. NIAMH O’CARROLL
MS. OLGA PEARSON
MS. MARITA PABERZA
MS RUTH MACKAY
C o l p o s c o p y  S e r v i c e
Service Overview 
Our Service Level Agreement with the National Cancer Screening Service was to
see 1500 new patients in 2014.  During the year 1503 new patients were seen and
there were 3424 return visits, giving a total of 4927 patient visits (Table 1). This
representing a slight increase in throughput compared to the previous year. We
believe that this is in part due to the new HPV “test of cure” which was
introduced last year. Our DNA rate is 14% which is within the NCSS target of 15%.
Every effort is made to accommodate patients who need to reschedule
appointments. 
Table 1. Clinic Attendances
2010 2011 2012 2013 2014
New attendances 1664 1908 1563 1569 1503
Return visits 2568 2769 3159 3325 3424
Total 4232 4677 4722 4776 4927
Of the 1503 new referrals, 221 (15%) had smears showing HSIL (moderate or
severe dyskaryosis) as shown in Table 2.  However, 353 (23%) were referred with
ASCUS (borderline) smears. This shows that women with borderline smears
continue to represent a significant burden on the clinical workload despite the
fact that these women have a very low risk of developing cervical cancer.  It is
hoped that the introduction of reflex HPV testing of ASCUS and LSIL smears in
2015 will reduce the number of referrals in this category.  
In 2014, the NCSS introduced changes in the management of women with low-
grade smears and biopsies (MUCH - Management of Uncertainty in Colposcopy
with HPV Testing). Women with ASCUS and LSIL smears are colposcoped and
when clinically indicated, a biopsy is taken. If a diagnosis of low-grade disease 
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is made, the woman is now brought back to one of our smear clinics 12 months
later for a smear and HPV test. The aim of this strategy is to reduce the number
of colposcopic examinations in women with low-grade disease and to reduce
the risk of overtreatment. 
Table 2. Cytology on referral of new patients (n=1569)
ASCUS LSIL HSIL ASC-H ASCUSG Clinical Other Total
Number 353 380 221 112 66 213 158 1503
% 23 25 15 8 4 14 11 100
The number of LLETZ treatments increased in 2014 (Table 3). We were surprised
by this as our aim is to avoid LLETZ treatment in women with CIN1 unless there
are strong clinical indications for this. Our aim is to avoid treating women with
low-grade lesions, but this requires the reassurance of a biopsy-proven
diagnosis. It is apparent that many women with histologically proven CIN2 and
CIN3 on biopsy were subsequently found to have no more than CIN1 on LLETZ.
One possible explanation for this is that the high-grade disease was removed by
the biopsy. 
Table 3. Biopsies and treatments
2010 2011 2012 2013 2014
Biopsies 732 991 1014 1013 1114
LLETZ 784 914 752 465 528
Total 1516 1905 1966 1478 1642
The histological diagnosis in LLETZ and biopsy specimens is shown in Table 4.
There were 12 cases of unexpected invasive disease in women who had a LLETZ
done for what was presumed to be pre-invasive disease. 
Table 4. Histology of LLETZ and Colposcopic Biopsies
CIN 1/HPV CIN 2 CIN 3 CGIN/AIS SCC Incl. Negative
Microinvasion
LLETZ 146 111 209 2 12 48
Biopsies 527 211 151 1 2 222
The provision of the colposcopy service in the Rotunda Hospital is based on the
Quality Standards set out by the National Cervical Screening Programme (NCSS).
These standards cover every aspect of the screening pathway. Some of the key
administrative and clinical targets are shown in Tables 5 and 6. The fact that we
have exceeded most of the targets in 2014 is a reflection of the hard work and
dedication of all members of the Colposcopy Team. All of this is done in a facility
that is far too small for the clinical workload. Our colposcopy clinic is currently
located in what was once the neonatal unit. We have two small clinical rooms,
with very limited office space. We need to increase our clinical space, both for
patient comfort and so that we can increase our clinical workload. There was a
minor improvement in 2014 in that the SATU was relocated to another building,
having shared some of our clinical space for many years. Colposcopy patients no
longer need to share a waiting room with women attending the SATU. We are
looking forward to gaining another clinical room in 2015 as part of the
redevelopment of the existing clinical area. Ultimately, we hope to be relocated to
a larger clinical area in the hospital.
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Table 5.
Administrative Standards Rotunda Target
Proportion referred with HSIL seen within 4 weeks 86% >90%
Proportion referred with LSIL seen within 8 weeks 89% >90%
Proportion of appointments that were unattended 14% <10%
Table 6.
Clinical Standards Rotunda Target
Proportion of LLETZ as outpatients 98% >80%
Proportion of women with CIN on histology
LLETZ 96% >85%
Biopsy 91% >85%
Proportion of women treated at first visit with CIN 
on histology 95% >90%
Proportion of women admitted as inpatients 
following LLETZ 0% <2%
Quality Initiatives in 2014
The NCSS Guidelines for Quality Assurance in Cervical Screening (2nd Edition)
lists over 200 Quality Requirements and Quality Standards.  This covers every
aspect of the service from the time a referral letter is received until the patient
is discharged from the service.  Our compliance with these guidelines is
monitored in a variety of ways as outlined below. 
1. Clinical Audit.
Several audits were completed in 2014 and certified by the Rotunda Hospital
Clinical Audit Department.
1.The incidence of HPV in LLETZ Specimens. 
2.Audit of the first 12 months of Nurse-led Colposcopy Clinics. 
2. MDT meetings
Monthly Multidisciplinary Team (MDT) meetings are held. 
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3. Failsafe reports
Failsafe reports are run daily and weekly on the Mediscan system.  These reports
ensure that the data is captured correctly for each visit.  This data is returned to
the NCSS on a regular basis.
4. Monthly Reports
A monthly report of key performance indicators is returned to the NCSS each
month. 
5. NCSS Report
In November 2014, The Performance Evaluation Unit of NCSS published the
document “CervicalCheck Colposcopy Services 2008-2013 – a comparative
analysis”.  Key performance indicators were evaluated and compared across the
15 colposcopy clinics in Ireland. The Rotunda Hospital Colposcopy clinic
compared very favourably with the other clinics across a wide variety of
standards. 
6. Patient Safety Meetings
We continue to hold an annual multidisciplinary patient safety meeting.
SERVICE DEVELOPMENTS IN 2014
1. Cold Coagulation
The therapeutic modality of “Cold Coagulation” was introduced in September
2014. Prior to this, all women with CIN2 and CIN3 were treated using Large Loop
Excision of the Transformation Zone (LLETZ). This treatment has been the gold
standard for over 20 years. However, recent publications have indicated that
there is an increased risk of miscarriage and preterm labour for some women
who undergo this type of treatment. Cold Coagulation allows treatment of CIN
without the risk of pregnancy complications. A recent meta-analysis has shown
that Cold Coagulation is as effective as LLETZ in the treatment of all grades of
CIN. We plan to review and audit the outcome of our first 100 cold coagulation
treatments when the data becomes available in mid 2015. 
2. Nurse-Led Clinics
Our nurse led colposcopy clinics have gathered momentum over the last year.
Three of the nurses in the department are now trained to work independently
as diagnostic colposcopists and run their own weekly clinics. This has had a
significant beneficial effect on the throughput to clinics, as it allows more
women with high-grade disease to be seen in the consultant clinics.   
3. Management of Low Grade Disease
In 2014, the NCSS introduced changes in the management of women with low-
grade smears and biopsies. Women with ASCUS and LSIL smears are colposcoped
and when clinically indicated, a biopsy is taken. If a diagnosis of low-grade
disease is made, the woman is now brought back to one of our smear clinics 12
months later for a smear and HPV test. The aim of this strategy is to reduce the
number of colposcopic examinations in women with low-grade disease and to
reduce the risk of overtreatment. 
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PRIORITIES FOR 2015.
1. Increased referrals
The introduction in 2015 of reflex HPV testing in Primary Care for women with
low grade smears will result in an increase in the number of referrals to
colposcopy clinics throughout Ireland. We plan to sign a new Service Level
Agreement with the NCSS. This will increase the number of new patients to
from 1500 to 2000 per year. This agreement will result in a significant increase
in the funding we will receive from the NCSS. An extra weekly consultant clinic
will be required to service this increase in referrals. 
2. Cold Coagulation
We aim to increase the use of Cold Coagulation for women who are suitable for
this type of treatment. As the numbers of treatments increase, an increase in the
number of cold coagulation probes will be required. 
3. Develop a 3rd Treatment Room
As part of the redevelopment of the Mortuary, we will gain one extra room in
the colposcopy clinic. The aim is to have this room fully equipped as a third
treatment room.  
4. Expand Nurse-led clinics
In 2015, we aim to progress the training of nurses who will run independent
colposcopy clinics. At present, the nurse-led clinics focus on diagnosis.  The
nurses are currently being trained in the use of Cold Coagulation and LLETZ with
a view to allowing them to run clinics that will include both diagnosis and
treatment. 
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DR. D. CORCORAN , DR. A. FORAN (CLINICAL DIRECTOR), 
PROF.  N. MCCALLION, DR A. EL KHUFFASH, DR B. HAYES, 
PROF. M. D. KING, DR. S. KEANE, DR J. FRANTA (TRANSPORT)
ADMISSIONS TABLES (1.1-1.10) 
2014 was an exceptionally busy year for the neonatal unit; overall our staff cared for
2,285 babies. The total number of admissions to the unit increased again for the third
consecutive year (1,439 Vs 1,323) with an average occupancy rate of 81% peaking in
December. We continued to provide Specialist paediatric input for over 800 babies on
the post natal wards. Both occupancy and workload intensity affect unit staffing
requirements and both have been an issue during 2014. At certain peaks, and with the
support of the Executive Management, we had to escalate our “nurse to infant” staffing
levels to the HSE, for example when we had 43 special and intensive care babies but
only 11 nurses. Ideally a minimum of 13 nurses per shift are required to reach a
minimum safe standard. At times close to 20 babies were being treated in the high
dependency unit, which is designed to have a maximum capacity of 13 beds. It is a credit
to all our staff, especially to our frontline nursing staff, that we managed to achieve
such good outcomes overall, but we are aware that this is not sustainable. At a national
level, the Clinical Lead for Neonatology is seeking significant increases in whole time
equivalent nurses and consultants for neonatal units throughout the country, and we
whole heartedly support this move.
This is the second year we are in a position to present more detailed data on babies
admitted with birth weights >1500g. We wish to thank the IT midwives, and especially
Kathy Conway, for their hard work in compiling this data. This will help us develop a
new model of care going forward, and help to identify those babies that can be nursed
safely in a transitional care unit.
Vermont OxfordNETWORK (SECTION 2 TABLES 2.1-2.5) 
This was our busiest year for admissions < 1500g with a total of 136 babies. Table 2.2
and 2.3 show our survival rates by gestation at delivery and birthweight.  The
survival rate for infants of 24 to 26 weeks gestation is 64%, however birth weight
remains an important predictor of outcome, we have a 66% mortality rate for
infants who weigh between 501 and 700g at birth.  
Table 2.4 shows morbidities and interventions in infants < 1500g compared to the
Network. 
Our outcomes for key indicators are generally consistent with the network
averages, though our interventions show some variation.  We have a high rate of
multiple births compared to the network (39 Vs 28%) and consistently higher rates
of babies born with any major birth defect 18% Vs 5%. There is a trend towards less
invasive respiratory support in preterm infants, and our rate of chronic lung disease
is lower than the network average 16 vs. 24%.
D E PA R T M E N T  O F  P A E D I A T R I C S
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We have a high availability of neonatal functional echocardiography in our unit and
this increases our rate of diagnosis of patent ductus arteriosus and also our use of
nitric oxide to treat pulmonary hypertension in preterm infants.  Our nosocomial
infection rates are similar to the network average.
Table 2.5 shows our most important outcomes for preterm babies which are adjusted
for birth weight and gestation, and are compared to average outcomes of over 50000
infants for the Vermont Oxford Network of neonatal units, and are also compared to
our outcomes over a 3 year period.  A standardized rate of < 1 indicates a better than
average outcome, if the upper confidence limit is also less than 1.   This table shows
our standardized mortality and severe intraventricular hemorrhage rates over the
past 3 years are slightly worse than the network average.  We are relatively under-
resourced and understaffed compared to most North American units.  Also the risk
adjustment model does not include multiple gestations and may not compensate
fully for the effect of congenital abnormalities which are over 3 times more frequent
in our population than the network average.  Nonetheless these data are a source of
concern and we will be reviewing all aspects of care including antenatal, delivery and
early NICU management to see if we can target areas for improvement
NEONATAL MORTALITY (< 28 DAYS)(TABLES 3.2 AND 3.3) 
Congenital Malformations (3.2)
There were 18 neonatal deaths attributed to congenital anomalies or
malformations. Their gestation at birth spanned from 27 to 36 weeks. Twelve (67%)
were male. All were born in the Rotunda Hospital. The majority of those were
identified antenatally with the exception of 2 preterm infants with transposition of
the great arteries and total anomalous pulmonary venous drainage born at 28 and
27 weeks respectively. Those were identified on routine echocardiography scanning
on day 1 of age. The majority of infants were delivered vaginally. Most deaths
occurred within the first 3 days of life. There were 5 late neonatal deaths. 
Deaths of Normally formed infants receiving intensive care (3.3) 
Excluding those babies who died from HIE at term, there were 15 neonatal deaths
of normally formed infants. All but 1 had a birth weight <1.25kg and all but 2 were
26 weeks or less gestation at delivery. Six were not offered any resuscitation and
were handed to mum at delivery, these are not presented in our tables but were
all <23 weeks and <700g. 2 were a set of 22 week twins who were both <
500g.Three didn’t respond to resuscitation and didn’t make it to NICU. There
were 3 late neonatal deaths.
Neonatal Encephalopathy (Table 3.1) 
In 2014, 40 babies (29 inborn) delivered at ≥35 weeks gestational age were
admitted with signs of neonatal encephalopathy. Of these 30 were classified as
having hypoxic ischaemic encephalopathy (HIE). HIE was graded as severe in 8
newborns (5 outborn), moderate in 9 (4 outborn) and mild in 13 (all inborn)
newborns.  15 /17 cases with moderate or severe HIE received therapeutic
hypothermia. The two cases (1 inborn) who did not receive therapeutic
hypothermia both presented to the neonatal intensive care unit outside the 6
hour window for initiation of cooling. Both babies who did not receive cooling
had clinical and/or electrographic seizures and both had abnormalities of the
white matter on brain MR imaging. The remaining 15 babies with moderate or 
severe encephalopathy started cooling within the 6 hour window. In general,
babies treated with therapeutic hypothermia are showing improved outcomes
especially in those with moderate encephalopathy.  All 7 babies with moderate
encephalopathy treated with therapeutic hypothermia had a normal brain MRI.
One child is being followed locally and the remaining 6 babies have normal
neurodevelopment to date. Of the eight babies with severe HIE, intensive care
measures were withdrawn in two babies (both outborn) given severity of
encephalopathy and no improvement in clinical exam and EEG at greater than
24 hours after delivery. Both babies died following extubation.  One baby with
severe encephalopathy and seizures developed refractory cardiac arrhythmias.
This baby died day 5 after birth. Post-mortem confirmed pan cortical necrosis of
virtually all areas of the neocortex , also affecting brainstem and cerebellum. In
addition established periventricular leucomalacia was noted.   The remaining
five babies had evidence of hypoxic ischaemic injury on brain MRI . Of these two
were showing signs of evolving cerebral palsy when last seen (5 months of age).
The remaining 3 babies have normal development to date (last seen at 6, 8 and
13 months respectively). 
A cause for encephalopathy was found in 8/10 babies who presented with
encephalopathy at ≥ 35 weeks gestation without evidence of HIE. Congenital
cytomegalovirus was diagnosed in three babies,1 was diagnosed with group B
streptococcus and parechovirus sepsis with meningitis. A mitochondrial
respiratory chain defect involving complex II was diagnosed on muscle biopsy
in 1 child.  Established periventricular leukomalacia was found in a 35 week
gestation baby on brain MRI. In another child subsequently diagnosed with
neonatal alloimmune thrombocytopenia, MRI brain confirmed extensive
cerebral and cerebellar abnormalities with large areas of parenchymal
haemorrhage and infarction and severe ventriculomegaly.  Another baby with
inutero polydrug exposure was found to have sinus venous thrombosis with
extensive interventricular and parenchymal haemorrhage and associated
hydrocephalus on brain MRI. In the remaining two babies with neonatal
encephalopathy but no evidence of hypoxia ischemia no clear cause for
encephalopathy was found.. Both children however had normal
neurodevelopment when last seen (10.5 and 9 months respectively). 
Follow-up of babies <1500g
There were 108 children <1500 gm eligible to be assessed in the year 2012. All were
sent appointments and 78 (38F, 40 M) attended. Follow up rate of 72%. 
Following assessment,17 had isolated speech delay, 8 were diagnosed with Global
delay, 2 with Spastic CP (Hemiplegia, Diplegia ), 2 with suspected Autism, 1 with
sensory processing disorder (already attending CRC), 3 with suspected ADHD.
27 were referred for Speech therapy, 14 for audiology assessment, 8 for
physiotherapy , 10 for occupational therapy and 14 for psychology assessment.
(These are total numbers including those who were already referred to early
intervention/enable Ireland because of delays).
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Comments
Paediatric outpatients’ attendances remained high at 9,595, which is a slight
increase from 2013 but significantly lower than previous years (when over 12,000
attendances were recorded). This is the first year we have a very detailed
breakdown of attendances and non attendances. Over 2575 babies were seen in our
midwifery led clinics; 711 for hip harness, 1621 for newborn blood spots and 243 for
post discharge checks. Much of this workload reflects the lack of local community-
based clinics taking newborn blood spots at weekends, as is the norm outside
Dublin. Such clinics could significantly reduce pressure on our busy nurse led out-
of hours clinics. Another factor contributing to patient attendances at midwifery
clinics is CDH follow-up. In the past we have considered sending babies for harness
to the children’s hospitals. Attendances have been reduced at consultant clinics.
2175 babies were seen in consultant led clinics, with a significant reduction in
return visits since  streamlining of NCHD working practices has increased the
number of babies directly seen by their named consultant. 489 infants attended
supervised SHO clinics for 6 week checks by our SHOs. While the numbers of “drop
in” or emergency reviews have fallen, over 3396 babies were unplanned reviews. 431
babies attended our orthopedic specialist clinic, 84 our specialist neurology clinic
and 87 our neurodevelopmental follow up clinic. 357 attended our rainbow clinic for
specialist follow up of those infants at high risk for infectious diseases. The overall
non-attendance (DNA) rate was low overall at 8%; lowest for new patients at 6.7%
but higher for returns (14.5%). 
The Dublin North East neonatal network (encompassing the Rotunda, Drogheda
and Cavan) continues to evolve. There were 63 transfers from Drogheda and Cavan
to the Rotunda either in (n=44) or ex utero (n=19), contributing to 162 maternal and
383 NICU bed days in the Rotunda respectively. Quarterly education meetings
continued and a more formal approach to joint guidelines is envisaged.
Following support from Executive Management and the HSE, we were able to appoint
a neonatal dietician towards the end of the year. Anna Claire Glynn has worked in a
tertiary NICU at UCL London and hopes to take up her post April 2015. The continued
evolution of allied health professionals in our NICU needs to evolve further. Now that
we have social work, physiotherapy and dietetics streamlined we hope to expand
with neonatal pharmacy, speech and language therapy and psychology. 
The neonatal transport (NNTP) finally moved to 24/7 in December 2013. The
appointment of Jan Franta as the consultant leading the service has had huge
impact on training of NCHDs and nurses, allowing more formal training especially
with respect to air retrieval. Dr Franta has travelled with the team for more complex
babies and has become a welcome addition to our consultant body. The associated
significant increase in numbers of babies transferred (549 Vs 300) had not been
anticipated. Weekly average transport numbers since going 24/7 is 10.4 compared
with 5.5 for the previous 5 years on the 9-5 service. The NNTP team from the
Rotunda Hospital conducted 32% (174) of the total number of NNTP transports in
2014, 105 of which were outside the greater Dublin area. While this has led to an
increase in work load and call outs between 5pm-8am, there is no doubt it has
significantly improved the quality and timely delivery of tertiary services to babies
from the country as a whole. Phase 2 will be the development of a return transfer
service, ideally should be nurse led, which should further serve to streamline
neonatal service delivery. 
The neonatal unit continues its active role in research, and during 2014 there were
a total of three higher degree candidates in the Department of Paediatrics: Drs
Adam James, Elaine Neary and Raga Malika. While consultants were invited
speakers and projects were presented at many local and national meetings, we
have presented only publications and presentations at larger international
meetings. 
Two staff successfully completed the Postgraduate Diploma in Neonatal Nursing
through the RCSI and a further three staff were sponsored to undertake the
program, which commenced in September 2014. One nurse also completed the
second year MSc program in neonatal intensive care nursing and three staff are
undertaking their MSc in 2014. A total of six nurses were facilitated to undertake
Foundation Programs in neonatal nursing in 2014.These programs are provided by
the clinical skills facilitators in the three Dublin Maternity Hospitals and
coordinated through the Centre of Midwifery Education. They focus on nursing
care of babies requiring special care (Level 1) and on High Dependency and
Intensive Care (Level 2). Mark Hollywood commenced the MSc Advanced Nurse
Practice Neonatology program in 2014, which will expand the ANP role within the
unit. Nursing staff were also supported to attend national and international
neonatal nursing conferences throughout the year.
The neonatal unit continues to identify quality improvement plans to enhance our
philosophy of a family centered care approach. The first parent satisfaction survey
was completed in May and highlighted that space and support for expressing and
overnight accommodation are badly needed. The need for a neonatal lactation
specialist and developmental care (NIDCAP) specialist, have been highlighted. In
2014 approval was sought and given to support a nurse within the unit to
undertake the lactation course. It is envisaged that this role/post will be provided
in addition to our current whole time equivalent in the near future.
2014 saw the retirement of Dr Susan Keane who has been responsible for the
formal follow up of all babies born with a birth weight <1.5kg. We wish Susan and
her husband Terri every success as they embark on a new phase of their lives in
Malaysia. We have had meetings with Dr Owen Hensey Prof King and the master
to look at expanding this role to allow more formal follow up of our asphyxiated
babies and those at high risk of disability. We are putting together a business case
for this new role.
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TABLE 1.1 
ADMISSION & DISCHARGE TO THE NEONATAL UNIT
 ADMISSIONS 1,439
DISCHARGES 1,416 
INFANTS > 1.5Kg 1,302
INFANTS TREATED ON WARD 846
*Including readmissions
TABLE 1.2 
ADMISSION WEIGHT TO THE NEONATAL UNIT
500 - 1000grms 37
1001 - 1500grms 77
1501 - 2000grms 141
2001 - 2500grms 194
Over 2500grms 967
TOTAL INFANTS DISCHARGED 1,416
* Based on Infants Discharged from NICU
SECTION 1
Gestational  Inborn Survival % Outborn Survival % Total %
Age Infants to Infants to Survival
(completed) Discharge Discharge Discharge to 
weeks
21 2 0 (0%) 0 0 (0%) 0 (0%)
22 7 0 (0%) 0 0 (0%) 0 (0%)
23 6 0 (0%) 0 0 (0%) 0 (0%)
24 6 2 (33%) 0 0 (0%) 2 (33%)
25 8 7 (88%) 1 1 (100%) 8 (89%)
26 5 3 (60%) 5 3 (60%) 6 (60%)
27 14 14 (100%) 0 0 (0%) 14 (100%)
28 21 18 (86%) 6 5 (83%) 23 (85%)
29 13 13 (100%) 0 0 (0%) 13 (100%)
30 13 12 (92%) 0 0 (0%) 12 (92%)
31 8 6 (75%) 0 0 (0%) 6 (75%)
32 9 8 (89%) 1 1 (100%) 9 (90%)
> 32 11 11 (100%) 0 0 (0%) 11 (100%) 
Total 123 94 (76%) 13 10 (77%) 104 (76%)
SECTION 2    -    VLBW INFANTS
TABLE 2.1
NUMBER OF CASES REPORTED TO VON 2014
All Cases Excluding Congenital 
Anomalies
Infants 401-500g 8 8
Infants 501-1500g 128 103
Infants > 1500g but ≤29 wks gestation 0 0
Total 136 111
TABLE 2.2
GESTATIONAL AGE BREAKDOWN AND SURVIVAL TO DISCHARGE OF ALL
INFANTS REPORTED TO VON (INCLUDING THOSE WITH CONGENITAL
ANOMALIES) 2014 (N=136)
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TABLE 2.3
BIRTH WEIGHT AND SURVIVAL TO DISCHARGE OF ALL INFANTS REPORTED TO
VON (INCLUDING THOSE WITH CONGENITAL ANOMALIES) 2014 (N=136)
Birth  Inborn Survival % Outborn Survival % Total %
Weight Infants to Infants to Survival
(grams) Discharge Discharge Discharge to 
<500 9 0 (0%) 0 0 (0%) 0 (0%)
501-600 7 1 (14%) 0 0 (0%) 1 (14%)
601-700 7 3 (43%) 1 1 (100%) 4 (50%)
701-800 5 3 (60%) 1 0 (0%) 3 (50%)
801-900 12 10 (83%) 0 0 (0%) 10 (83%)
901-1000 12 10 (83%) 5 5 (100%) 15 (88%)
1001-1100 7 6 (86%) 1 1 (100%) 7 (88%)
1101-1200 14 13 (93%) 1 0 (0%) 13 (87%)
1201-1300 20 20 (100%) 2 2 (100%) 22 (100%)
1301-1400 15 13 (87%) 1 1 (100%) 14 (88%)
>1400 15 15 (100%) 1 1 (100%) 16 (100%) 
Total 123 94 (76%) 13 11 (85%) 105 (77%)
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TABLE 2.4
MORBIDITY FIGURES FOR INFANTS 501-1500G BORN (CONGENITAL
ANOMALIES INCLUDED) COMPARED TO THE VERMONT OXFORD NETWORK
N Rotunda VON
(n= ) n= 
Inborn  136 123 (90.4%) 86.8%
Male 136 74 (54.4%) 50.5%
Antenatal Steroids (partial or complete) 127 101(79.5%) 81.6%
Caesarean section 134 90(67.2%) 72.6%
Antenatal Magnesium Sulphate 123 52(42.3%) 52.4%
Multiple Gestation 136 53(38.9%) 28.0%
Any major birth defect 135 25(18.5%) 4.8%
Small for gestational age 135 33(24.4%) 23.7%
Surfactant in DR 132 66(50%) 26.8%
Conventional Ventilation 118 59 (50%) 56.6%
High Frequency Ventilation 117 14(12%) 20.3%
Any Ventilation 118 59(50%) 58.8%
High Flow Nasal Cannula 118 19(16.1%) 53.7%
Nasal CPAP 118 95(80.5%) 76.1%
Nasal CPAP before or without ETT Ventilation 103 43(41.7%) 57.1%
Ventilation after Early CPAP 43 13(30.2%) 37.4%
Surfactant at any time 124 68(54.8%) 58.8%
Steroids for CLD  118 2(1.7%) 9.0%
Inhaled Nitric Oxide 118 13(11.0%) 4.6%
RDS 118 102(86.4%) 72.5%
Pneumothorax 118 8(6.8%) 4.3%
Chronic Lung Disease (at 36 wks) 93 15(16.1%) 24.8%
"Chronic Lung Disease, Infants <33 wks" 82 15(18.3%) 26.3%
Early Bacterial Infection 115 2 (1.7%) 2.3%
Late Bacterial Infection  111 4(3.6%) 8.3%
Coagulase Negative Staphylococcus Infection 111 11(9.9%) 5.3%
Nosocoial Bacterial Infection 111 13(11.7%) 11.8%
Fungal Infection 111 0 0.8%
Any Late Infection (Bacterial or Fungal) 111 13(11.7%) 12.2%
NEC Surgery 118 0 3.3%
PDA ligation 118 3 (2.5%) 4.5%
Surgery for ROP 118 5 (4.2%) 2.6%
Any Grade of IVH (Grade 1-4) 111 40(36.0% ) 24.2%
Severe IVH (Grade3-4)  111 15(13.5%) 7.9%
Cystic PVL 112 1(0.9%) "2,8%"
Retinopathy of Prematurity 93 10(10.8%) 31.1%
Severe ROP (Stage 3 or more) 93 3 (3.2%) 5.9%
Anti-VEGF Drug 118 0 1.1%
Focal GI perforation 118 0 1.8%
Indomethacin 118 0 14.5%
NEC  118 7(5.9%) 5.4%
PDA 118 41(34.7) 28.2%
Ibuprofen for PDA 118 10(8.5%) 6.8%
Probiotics 118 98(83.1%) 12.0%
Mortality 135 32 (23.7%) 11.9%
Mortality excluding Early Deaths 116 13(11.2%) 9.0%
Survival 135 103 (76.3%) 85.0%
Survival without Specified Morbidities 135 67(49.6%) 56.0%
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Measure N SMR SMR 95% SMR 95% N SMR SMR 95% SMR 95%
Lower Upper Lower Upper 
Mortality 127 1.3 0.9 1.8 387 1.3 1 1.7
Mortality Excl Early Deaths 117 1.2 0.7 1.9 370 1.4 1 1.8
Death or Morbidity 127 1.1 0.9 1.3 387 1 0.9 1.2
Chronic Lung Disease 93 0.9 0.6 1.3 309 1 0.8 1.2
CLD: Infants < 33 Weeks 82 0.9 0.6 1.3 284 1 0.8 1.2
NEC 118 1.1 0.5 1.8 375 1.6 1.2 2.2
Late Bacterial Infection 111 0.6 0.2 1.1 355 0.7 0.4 1
Coag Neg Staph infection 111 1.8 0.9 2.9 355 1.3 0.9 1.9
Nosocomial Infection 111 1 0.6 1.6 355 0.9 0.6 1.2
Fungal Infection 111 0.2 0 1.5 355 0.1 0 0.6
Any Late Infection 111 1 0.6 1.6 355 0.8 0.6 1.1
Any IVH: 111 1.5 1.1 1.9 359 1.4 1.2 1.7
Severe IVH 111 1.4 0.9 2 359 1.4 1 1.8
Pneumothorax 118 1.3 0.7 2 376 1.4 0.9 1.9
Cystic PVL 112 0.6 0.1 1.5 362 0.6 0.3 1.2
Any ROP 93 0.5 0.3 0.8 305 0.5 0.4 0.6
Severe ROP 93 0.9 0.4 1.8 305 0.8 0.5 1.3
TABLE 2.5 
SHRUNKEN STANDARDISED 
MORTALITY AND MORBIDITY (SMR) 
RATES 2014
SHRUNKEN STANDARDISED 
MORTALITY AND MORBIDITY (SMR) 
RATES 2011- 2014 INCLUSIVE
SECTION 3  - HYPOXIC ISCHAEMIC ENCEPHALOPATHY AND MORTALITY TABLES
TABLE 3.1  -  HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE)
Inborn Outborn
TOTAL 21 9
Mild HIE (Grade 1) 13 0
Moderate HIE (Grade 2) 5 4
Severe HIE (Grade 3) 3 5
Therapeutic Hypothermia 7 8
Grade Inborn/ Gestation Mode of    Arterial      Venous 1 Minute 5 Minute Therapeutic Seizures Brain Follow
HIE outborn delivery   Cord Gas Cord Gas Apgar Apgar Hypothermia MRI up
pH BE pH BE Outcome Age
(months)
Last 
Reviewed
2 Outborn 41+2 EMCS nd nd 5 6 No Yes Abnormal Followed 
diffusion Locally
posterior 
right 
corpus 
callosum
2 Inborn 39 EMCS 7.33 -2.3 7.34 -2.6 2 0 Yes Yes Normal Normal 11
2 Outborn 40+2 ELCS 6.8 -13 6.8 -16 3 5 Yes No Normal Normal 4
2 Outborn 38 SVD 7.06 -12 2 4 Yes Yes Normal normal 4
2 Inborn 38+3 EMCS 6.92 -15 6.97 -12 3 6 Yes No Normal normal 4.5
2 Inborn 41+1 Ventouse 7.05 -12 7.21 -11 0 4 Yes No Normal normal 6.5
2 Outborn 41+2 EMCS 7.01 -8.6 7.16 -12 2 6 Yes No Normal Followed Locally
2 Inborn 36+2        Ventouse nd nd 9 10 No Yes Restricted Evolving 6
& Forceps diffusion Cerebral
deep white Palsy
matter both 
cerebral 
hemispheres
2 Inborn 37 SVD 7.18 -5 7.22 -5 3 7 Yes No Normal Normal 4
3 Inborn 39 Ventouse 7.16 -1.1 7.2 -11 1 2 Yes Yes Restricted Normal 13
diffusion 
PLIC and  
hippocampi 
bilaterally 
and possibly  
left thalamus
TABLE 3.1a CLINICAL DETAILS OF NEWBORNS WITH SIGNS OF MODERATE TO
SEVERE HIE
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Grade Inborn/ Gestation Mode of    Arterial      Venous 1 Minute 5 Minute Therapeutic Seizures Brain Follow
HIE outborn delivery   Cord Gas Cord Gas Apgar Apgar Hypothermia MRI up
pH BE pH BE Outcome Age
(months)
Last 
Reviewed
3 Inborn 41+4 Ventouse 7.188 -7.7 7.22 -7.7 3 7 Yes Yes "Extensive Evolving 5
areas of Cerebral
acute Palsy
infarction 
cortical and 
whitematter 
left frontal 
lobe left 
parietal region 
left basal 
ganglia, corpus 
callosum, right 
frontal and 
parietal 
whitematter 
equivocal 
changes 
bilateral 
hippocampi"
3 Outborn 41+3 EMCS 7.22 -11 nd 1 3 Yes Yes No RIP Day 2 -
3 Outborn 41+6 Induced 6.79 -18 6.8 -17 2 3 Yes Yes Acute Normal 8
Vaginal ischaemia
Delivery splenium and 
periventricular 
white matter; 
posterior 
brainstem and 
ventroateral 
thalami 
bilaterally.
3 Outborn 41+5 EMCS nd nd 0 1 Yes Yes T2 hyperintensity Normal 6
posterior 
periventricular 
white matter
3 Inborn 35+5 EMCS nd nd 1 5 Yes No Significant Evolving 5
ischaemia Cerebral
thalami and Palsy
lentiform nuclei 
bilaterally; 
restricted 
diffusion high 
in left parietal 
region
3 Outborn 40+3 EMCS 6.9 -12 7.06 -12 1 1 Yes Yes No RIP Day 5 -
3 Outborn 40+5 EMCS nd nd 0 4 Yes Yes No RIP Day 2 -
EMCS= Emergency Caesarean Section; ELCS=Elective Caesarean Section; SVD= Spontaneous Vaginal Delivery; nd= Not Documented;
PLIC= Posterior Limb of Internal Capsule  
TABLE 3.1a cont. CLINICAL DETAILS OF NEWBORNS WITH SIGNS OF MODERATE
TO SEVERE HIE
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Birth Wt Gestation Sex Delivery Apgars Age Principle Cause of Death
700g 25+5 male EmLSCS "0,4,0" Day 1 "Hypoxic ischaemic encephalopathy, twin twin 
estimated transfusion with demise in utero of co-twin, 
extreme prematurity at 25 weeks gestation"
590g 23+5 female SVD "1,0,0" Day 1 Extreme prematurity
600g 24+1 female SVD "1,1,1" Day 1 "Extreme prematurity, unresponsive to 
resuscitation including ventilation, CPR and 
adrenaline"
1060g 26+2 male EmLSCS "5,8" Day 3 "Pulmonary haemorrhage, severe pulmonary 
hypertension, RDS, bilateral grade IV IVH, extreme
prematurity"
855g 26+4 male EmLSCS "5,8" Day 3 "Prematuriy, presumed sepsis (pseudomonas on 
placental swab), refractory hypotension and 
cardiac dysfunction despite multiple inotropes, 
mechanical ventilation, oliguria, bilateral severe 
intraventricular haemorrhage"
690g 24+1 male SVD "3,8" Day 8 "Prematurity, right grade IV and left grade II IVH, 
RDS requiring HFOV,insulin for hyperglycaemia, 
PPHN, nitric oxide dependent."
1780g 30+4 male SVD "9,9" Day 10 "Prematurity, severe intracranial haemorrhage, 
coagulopathy, family history factor VIII 
deficiency"
1.17kg 31+1 female EmLSCS "  1,1,2" Day 2 "Anhydramnios, PPROm at 14 weeks, severe 
pulmonary hypoplasia, arthrogryphosis, 
respiratory failure refractory to HFOV and Nitric 
oxide."
2.27kg 37+0 male SVD "1,1,0" Day 1 "Bradycardia, apnoea and hypotonia at delivery 
unresponsive to full resuscitation for 37 minutes. 
Complex I mitochondrial respiratory chain 
disorder confirmed on postmortem."
1.78kg 30+4 male SVD "9,9" Day 9 "Coagulopathy requiring fibrinogen, fresh frozen 
plasma and factor VIII. Family history 
haemophilia. Catastrophic intracranial 
haemorrhage. Comfort care."
TABLE 3.3  -  INBORN /OUTBORN INFANTS NORMALLY FORMED  > 500G
Gestation Age at Birth Gender Delivery Apgars Inborn Congenital Anomaly
(weeks) Death weight Outborn / Malformation 
(Days) (g)
36 2 3.52 Male Vaginal "5,8" Inborn TOF/Epispadias-Extrophy Complex 
/Anal Atresia/Pulmonary Hypoplasia
36 3 1.86 Male Vaginal "9,9" Inborn Truncus Arteriosus  / TOF
37 4 1.59 Male Elective CS "3,6" Inborn Edwards Syndrome 
34 1 2.76 Male Vaginal "4,4" Inborn Hypoplastic Left Heart Syndrome / 
Dysmorphic Features 
31 3 1.33 Female Vaginal "5,8" Inborn Triploidy 69XXX
39 3 3.05 Female Vaginal "6,7" Inborn Left sided diaphragmatic hernia 
30 1 0.88 Male Elective CS "3,3" Inborn Chromosome 13 Deletion 
28 8 0.8 Male Emergency CS "3,6" Inborn Transposition of great arteries 
36 1 3.38 Female Vaginal Unassigned Inborn Skeletal Dysplasia 
39 1 3.85 Female Vaginal "9,10" Inborn Pulmonary atresia with intact 
ventricular septum 
34 1 2.1 Female Vaginal "2,1" Inborn Severe Hydrops Fetalis 
39 3 2.37 Male Vaginal "4,6" Inborn Edwards Syndrome 
35 6 3.19 Male Vaginal "3,7" Inborn Autosomal Recessive Polycystic 
Kidney Disease 
38 13 3 Male Vaginal "4,7" Inborn Hard Palate Teratoma / Spinabifida 
/ Severe Arnold Chiari 
Malformation
31 14 2.26 Male Elective CS "6,9" Inborn Chromosome 8p deletion / Cystic-
dysplastic Kidneys 
35 24 2.19 Female Emergency CS "9,9" Inborn Polycystic Kidneys / Meconium 
cysts with necrotic bowel
32 1 1.34 Male Vaginal "5,5" Inborn Congenital Renal Agenesis 
27 22 1.05 Male Emergency CS "2,6" Inborn Total Anomalous Pulmonary 
Venous Drainage
TABLE 3.2  - INBORN /OUTBORN INFANTS WITH CONGENITAL ANOMALIES (18)
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CONSULTANT SURGEON Mr. Paul Connolly FRCSI, FRCSOrth
ORTHOPAEDIC PHYSICIAN Dr. Hilary Lane MB, PhD
The Department of Orthopaedic Surgery has primary responsibility for
management of all orthopaedic  anomalies  in infants born in the Rotunda
Hospital. The majority of cases concern Developmental Dysplasia of the Hip.
The Department is responsible for compiling screening protocols, including
screening criteria and review of all patients who require follow up for DDH. 
Table 1. In-Patient and Outpatient activity
2012 2013 2014
No of babies reviewed by Orthopaedic 
Service as in-patients 5172 5348 4440
No. of babies reviewed by DDH outpatient service 786 978 711
No. of babies reviewed at Orthopaedic outpatients 427 413 431
% of babies examined by Orthopaedic 1.0% 1.0% 1.1%
service with clinically unstable hips (n=52) (n=49) (n=48)
The principal modes of screening for DDH are clinical examination in the first few
days of life and radiological investigation of the hips. Clinical screening for hip
instability , while a useful tool in experienced hands is fraught with pitfalls for less
experienced practitioners. It also does not address the issue of stable dysplasia
which is clinically silent. Stable dysplasia, without hip joint luxation, is detectable
on hip US or X-ray only.
There has been a steady ideological move away from clinical screening toward
radiological diagnosis. This is in keeping with the Department of Orthopaedic
Surgery's objective to introduce Universal Hip Ultrasound Screening for DDH. 
There has been an increase in the diagnosis of DDH on US and X-ray. See Table 2.
There has been a concomitant increase in the number of babies treated for DDH  in
a Pavlik harness  and abduction brace secondary to radiological diagnosis of DDH.
Table 2. Hip Instability and Subluxation. Clinical and radiological diagnoses. 
No of Patients 2012 2013 2014
No. of neonates diagnosed with hip instability; 
clinical diagnosis (all depts.) 77 75* 66
No. of babies with hip instability; US Dx 13 13* 16
No. of babies with hip dysplasia and 
minor hip subluxation; US Dx 18 15 14
Total No. of babies Tx in Pavlik Harness 108 103 96
* 6 cases previously attributed to clinical Dx found in retrospect to have been
diagnosed on hip US
DEPARTMENT OF ORTHOPAEDIC SURGERY
Table 3. US and X-Ray diagnoses of Stable Dysplasia
2012 2013 2014
No. of hip x-rays reviewed by Orthopaedic Service 1435 1281 1395
No. of cases of Hip Dysplasia detected on X-ray 11 15 33
No. of hip US conducted for the Orthopaedic Service 1733 1715 1847
No. of cases of dysplasia detected on hip US;  
Tx in Abduction Brace 0 7 24
Total No. of babies Tx in Abduction Brace 11 22 57
The use of Pavlik harness in an infant diagnosed with hip dislocation within the
first few days of life  is a highly successful form of treatment. It is associated with
a >98% success rate. The success of Pavlik harness treatment is dependent on the
expertise of the person applying the device. The best results are obtained when a
small number of dedicated  experts apply the harnesses only.
The commonest serious complications associated with Pavlik harness use are
femoral nerve palsy and avascular necrosis of the femoral head.  The probability
of complications increases with an increased interval between harness refitting.
In the Rotunda Hospital , the Pavlik harnesses are refitted weekly. 
Pavlik harness treatment is deemed to have failed if the hip(s) remain
persistently dislocated after 8 weeks of treatment. The baby is then referred for
EUA, hip arthrogram, closed or open reduction  of the affected hip and Spica
plaster-casting. See Table 4.
Table 4.
2012 2013 2014
No. of complications associated 
with Pavlik Harness Use 0 0 0 N/A
No. of cases of persistent dislocation
/subluxation of the hip; Failure of 
Pavlik Harness Tx 1 (<1%) 1(1%) 2 (2%)
No. of cases of persistent 
dislocation or subluxation 
of the hip;  Delayed Dx 2 1 4
No. of cases of late presenting DDH referred
to CUH, Temple St. ** 6 (0.66/1000) 2 (0.2/1000) 7 (0.7/1000)
No. of cases of stable dysplasia, 
persisting  despite Tx ** 8 10 2
Total No. of cases of DDH referred 
for surgery to CUH, Temple St ** 17 16 11 
** More case will be added as they come to light.
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Delayed diagnosis is taken to mean hip subluxation or dislocation diagnosed
after 6 weeks of age (chronological) but before 4 months of age.
Late diagnosis is taken to mean diagnosis of hip subluxation or dislocation after
4 months of age.
Success rate for Pavlik Harness treatment is in excess of 98%.
Overall Late DDH rate for  The Rotunda Hospital
for the last 3 years averages 0.5/1000.
Rate of diagnosis of DDH  (including clinical, hip  
US and X-ray diagnosis of hip dislocations, 
subluxations, and dysplasia) 15/1000 (1.5%)
The incidence of  DDH in The Rotunda is 1.5%. This is higher than the incidence
given in published works. This figure is consistent over the last 10 years and
probably more accurately reflects the true incidence in Ireland.
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D E PA R T M E N T  O F  A N A E S T H E S I A
DR. MARY BOWEN, DR. NIAMH HAYES, DR. JOHN  LOUGHREY  
DR. CONÁN MC CAUL, DR. RÓISIN NÍ MHUIRCHEARTHAIGH, 
DR. PATRICK THORNTON.
Dr. Conán McCaul resigned from his position as Clinical Tutor and Dr. Patrick
Thornton has been appointed to this role.  Dr. John Loughrey in his capacity as
President of ISOA was involved in the organisation of a successful OAA Meeting
which was held in the Conference Centre in Dublin this year.
Non-Consultant Hospital Doctors:
The Department continues to provide training in Obstetrical Anaesthesia and to
avail of five trainees from the National training programme, two other NCHDs and
one Fellow in Obstetrical Anaesthesia. We would like to congratulate Dr. Azza
Kibeidi and Dr. Joseph Keaveney who both passed the Final FCA and received their
Fellowship from the College of Anaesthetists and Dr. Rosemarie Kearsley who both
passed her Part 1 examination.
The Department continues to participate in high risk cardiac obstetrical cases and
multidisciplinary six weekly meetings with Dr. Kevin Walsh, Consultant
Cardiologist, Mater Misericordiae University Hospital, Dr. Fionnuala NíAinle,
Consultant Haematologist (Adult) and Dr. Peter McKenna, Consultant Obstetrician
Gynaecologist.
DELIVERY  SUITE  ACTIVITY
DELIVERIES UNDER EPIDURAL
The number of deliveries under epidural remains high, a similar rate to the
previous year. Patients receiving epidurals continue to receive patient controlled
epidural infusions PCEA with a background infusion.
Labour Analgesia is also provided by Entonox, TENS and Remifentanil PCA.
A Remifentanil PCA is available to patients in whom epidurals are
contraindicated or who want an alternative to epidural analgesia.  27 patients
this year opted for Remifentanil PCA.
Mode of Delivery for Parturients who select Epidural Analgesia.
Epidural  Workload 2014
Deliveries Under Epidural 2013 % 2014 %
Nulliparous {% of Primips less C/S 2327 72% 2331 70%
before labour {2013-3247}   {2014-3311}
Multiparous {% of Multips less C/S 1697 45% 1696 45%
before labour {2013-3740} {2014-3800}
TOTAL {Multips & Primips excluding Emerg/Elec 4024 4027
Onsets of labour  {2013-6987} {2014-7111}
Both Nulliparous & multiparous are less C/S onset
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Mode of Delivery for Parturients who Select Epidural Analgesia
NULLIPAROUS
Mode of Delivery 2013 % 2014 %
Normal 778 33.4 711 30.5
Forceps 298 12.8 254 10.9
Vacuum (Vacuum & 
Vacuum/Forceps) 715 30.7 757 32.5
L.S.C.S 535 23.0 606 26.0
Breech 1 0.04 3 0.1
Total 2327 2331
MULTIPAROUS
Mode of Delivery 2013 % 2014 %
Normal 1294 76.3 1281 75.5
Forceps 58 3.4 51 3.0
Vacuum (Vacuum & 
Vacuum/Forceps) 193 11.4 213 12.6
L.S.C.S 146 8.6 149 8.8
Breech 6 0.4 2 0.1
Total 1697 1696
Epidural % CSE %
2163 65.3 194 5.9
1517 39.9 197 5.2
3680 391
Some patients had CSE + Epidural so combined totals different
The obstetrical outcomes for  parturients receiving epidural analgesia remains
consistent with low dose techniques  with 33.5% of primiparous patients  and
75.5% of mutiparous patients  having normal unassisted deliveries.
CAESAREAN SECTION RATE 2013- 2014
2013
Mode of Anaesthesia Elective % Emergency %
Spinal 1312 96.8% 573 39.6%
GA 10 0.7% 160 11.1%
Epidural 2 0.1% 612 42.3%
CSE 32 2.4% 102 7.0%
Total 1356 1447
2014
Mode of Anaesthesia Elective % Emergency %
Spinal 1281 96.0 630 40.1
G.A. 13 1.0 139 8.8
Epidural 5 0.4 718 45.7
CSE 36 2.7 84 5.3
Total 1335 1571
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ANAESTHESIA OUTPATIENT CLINIC
The pre-operative assessment clinic continues on a weekly basis with 467
attendees.
The Cardiac Anaesthetic Clinic runs on a monthly basis.
OPERATING THEATRE ACTIVITY
GYNAECOLOGICAL REPORT
Operation Categories 2010 2011 2012 2013 2014
Obstetrical Majors 2469 2745 2604 2717 2821
Obstetrical Minors 1273 1287 1284 1259 1242
Vaginal  Surgery 677 626 610 609 592
Abdominal:Uterus 113 110 125 93 88
Abdominal:Tubes & Ovaries 360 336 317 311 295
Other procedures 2760 2615 2365 2245 2369
POST DURAL-PUNCTURE HEADACHE (PDPH)
There were 4027 epidurals performed and 1885 obstetric spinal anaesthetics and
614 combined spinal epidurals CSEs.  31 Post Dural Puncture Headaches (PDPH)
following placement of an epidural and 12 PDPH following spinal anaesthesia
were reported.  18 epidural blood patches were performed, 3 of these were to treat
spinal induced headache and 1 for CSE induced headache.  4 patients required a
second blood patch.  The rate of PDPH was 0.6%.                                                                                                                                             
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H I G H  D E P E N D E N C Y  U N I T
DR. MARY BOWEN  CONSULTANT ANAESTHETIST
Total   Admissions 245
Obstetrical  232
Gynaecological 13
Obstetric Category Number % Overall % Obstetric Admissions
Haemorrhage (APH/PPH)   86 35 35.1
PET / Eclampsia/ HELLP 40 16 17
Sepsis   33 13.4 14.2
Cardiac 15 6.1 6.4
Miscellaneous 47 19 20
Transfers 30
Mater Misericordiae 22 20 Transfers to MMUH
University Hospital (MMUH) 2   Transfers from MMUH
Beaumont Hospital (BH) 5 3   Transfers from BH
2   Transfers to BH
JCMH 1 1   Transfer from  JCMH
Cavan Hospital 2 2 Transfers from Cavan  Hospital
Transfers To MMUH 20 1. Hypotension post LSCS for CTPA 
/ Inotropic support, LVF.
2. Elective LSCS for placenta accreta in 
MMUH, cell salvage, radiology 
3. Transfer from Holles St. to MMUH 
acute Cauda Equina plus LSCS in MMUH,
transferred to Rotunda post delivery. 
4. Elective LSCS in MMUH. Patient with 
Kyphoscoliosis, restrictive lung 
disease, short stature, previous 
Tracheo-oesphageal fistula repair and 
ASD repair.
5. Patient with PET for plasmaphoresis. 
6. Complete heart block post SVD. 
7. Patient Massive PPH post delivery re-
laparotomy, abdominal packs in situ. 
8. Patient septic post LSCS under GA. ? 
Malaria. Unbooked pregnancy.
9. Maternal sepsis post SVD, pelvic 
abscess drained.
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10. Patient 5 days post SVD, severe 
headache. CT brain normal.
11. Post partum, unbooked pregnancy, 
thrombocytopenic, urosepsis. 
ARDS, Acute renal failure.
12. Patient with labial abscess, post 
operative stridor. ENT consultation.
13. Peripartum Cardiomyopathy. 
Transferred to CCU.
14. Patient developed Takotsubo 
Syndrome  perioperatively.
15. Patient 2 weeks post partum. 
Emergency LSCS 34/40. Intracranial 
bleed.  RIP.
16. Septic post caesarean section. Previous
myomectomies x2, laparotomies x 
2Tubo-ovarian abscess.
17. Emergency caesarean section. 
Multiple P.E. post caesarean section. 
IVC filter + anticoagulation.
18. Severe Thrombocytopenia post PET.
19. Seizures at 19weeks gestation. Hx of 
Heroin/substance abuse. Developed 
Tonic Clonic Seizures.
20. 6th caesarean section. PPH. Pink 
Serous fluid from abdominal drains. 
CT Abdomen. 
Transfer from MMUH. 2 • Patient 27/40 pregnant post 
laparotomy for appendicectomy.
• Ruptured Ectopic Pregnancy. 
Haemorrhagic Shock.
Transfer to Beaumont Hospital 2 • Acute renal impairment post delivery 
(Creatinine 773)
• Urosepsis and renal calculi.
Transfer from Beaumont Hospital 3 • Gynaecological patient with 
presumptive diagnosis of 
haemorrhagic cyst. Tachycardic, 
acidotic transferred back to Beaumont
hospital. Confirmed diagnosis of acute
Thyrotoxicosis.
• Ruptured Ectopic pregnancy, 2 litre 
blood loss.
• Vaginal Hysterectomy @ Mater Private
Hospital – Open Vault. Transfusion.
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Transfer From Cavan Hospital 2 • 21 /40 Twin pregnancy with Mirror 
Syndrome.
• DVT post SVD. Perineal haematoma. 
IVC filter in MMUH 3RCC transfused. 
Evacuation of haematoma.
Transfer from JCMH 1 • Previous LSCS. Involved in RTA- 
admitted to JCMH. Referred to 
Rotunda Hospital for assessment- not 
in labour at that time. Labour 
commenced, had emergency LSCS 
under general anaesthesia in Rotunda
Hospital. 
Cardiac Admissions: 5
1 Hypertrophic Obstructive Cardiomyopathy; ICD in situ LSCS.
2 Tetralogy of Fallot, emergency LSCS with pulmonary regurgitation 
awaiting valve replacement.
3 Transposition of Great Vessels. Thrombocytopenic: GA  LSCS.
4 Peripartum Cardiomyopathy.
5 Patient with SVT post delivery.
Miscellaneous  Admissions: 6
1 Patient with Gitelman Syndrome.
2 Patient with Bartter Syndrome.
3 Patient with Brugada Syndrome.
4 Patient with Lupus Nephritis.
5 6  Patients For Post Operatively Analgesia.
6 Pulmonary Embolism Post delivery.
Arterial   Lines   68
CVP Lines 15
D O V E  C L I N I C
DR MAEVE EOGAN, Consultant Obstetrician and Gynaecologist
DR JACK LAMBERT, Consultant in Infectious Diseases
DR WENDY FERGUSON, Infectious Diseases Associate Specialist Paediatrician 
(The Rainbow Team)
DR BARRY KELLEHER, Consultant in GI/Hepatology
DR RICHARD DREW, Consultant Microbiologist 
MS MAIREAD LAWLESS, ID Liaison Midwife
MR JUSTIN GLEESON, Drug Liaison Midwife 
MS RUTH POWER, Medical Social Worker
DR VALERIE JACKSON, Clinical Audit & Surveillance Scientist
INTRODUCTION
The DOVE clinic was set up to look after the specific needs of women who have
or are at risk of blood and sexually transmitted bacterial and viral infections.
This could be through drug use, unprotected sex, or any contact with infected
blood or body fluid.   
DOVE BOOKINGS IN 2014
During 2014,178 women booked into the DOVE clinic for their antenatal care. Of
these,
• 43 (24.1% of bookings) women were positive for Hepatitis B surface antigen,
representing a decrease of 27% compared to 2013 (Fig 1). 
• 51 (28.6%) women were positive for Hepatitis C antibody, a decrease of 14% 
compared to 2013.
• 25 (14%) were positive for HIV infection an increase of 4% compared to 2013.
• 24 (13.4%) women had positive Treponemal serology, an increase of 10% 
compared to 2013.
• 52 (29.2%) women were known to be on prescribed methadone programs, 
an increase of 8% compared with 2013. 
• 72 women attended for treatment for Chlamydia Trachomatis infection in 
2014. 
Fig 1: DOVE Bookings by Year
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DOVE DELIVERIES 2014
Deliveries to HIV Positive Mothers 2014
Total Mothers Delivered <500g (incl miscarriage) 0
Total Mothers Delivered >500g 18
Total Mothers Delivered 18
Live Infants 18
Miscarriage 0
Stillbirths 0
Infants <37 weeks gestation 1
Infants ≥37 weeks gestation 17
Infants delivered by Caesarean Section 8
HIV Positive Infants 0
Maternal Data (n=18)
Median Age 34
Newly Diagnosed at ANS 4
NND = neonatal death
Deliveries to HCV Positive Mothers 2014
Total Mothers Delivered <500g (incl miscarriage) 1
Total Mothers Delivered >500g 43
Total Mothers Delivered 44
Live Infants 44*
Miscarriage 1
Stillbirths 0
Infants <37 weeks gestation 6
Infants ≥37 weeks gestation 36
Infants delivered by Caesarean Section 17
HCV Positive Infants 3**
Maternal Data (n=43)
Median Age 33
Newly Diagnosed at ANS 4
* 2 delivered elsewhere/ 1 set of twins **Final serology not yet available for all infants.
Deliveries to HBV Positive Mothers 2014
Total Mothers Delivered <500g (incl miscarriage) 1
Total Mothers Delivered >500g 39
Total Mothers Delivered 40
Live Infants 41*
Miscarriage 1 
Stillbirths 0
Infants <37 weeks gestation 3
Infants ≥37 weeks gestation 38
Infants delivered by Caesarean Section 15
HBV Positive Infants 0**
Maternal Data (n=43)
Median Age 31
Newly Diagnosed at ANS 5
*3 delivered elsewhere/ 2 sets of twins **Final serology not yet available for all infants
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Deliveries to Syphilis Positive Mothers 2014
Total Mothers Delivered <500g (incl miscarriage) 2
Total Mothers Delivered >500g 20
Total Mothers Delivered 22
Live Infants 20
Miscarriage 2
Stillbirths 0
Infants <37 weeks gestation 0
Infants ≥37 weeks gestation 20
Infants delivered by Caesarean Section 8
Syphilis Positive Infants 0
Maternal Data (n=20)
Median Age 31.9
Newly Diagnosed at ANS 10
Deliveries to Mothers under DLM* service 2014
Total Mothers Delivered <500g (incl miscarriage) 2
Total Mothers Delivered >500g 68
Total Mothers Delivered 70
Live Infants 69(2 sets of twins)
Miscarriage 2
Stillbirths 1 (cord prolapse)
Infants <37 weeks gestation 12
Infants ≥37 weeks gestation 58
Infants delivered by Caesarean Section 24
NICU admissions for NAS 14
*DLM: Drug Liaison Midwife
In 2014, 231 infants attended the Rotunda Paediatric Infectious disease clinic (The
Rainbow clinic) for follow up. The clinic is delivered solely by a paediatric specialist
(Dr Ferguson).
EDUCATION AND TRAINING 
Members of the DOVE team continue to be actively involved in undergraduate,
postgraduate and hospital education programmes. 
The British Association for Sexual Health and HIV (BASHH) accredited Sexually
Transmitted Infection Foundation (STIF) Course continues to be held Dublin,
with Dr Lambert acting as course director, and Dr Eogan providing teaching on
management of rape and sexual assault. The course took place in June and
November 2014 and provided multidisciplinary training in the attitudes, skills,
and knowledge required for the prevention and management of STIs. Further
courses are planned for 2015. 
Dr Wendy Ferguson was a member of the writing committee for the revised
national guidelines on Preventing Perinatal Transmission. This document gives
a comprehensive and practical overview of care pathways for antenatal,
perinatal and postnatal management of HIV, HBV, HCV, Syphilis and Herpes
Simplex Virus. This document was presented, with feedback requested, at an
interdisciplinary forum at the Annual JOGS meeting and Four Provinces Study
day at the Institute of Obstetrics and Gynaecology in November 2014. It is
anticipated that the peer reviewed Guidelines will be launched in mid 2015 and
will be available at www.sstdi.com 
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Members of the DOVE team, particularly Dr Jack Lambert, were actively involved
with multidisciplinary discussions and training on care of pregnant patients in the
context of the largest known outbreak of Ebola Virus (EVD) in West Africa. While
Ebola virus has never been diagnosed in this country, and indeed the risk of imported
cases was low, it was not impossible that a case could arise and it was vital that
infrastructure, staff and services were prepared to respond safely and appropriately. 
RESEARCH ACTIVITIES OF THE DOVE CLINIC
There are several research projects ongoing, many in collaboration with other
disciplines within the Rotunda Hospital and also with the ID and Hepatology teams
at the Mater Misericordiae University Hospital. Areas of interest include the
emergence of drug resistance and the pharmacokinetics of HAART during pregnancy. 
STAFF CHANGES
In 2014 we welcomed Ruth Power (Medical Social Worker) to the DOVE team. In
2014 Dr Richard Drew also joined the Rotunda and Temple Street hospitals as
Consultant Clinical Microbiologist. He has been a most welcome addition to the
team and we acknowledge the significant work of all laboratory staff with regard
to provision of a prompt and efficient service for our patients. We also welcome
Brian Cleary, Chief Pharmacist, back to the Rotunda. Brian has collaborated with
the team previously and we look forward to his ongoing support and further
collaborative projects. 
PUBLICATIONS AND PRESENTATIONS
1. Jackson V, Ferguson W, Kelleher TB, Lawless M, Eogan M, Nusgen U, Coughlan S,
Connell J, Lambert JS. Lamivudine treatment and outcome in pregnant women
with high hepatitis B viral loads. Eur J Clin Microbiol Infect Dis. 2014 34 (3) 619-23. 
2. Bergin S, Ferguson W, Corcoran S, Varughese, Byrne D, Lawless M, Eogan M,
Lambert J. Symptomatic primary Cytomegalovirus infection in a HIV-positive
pregnant woman. International Journal of STD & AIDS 2014. Vol 25 (14) 1041-3. 
3. Monteith C, Ní Ainle F, Cooley S, Lambert JS, Kelleher B, Jackson V, Eogan M.
Hepatitis C virus- associated thrombocytopenia in pregnancy: impact upon
multidisciplinary care provision. J Perinatal Med. 2014; 42(1):135-8
4. LJ Else, V Jackson, M Brennan, DJ Back, SH Khoo, S Coulter-Smith and JS
Lambert. Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy.
HIV Medicine. 2014 Nov;15(10):604-10.
5. Lambert J, Jackson V, Else L, Lawless M, McDonald G, Le Blanc D, Patel A,
Stephens K, Khoo S. Darunavir pharmacokinetics throughout pregnancy and
postpartum. HIV Drug Therapy, 2-5 November 2014, Glasgow, UK
6. Lambert J. HIV in Pregnancy. Royal College of Obstetricians and
Gynaecologists, Maternal Medicine: Medical Complications in Pregnancy. 5-
6 March 2014, RCOG, London, UK. 
7. Lambert J. The Ebola Virus Disease Outbreak-update and implications for
Health Professionals. Faculty of Occupational Medicine, 2014 Autumn
Conference, 3rd October 2014. 
8. Lambert J. Ebola Conference. 12th November 2014. Catherine McAuley
Education & Research Centre, 21 Nelson St, Dublin 7, Ireland.
9. JS Lambert. Incidence of gestational diabetes mellitus (GDM) in a cohort of
HIV positive pregnant women.Third Joint Conference of the British HIV
Association (BHIVA) with the British Association for Sexual Health and HIV
(BASHH)1–4 April 2014, Arena and Conference Centre, Liverpool, UK.
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STEPHANIE RYAN  FFR RCSI 
NEIL HICKEY FFR RCSI
AILBHE TARRANT FFR RCSI
The radiology department in the Rotunda Hospital performed 7,341 exams in
2014 representing no significant change in activity over 2013 figures. Our
department images both adults and children. 94% of these were pediatric
examinations and 6% were adult examinations.
We continue to train radiographers in ultrasonography and in particular in hip
sonography and continue to provide a neonatal hip screening programme.  We
continue to have quarterly meetings in quality improvement and audit.
ADULT RADIOLOGY 
The adult radiology service in the Rotunda Hospital is provided by Dr. Neil
Hickey. In 2014 a total of 440 adult radiological examinations were performed of
which 151 (34%) were hysterosalpingograms, performed as part of the fertility
clinic work up. Other examinations also include other fluoroscopic procedures
such as cystograms, non-obstetrical ultrasound (general abdominal, renal,
pelvic, head and neck, vascular and soft tissue) and plain films.
PAEDIATRIC RADIOLOGY 
Pediatric imaging accounts for 94% of the workload in the Department of Radiology.
In 2014, a total of 6,900 paediatric studies were performed. Of these, just over half
(3,634) were paediatric ultrasound examinations. 
Over half (1,819) of the ultrasounds performed are hip ultrasounds performed as part
of the screening service for developmental dysplasia of the hip. As the hip screening
service is well established now, there has been no significant change in the number
of hip ultrasound scans performed since 2013. The number of hip x-rays performed
was 1,001, a slight decrease when compared with the same period in 2013. 
In addition, 59 fluoroscopic studies were performed predominantly for investigation
of the upper GI tract (51), but also for evaluation of the lower GI tract (8), often as an
emergency out of hours study. There continue to be modified feeding studies
performed in Rotunda hospital but many of these still need to be referred to TSH
where facilities for feeding the baby upright are available and where the advice of
the Speech and Language therapists can be sought.
The MRI unit at the Children’s University Hospital, Temple Street, which has state of
the art neonatal monitoring equipment, scanned a total of 119 Rotunda babies from
both NICU and POPD.  This is particularly valuable in the evaluation of the newborn
with neonatal encephalopathy and adds very useful additional information to the
bedside cranial ultrasound examination. MRI scanning was also used for the 
R A D I O L O G Y /
P A E D I A T R I C  U L T R A S O U N D
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evaluation of babies with brain and spine malformations as well as metabolic
and other diseases.  15 paediatric patients were referred to Temple Street for CT
scanning.  Fetal MR imaging was also done in Temple Street for 32 obstetric
patients at the Rotunda. Many of these Rotunda babies are discussed at
multidisciplinary meetings in Temple Street Children’s University Hospital
attended by Rotunda neonatologists and radiologists and where the input of
paediatric neurology and paediatric neurosurgery teams is valuable.
Both Dr Ryan and Dr Tarrant are actively involved in training at several levels
and in paediatric radiology research. Several audits have been performed. There
were several publications from our department as well as presentations and
lectures at national meetings. 2014 was the 3rd year of a cranial ultrasound
course, organised by the pediatric MD registrar and the department of radiology.
This course is a practical course for pediatric trainees designed to give
participants an introduction to cranial ultrasound and provide practical hands
on experience for neonatal/paediatric trainees. Again, this was well attended
and it is foreseen that it will continue on an annual basis. 
TABLE 1: STAFF COMPLIMENT 2014
WTE
Diagnostic radiographers / ultrasonographers 2.5
Secretary 0.5
Consultant paediatric radiologist 0.76
Consultant adult radiologist 0.20
Senior medical physicist As needed
TABLE 2: ACTIVITY LEVELS 2014
TOTAL ACTIVITY 7,341
TOTAL ADULT EXAMS 440
HSG 151
TOTAL PAEDS   (X-ray & US) 6,900
TOTAL PAEDS US 3,634
HIP US 1,819
NEONATAL FLUOROSCOPY 59
PUBLICATIONS AND PRESENTATIONS
PUBLICATIONS 2014
1. J Perinatol. 2014 Dec 11. doi: 10.1038/jp.2014.219. [Epub ahead of print]
Inclusion of extremes of prematurity in ventricular index centile charts.
Boyle M1, Shim R2, Gnanasekaran R2, Tarrant A3, Ryan S3, Foran A4, McCallion
N4.
2. Using lateral radiographs to determine umbilical venous catheter tip position
in neonates.Butler GC, Al-Assaf N, Tarrant A, Ryan S, El-Khuffash A.
Ir Med J. 2014 Sep;107(8):256-8. PMID: 25282975
PUBLICATIONS AND PRESENTATIONS STEPHANIE RYAN 2014
Book Chapter
1. S. Ryan - CD of Radiological case studies in Diagnosing and Treating 
Common Problems in Paediatrics - The Essential Evidence-Based Study 
Guide  Michael O'Neill, Michelle McEvoy, Alf Nicholson. Radcliffe Publishing,
London. 2014
Publications
1. Butler G, Assaf N, Tarrant A, Ryan S, EL-Khuffash A. Using Lateral 
Radiographs to Determine Umbilical Venous Catheter Tip Position in 
Neonates: A Comparison with Anteroposterior Films. IMJ (2014) 107(8): 256- 8
2. Boyle M, Shim R, Gnanasekaran R, Tarrant A, Ryan S, Foran A, and McCallion
N. Inclusion of extremes of prematurity in ventricular centile charts.  
J Perinatology. Accepted for publication Oct 2014
Presentations
1. Botulinum Toxin Injections for Sialorrhoea: too hard to swallow? A. 
O’Riordan, C. Moore, K. Davies,  S. Ryan, O. Hensey. Joint Irish Paediatric 
Association(IPA)/Irish & American Paediatric Society(IAPS) Annual Meeting,
September 2014, Cork
2. Non Traumatic Low Back Pain in Children.  G Prego, S Ryan et al. European 
Course Paed MSK Radiology, Sheffield, England Oct 2014.
3. Gastro-jejunal Feeding: Service evaluation in Temple Street University 
Hospital. M Walsh, A Sills, S Macken, E Laffan and S Ryan. Temple Street 
Hospital Audit Day, 12 Dec 2014
Invited Lectures
1. Imaging of feeding and swallowing disorders in Children at Introduction to
Paed Videofluoroscopic Swallow Studies Study Day Crumlin 28 May 2014
2. Role of Neuroimaging in Medicolegal Birth Injury cases. Conference on 
Medico-Legal Issues in Obstetric and Neonatal Care, Dublin,  9 October 2014,
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MS. MARGARET PHILBIN, DIRECTOR OF MIDWIFERY/NURSING
The hospital again experienced high levels of activity throughout 2014.
Midwives and Nurses continued to meet the challenges posed by capacity and
activity issues. The team worked with skill and dedication to provide high
quality care for women, babies and families both within the hospital and in the
community. The ongoing commitment of staff to the hospital and to those who
attend for care is truly appreciated. 
STAFFING
Ms. M. Philbin Director of Midwifery/Nursing
Ms. P. Williamson Assistant Director of Midwifery/Nursing
Ms. F. Hanrahan Assistant Director of Midwifery/Nursing
Ms. M. Keane Assistant Director of Midwifery/Nursing
Ms. C. Halloran Assistant Director of Midwifery/Nursing (from 24/03/14)
Ms. M. O’Reilly            Practice Development Co-ordinator
Ms. A. O’Byrne Practice Development Co-ordinator
Ms. M. Brennan Assistant Director of Midwifery/Nursing-Infection Control
Ms. J. MacFarlane Night Superintendent
Ms. Aideen Keenan Acting Night Superintendent (from 02/07/14)
Ms. M. Whelan Clinical Audit Facilitator
STAFF IN POST AT 31ST DECEMBER 2014
POST WTE in Post
Director of Midwifery/Nursing 1
Midwifery/Nursing Administration 7.76
Practice Development Co-ordinators 1.60
Advanced Nurse Practitioner (Neonatology) 2
CMM/CNM 3 5.90
Clinical Skills Co-ordinator 1.80
Clinical Placement Co-ordinator (BSc Midwifery) 2.90
Allocations Officer (BSc Midwifery) 0.45
PGDM Clinical Co-ordinator 1
Neonatal Discharge Co-ordinator 1
Colposcopy Nurse Co-ordinators                                                                           2
CMM/CNM 2 33.11
CMS/CNS 10.80
CMM/CNM 1 21.46
Staff Midwives 145.98
Staff Nurses 75.45
Student Midwives 19.95
Maternity Care Assistants 28.60
Total 362.76
D E PA R T M E N T  O F
M I D W I F E R Y / N U R S I N G
APPOINTMENTS WTE
Midwives and Nurses        Midwifery Students
18.33   28.5
TOTAL:   46.83
RESIGNATIONS/ RETIREMENTS
Midwives and Nurses    Midwifery Students
27.90 17
TOTAL:    34.90
RETIREMENTS/RESIGNATIONS
There were no retirements from the Midwifery and Nursing staff in 2014. 
RECRUITMENT AND RETENTION
Recruitment and retention of appropriately trained and skilled Midwifery and
Nursing staff continued to be a major focus for the hospital in 2014 as in previous
years. We were extremely fortunate to have been in a position to offer a
substantial number of midwifery positions to our Higher Diploma and
Undergraduate Midwifery Students upon receipt of their NMBI registration.
Despite this we continue to experience difficulty recruiting staff into specialised
areas, in particular, the Neonatal Intensive Care Unit. 
HOSPITAL BASED MIDWIFERY AND NURSING SERVICES
Staff in the Adult Outpatient Department led by CMM2 Chanelle Porter facilitated
a total of 42,635 attendances of pregnant women during 2014 representing an
increase of 600 on the previous year. An additional 9,243 attendances to specialist
clinics were recorded, an increase of almost 3,000 from 2013.  A further 4,005
women attended the Early Pregnancy Unit. This heightened workload is reflective
of the increasing complexity faced by the Maternity services.
The Midwifery Inpatient Antenatal Service incorporating Day Care, Fetal
Assessment, Ultrasound and Fetal Medicine is led by CMM 3 Mary Deering working
with a team of dedicated Midwives and Sonographers. The service provided by the
team is recognised as being critical to the successful management of patients. There
were a total of 20,774 attendances at Ultrasound, Fetal Assessment and Prenatal
Diagnosis clinics during the year, which represents an increase of approximately
700 in the last 12 months. The new Day Assessment Unit was officially opened on
2nd March 2014 following a multidisciplinary collaboration lead by the Clinical
Director and CMM 3. The unit now provides a full 5 day service operating until
18.00hrs most days. Previously located in the Outpatients Department the unit was
relocated to a designated ward in the General Prenatal Department to facilitate this
service development. The new service facilitates the ongoing assessment and
management of women with a variety of conditions. Women with Intrauterine
Growth Retardation, Cholestasis, PPROM and Blood Sugar Series are now managed
on an outpatient basis following diagnosis thus reducing inpatient stay. The total
number of attendances in 2014 was 3,773 and the admission rate from the Day Care
Unit was between 5 – 9%. Table 1 illustrates the reason for attendance to the unit and
the numbers of attendees during 2014:100
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Table 1: Attendance at Day Care 
Attendance Reason Number
Antenatal and Postnatal Hypertension 1109
Cardiotcograph Monitoring 1101
Obstetric Cholestasis 212
Intrauterine Growth Retardation 199
Blood Sugar Series 189
Preterm Pre-labour Rupture of Membranes 128
Hyperemesis 49
IVIG 21
IV Antibiotic Administration 19
Prolutin Administration 326
Dexamethazone Administration 139
Insulin Education 70
Iron Infusion 19
Miscellaneous 192
I am extremely grateful to the many staff members who worked so hard to ensure
the success of this new venture.
The Nurses and Midwives in the Neonatal Intensive Care Unit led by CMM 3 Orla
O’Byrne faced an increase in activity with a total of 1,417 babies being admitted to
the unit compared to a figure of 1,331 in 2013. Seventy-eight of these babies were
transferred into the unit from other hospitals situated within and outside of the
RCSI Hospitals Group. The Paediatric Outpatients Department facilitated 8,757
neonatal reviews which was similar to the figure for the previous 12 months.
Ongoing education for all staff in the neonatal unit continued throughout 2014.
Two staff successfully completed the Postgraduate Diploma in Neonatal Nursing
with the RCSI and a further three staff members were sponsored to undertake the
programme, which commenced in September 2014. A number of staff are also
undertaking educational programmes at Master of Science level in Neonatal
Intensive Care Nursing. In 2014, the Foundation Programme in Neonatal Nursing
was well supported with four staff from the Rotunda in attendance. The feedback
from staff participating in both Level 1 and Level 2 programmes has been very
positive and it is envisaged that more staff will be supported to do this course in
the future. CNM 1 Mark Hollywood commenced the MSc in Advanced Nurse
Practice (Neonatology) Programme in 2014 with a view to facilitating an expansion
of numbers of Advanced Practitioners within the unit. Throughout the year
Nursing staff were also supported to attend National and International Neonatal
Nursing Conferences.
2014 was another challenging year for the staff in the Delivery Suite with a rise in
deliveries from the previous year. A total of 8,787 women delivered 8,980 babies in
the unit. Despite this increase the staff led by Acting CMM 3 Geraldine Gannon,
continued to provide individualised care to women and families in a competent
professional manner. Approximately 27,000 women attended the Emergency and
Assessment Unit (which falls under the remit of the Delivery Suite) in 2014, the
majority of whom were attending with pregnancy related problems. The
Manchester Triage system was introduced this year which resulted in a reduction
in the average waiting time for a midwife assessment from 1 hour to 20 minutes 
102
with urgent cases being seen immediately. Advanced Midwife Practitioner
Candidate Bernadette Gregg joined the department late in 2014. Work is
progressing to have this post fully accredited in the latter part of 2015. This will be
the first midwifery post of this nature to be introduced in to the Rotunda Hospital
and will enhance existing services in the Emergency and Assessment Unit. 
We are constantly striving to improve the quality of care for women, and staff
continued to enhance their professional development and skills in a variety of
ways with an emphasis on Obstetric Emergency Skills, Basic Life Support and
Neonatal Resuscitation Programmes. Five Midwives completed the advanced
cardiac life support programme in 2014. Twenty-two Midwives completed the
Perineal Suturing Programme and sixteen have completed competency
assessments in this regard. All Midwives in the Delivery Suite have completed the
K2 training programme (CTG) and over 90% are competent in IV cannulation. A
number of staff have completed a programme of study in Hypnobirthing. This will
enable the introduction of antenatal education in Hypnobirthing Techniques
which use relaxation tools to support women and their birthing partners during
labour and delivery. 
The Theatre Nursing and Midwifery Team led by CMM 3 Jane Hickey continued to
experience high levels of activity. The team assisted with a total of 1,707
Colposcopy, 1,174 day cases and 1,878 elective and non elective Gynaecological
surgical operations in 2014. In addition, a total of 2,753 Caesarean Sections were
performed. We were fortunate to be in a position to increase the Nursing
/Midwifery staffing levels in Theatre during the year which had a positive impact
on our ability to face the challenges posed by the level of activity.
Staff in the Gynaecological Department led by CNM 2 Helen Enyinnaya also faced
a challenging year. Care was provided to a range of antenatal, postnatal and high
dependency admissions coupled with elective and emergency gynaecological
cases. Bereaved couples were also predominantly cared for in the Gynaecological
Department. This diverse casemix results in a complex and hugely demanding
work environment for the staff in this department.
Maternity Care Assistants continue to play a pivotal role in assisting in the
provision of patient care. Their contribution to the services provided by the
hospital throughout the year is enormous and is very much appreciated.
COMMUNITY MIDWIFERY SERVICES
The Community Midwifery Team led by CMM 3 Sinead Heaney continued to
enhance the services they provide throughout 2014. A new clinic in Darndale
was opened which brings the total number of clinics provided in community
settings to eight. This clinic is being run in conjunction with the ‘Preparing for
Life’ and Northside Partnership. The clinic is run every Tuesday from 10.00hrs to
12.00hrs. As this is a new clinic the uptake has been slowly growing throughout
the year with approx 10-15 women now attending each session.
In 2014, a total of 1,545 women booked for antenatal care with the Community
Midwifery Team which represents a significant increase on the previous year.
Women are booked directly (home booking visits with the Community Midwife) and
indirectly (referrals from the Adult Outpatients Department). The team continue
to provide all aspects of antenatal care including booking visits and 
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subsequent home visits where appropriate in addition to facilitating a number
of clinics in local health centres.
A total of 264 women left the scheme at varying stages of their pregnancies. These
women were deemed unsuitable to continue under the care of the Community
Midwifery Team for varying medical reasons and were referred back to the hospital
for Obstetric care by the attending Midwives at the outlying antenatal clinics as
referenced in Table 2 below. Ten women moved out of our catchment area during
their pregnancy and a total of 23 women were referred back to the AOPD as they had
defaulted on appointments for 2 or more community visits. 
Table 2: Indications for referral from the Community Midwifery Service for
Obstetric Review and Ongoing Care
Referrals Numbers
Small for Dates/ Oligohydramnios 24
Large for Dates / Polyhydramnios 18
Breech Presentation 7
Positive Glucose Tolerance Test 26
Abnormal Glucose Tolerance Test 25
Ante Partum Haemorrhage / NSAPH 11
Hypertension 9
Outcomes for women attending the Community Midwifery Services remained
roughly on a par with the 2013 figures. Out of a total of 1,281 deliveries, 63.5%
(N=818) of women had a spontaneous vertex delivery. The emergency caesarean
section rate within this cohort remained at 12% (N=154) and the elective
caesarean rate was 3% (N=36). Two women suffered late miscarriages with
babies delivered at 20+4 and 23 weeks gestation respectively representing 0.15%
of the total delivered. These babies were diagnosed with a fetal anomaly on post
mortem examination.  There was one unexplained stillbirth recorded of a baby
at 39 weeks gestation. This mother had no antenatal complications observed and
no post-mortem was undertaken at the request of the parents.  Our sincere
sympathies are extended to these bereaved families. Further details of the
outcome of care are reflected in Table 3 below:
Table 3: Outcomes of Care
Total Deliveries 1,281 100%
Spont Vertex 818 63.5%
Ventouse 181 14%
M/C Forceps 46 4%
Ventouse/Forceps 23 2%
Emergency Caesarean Section 154 2%
Elective Caesarean Section 36 3%
Born Before Arrival 6 0.5%
Face to Pubis 6 0.5%
Breech 3 0.2%
Late Miscarriage 2 0.15%
Stillborn 1 0.07%
Choice of Analgesia
Pethidine 79 6.2%
Entonox 682 53%
Epidural 635 50%
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LACTATION SERVICES
The Rotunda Hospital remains the only Dublin Maternity Hospital to have
achieved the National Baby Friendly Accreditation Award. The hospital also
continues to hold the Baby Friendly Health Initiative ‘Breastfeeding Supportive
Workplace’ Silver Award. 
We are extremely grateful for the work of our Lactation Specialists, Maura Lavery
and Aisling Breathnach, who assist the hospital to protect, promote and support
breastfeeding as the optimal way for a mother to feed her baby.  Acknowledging
that breast milk offers important health benefits for both mother and child we
strive to assist as many women as possible to initiate breastfeeding. The
initiation rate remained high at 67 % in 2014. 
Supports available for breastfeeding mothers and babies in the hospital include:
• Breastfeeding information is given to the expectant mothers by 
midwives in the Antenatal Clinic. If mothers have a specific problem 
they may be referred to see the Lactation Specialist.
• Pregnant women and their partners who attend antenatal clinics and 
classes are informed of the benefits and management of breastfeeding. 
• A breastfeeding workshop is provided by the Lactation Specialist every 
Tuesday and Thursday evening.
• Hospital policies include mother friendly labour and birthing practices.
• Skin to Skin contact is policy for all mothers and babies including those
following a caesarean section. 
• Skin to skin contact is encouraged for at least 60 minutes post delivery 
and babies are offered the first breastfeed at this time.
• Individual assistance and support with early breastfeeding problems is 
available from postnatal ward staff. 
• The Lactation Specialist attends the ward when more specialised care 
and advice is necessary.
• Postnatal breastfeeding information sessions are held at ward level.
• An outpatient service is available for mothers with breastfeeding issues
from Monday to Friday.
• A phone counselling and advice service is available Monday to Friday.
• A breastfeeding support group is held every Thursday between 11.30hrs 
and 12.30hrs.
• Community links with Public Health Nurses, General Practitioners and 
Voluntary Support Groups are an important resource outside of the 
hospital setting. Mothers are advised to link in with these services. 
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Breastfeeding Committee Meetings  
This multi-disciplinary committee which also includes members from the
voluntary breastfeeding support groups continued to meet during 2014. There
were 4 meetings held during the year. 
Breastfeeding Education
Joint breastfeeding training continued to be facilitated by the 3 Dublin
Maternity Hospitals for Nurses and Midwives comprising of four 20 hour
training sessions and three refresher courses. Breastfeeding lectures were
included in orientation days for all new staff. Breastfeeding lectures were also
provided for Medical Students and those attending the Higher Diploma in
Neonatal Nursing programme. In service training for Midwives and Nursing
staff was provided at ward level.
National Breastfeeding Week
To celebrate this important week a breastfeeding information stand was
positioned in the main reception area for all staff, expectant and delivered
mothers and their families. A coffee morning was organised in the Board Room
on Thursday the 2nd of October which was attended by a large number of
mothers and their babies. A breastfeeding quiz was held for staff which proved
to be very popular.
PERINATAL MENTAL HEALTH SERVICE
The Midwifery Perinatal Mental Health Team comprising of CNM2 Kathleen O’
Donohoe and CMM2 Ursula Nagle continued to play a very active role in the
provision of this specialised service in 2014. A total of 1,432 women reported a
mental health history at their booking visit during the year. All of these women
were given the opportunity to contact the services antenatally following which
individual meetings were organised to continue to support them during their
pregnancy and to facilitate brief intervention following delivery. 
The 1,432 women who reported a history a mental health illness represented 16%
of the total number of women (8,787) who delivered in the Rotunda Hospital in
2014.  The variety of mental health illnesses reported at booking are illustrated
in Table 4 below:
Table 4: Mental Illness History Reported at Booking Visit 
Depression No Treatment 169
Depression 16
Anxiety 427
BPAD 17
Depression Requiring Treatment 462
No Diagnosis 0
Manic Depression 1
Other 279
Post Natal Depression 220
Puerperal Depression  Requiring Treatment 63
Schizophrenia 3
106
A total of 462 women gave a history of Depression requiring treatment. A further
427 gave a history of Anxiety with a number reporting co-morbidities. A small
number of women reported a previous diagnosis of Schizophrenia and 18 reported
a history of Bipolar Disorder/Manic Depression. An enquiry at booking regarding
personal and family history of mental illness is recognised as best practise as a
history of same is a predictor of perinatal mental illness.
The team saw 515 women in the Health Promotion Clinic.  These women are seen
individually for up to an hour each. The sessions include an individual assessment;
talk therapy, support and relaxation techniques which are provided in both the
antenatal and postnatal periods. Women can avail of this service for up to four
months post delivery. 
A further 1,406 women with a mental health history were reviewed at ward level
for brief intervention, including health promotion, mental health management and
follow up service advice. In addition, the Mental Health Support Midwives support
the practice of offering every woman in the Rotunda the opportunity to complete
the Edinburgh Postnatal Depression Score before discharge. 
Staff in the department undertook a number of audits during the year:
• An Audit of the documentation of mental health care in the Obstetric Chart 
was conducted in March 2014. Documentation to support the two way flow of
information between the Mental Health Team and Obstetric/Midwifery 
Teams in the hospital throughout the antenatal and postnatal period was 
introduced following a Coroner’s recommendation in 2013. The results 
indicated a 95% compliance rate with the hospital protocol. 
• An audit of completion of the Edinburgh Postnatal Depression Scale (EPDS) 
on discharge was undertaken during the year. The EPDS is a self reporting 
assessment tool to monitor mood.  All women are offered the opportunity to
complete the EPDS prior to discharge.  The results showed that 66% of women
discharged home from the Rotunda had completed the EPDS.
Completion of the EPDS prior to discharge is recommended best practice.  There is a
well established discharge summary with a mandatory section for EPDS scores that
is distributed to all General Practitioners and Public Health Nurses. In order to
increase the rate of compliance the Mental Health Support Midwives collaborated
with colleagues on the postnatal wards, in Outpatients and on the Community
Midwives Team to improve staff education regarding the importance and value of
the EPDS and the recommendation of offering women the opportunity to complete
the tool. A further EPDS Audit has been conducted the results of which will be
available in early 2015.
The team organised a colourful poster and leaflet stand at the Rotunda Reception of
the Rotunda to raise awareness of Mental Health for World Mental Health Week in
October 2014.  The promotion created much interest as evidenced by the numbers of
leaflets taken and enquiries provoked.
There is a steady demand for the Mental Health Support Team to present to
Midwifery Students in TCD. Public Health Nurse colleagues also attended for
training on assessment, treatment and referral of women with a mental health
history.
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The Rotunda Mental Health Support Midwives and Public Health Nurses from
Dublin’s North City have joined together to form a working group to develop and
improve services in Perinatal Mental Health in the region. The team also work
closely with Perinatal Mental Health colleagues in the National Maternity and
Coombe Hospitals which culminated in a very successful Study Day for Midwives
hosted by the Rotunda in March 2014.
BEREAVEMENT SUPPORT AND CHAPLAINCY SERVICES
The Rotunda Hospital acknowledges that the loss of a baby during pregnancy or
following delivery is a one of the most painful experiences imaginable in any
parent’s life, and we offer a range of services provided through the Bereavement,
Recurrent Pregnancy Loss, and Prenatal Diagnosis clinics to afford bereaved
parents the necessary support to meet their individual needs. 
The Bereavement Team, which includes the Bereavement Support Midwife Trish
Butler, the Hospital Lay Chaplain Ann Charlton, a dedicated Medical Social
Worker, Administrative Assistant, and Anatomical Pathology Technicians
provided sensitive, compassionate and individualised care to the families of the
259 babies who died at all gestations in 2014. 
Education sessions were provided by the Bereavement Team during the year,
including full study days for BScM Midwifery Students, and Midwives and Nurses
in conjunction with the Centre for Midwifery Education. Training sessions for
Non Consultant Hospital Doctors and Non Medical Staff were also delivered. 
The work of the hospital is greatly assisted by the Chaplains and Ministers who
are available to offer support to patients and staff alike. Their dedication and
attention to women, their babies, families and staff is very much appreciated. 
ANNUAL SERVICE OF REMEMBRANCE
The Annual Service of Remembrance was held in the Pro-Cathedral in November
2014 with an attendance of approximately 1,100. We are again very grateful for
the continued support of The Very Reverend, Cannon Damian O’Reilly in
facilitating this extremely important event where we gather to remember and
honour the precious short lives of babies who died during the year. Increasingly
we see parents and families of babies who died long ago attend this service. The
service was also attended by Chaplains from the main Churches, members of the
Board of Governors, the Executive Management Team and many staff members.
The occasion was enhanced by the music provided by soloist Mary Flynn and
harpist Denise Kelly. We extend our gratitude to the numerous staff members
who volunteered to assist on the day. Following the Service many families joined
the Governors and staff in the Gresham Hotel for light refreshments. 
BOOKS OF REMEMBRANCE
The Books of Remembrance which are a key feature of the Remembrance Service
are reserved in the Hospital Mortuary Chapel. Babies’ names are entered by the
Hospital Chaplain at the request of parents.
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PARENT EDUCATION
The Parent Education Midwife, Margaret Merrigan Feenan working closely with the
Physiotherapy Department continued to provide an extensive range of education
sessions to both in-patients and outpatients during 2014. Demand for this service
remained high and an additional first class was added to meet the requirements.
Parent education sessions aim to convey positive messages to parents regarding their
role in the development of healthy children and their lifestyles.  This is achieved by
woman focused sessions with the role of the father emphasised throughout.
Education is provided to expectant women and their birth partners on issues relating
to pregnancy, labour and the immediate postnatal period with feeding choices, baby
care and the future demands of parenthood also discussed.  Information is also
provided to inform parents where to source support and resources when they go
home with their new baby. Special education sessions were organised for groups
with specific identified needs including:
• Those with hearing disabilities
• Parents with sight disabilities
• Those with language difficulties
MIDWIFERY EDUCATION / PRACTICE DEVELOPMENT UNIT 
The role of Practice Development is tripartite in nature and includes:
• Student support through supervision and guidance 
• Implementation of quality improvement measures
• Midwifery/Nursing practice development through staff development, 
education and support
Throughout 2014 the Practice Development Team led by Mary O’Reilly and Ann
O’Byrne were actively involved in supporting 71 Undergraduate and 19 Postgraduate
Midwifery Students in clinical placement from the University of Dublin, Trinity
College. A total of 170 other students attended at various stages of their education
programme, which included Public Health Students from University College Dublin,
General Nursing Students from Dublin City University and Integrated Nursing
Students from Temple Street University and Tallaght hospitals. In facilitating this
clinical experience, the Practice Development Team are committed to enhancing the
development of these students on their journey to become qualified, competent,
reflective practitioners.
Monthly in-service education programmes were provided for qualified Midwifery
and Nursing staff for ongoing professional development with the aim of continuous
improvement in the quality of service provided to the patients, in addition to being
responsive to the ever changing needs of the health service. A significant number of
courses were facilitated in partnership with the Centre of Midwifery Education based
in the Coombe Hospital.
The team was involved in a number of quality initiatives to advance improvements
in patient outcomes, including a collaborate approach to reduce pressure sores to
zero, working with the Health Service Executive and the Royal College of Physicians.
The healthcare teams worked as a group utilising individual skills and talents to
accomplish the goal. The initiative was run over a 9 month period in the Delivery 
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Suite and one of the Postnatal Wards and within this time, staff reached and
sustained the goal of “zero pressure sores”. The learning from this initiative has
now been incorporated into routine practice throughout the hospital. A second
initiative involved members of the team working as facilitators in the ‘Leading in
Uncertain Times’ Programme, a National two day programme for Staff Nurses
and Midwives and Clinical Midwife Managers 1 and 2. This programme offered an
exciting opportunity to explore why leadership is important within the context
of healthcare, providing staff with an opportunity to become more effective in
the provision of safe, quality and person-centred care. Two training sessions were
facilitated during 2014.
Staff continued to avail of the opportunity to progress their professional
development through a variety of Education Programmes at Master’s, Diploma
and Degree level. Funding and study leave was provided by the hospital to enable
staff to attend these courses in addition to staff attendance at National and
International Conferences, the most notable of which was the 30th Triennial
Congress Midwifery Conference which took place in Prague. This proved a unique
experience for the staff who were supported to attend. At local level a total of 822
study days were provided for ongoing education, demonstrating the commitment
of the hospital in ensuring the provision of care at the highest standard for all
patients and a highly motivated workforce. 
CLINICAL AUDIT
Ms Mary Whelan, Clinical Audit Facilitator, continued to promote and support all
disciplines of staff to undertake clinical audit throughout the year. In 2014,
Midwifery and Nursing staff registered 18 audits. Outcomes from all audits were
presented at the Quality and Safety Committee Meetings and Patient Safety
Meetings and at the Quarterly and Biannual Audit Results meetings.
HEALTH PROMOTING HOSPITALS
The Rotunda Hospital is a committed member of the Health Promoting Hospitals
Network. The Smoking Cessation Service led by Staff Midwife Marion Gibbs
continues to offer support to the patients and staff who wish to reduce and/or quit
smoking.  Motivational interviewing techniques are used to help individuals address
the issues around their smoking with intensive follow up support offered to those
who quit. Training in these interview skills is included in the ‘Brief Intervention in
Smoking Cessation’ training (BISC) for staff, assisting them with the management
and support of patients and colleagues who are trying to stop smoking. 
On the 8th May this year, 11 individuals attended BISC training bringing to a total
of 44, the number of staff across all disciplines trained since 2013.  We anticipate
that training will continue to be held bi-annually in 2015.
Patient referrals to the Smoking Cessation Service come primarily from the
Midwives and Doctors in the Outpatient Department with the highest number of
referrals following the first booking visit. Self referrals are invited from members
of staff either through the Smoking Cessation Service or the Occupational Health
Department. A total of 164 new clients availed of the service in 2014, an increase
of 25 on the 2013 figure. The ‘quit rate’ has been found to be just below 10%
highlighting the difficult challenges facing individuals trying to quit smoking.
The Rotunda Hospital marked the first year of becoming a Tobacco Free Campus in
November.  By providing a smoke free environment, the hospital supports each 
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patient, member of staff and visitor who are trying to quit and protects everyone
from the dangers of second hand smoke.
OCCUPATIONAL HEALTH DEPARTMENT
The Department of Occupational Medicine is run by Dr Dominick Natin,
Consultant in Occupational Medicine and CNM2 Stephanie McCann. The
Department endeavours to promote and maintain the highest degree of physical
and mental health of all employees by preventing departures from good health,
controlling risks and adapting work to people and people to their jobs as much
as possible. The Department provides an independent and confidential service
for all employees hosting a clinic for staff on one morning per week.
Occupational blood and body fluid exposures continue to be regularly monitored
within the department. A hospital sub-committee which was established in
advance of the introduction of the European Union (Prevention of Sharps Injuries
in the Healthcare Sector) Regulations 2014 continued to meet throughout the year.
The landmark legislation was finally transposed into Irish law in March 2014. New
sharps devices with safety technology continue to be researched and trialled.
Induction training for all staff and in-service training continued with an emphasis
on raising awareness of the prevention of blood and body fluid exposures.
In October 2014, the Department of Occupational Medicine began a rigorous
campaign to promote and administer the flu vaccine to all staff. The annual
vaccination clinic was held in the Front Hall over a 12 hour period to facilitate staff on
duty. Thereafter, the Occupational Health Nurse Manager held regular vaccination
clinics in the Department of Occupational Medicine and the NICU Department. The
campaign will continue until the end of the flu season in April 2015.
CONCLUSION
I would like to take this opportunity to thank the Chairman Ms. Hilary Prentice
and the members of the Board of Governors for the support they have continued
to provide to Midwifery and Nursing in 2014.  I would like to extend my sincere
thanks to the Master, Dr. Sam Coulter Smith and Secretary/Group General
Manager, Ms. Pauline Treanor for their support, and to extend my appreciation
to Medical, Allied Health and Support staff colleagues for their continued
assistance. I wish to acknowledge and thank all of the external agencies that
have continued to support Midwifery and Nursing Education and Practice and
the Hospital throughout the year especially Ms. Eithne Cusack, Director, Nursing
and Midwifery Planning and Development Dublin North East, Ms. Kathryn
Muldoon, Director of Midwifery Programmes, Trinity College and Ms. Triona
Cowman, Director, Centre for Midwifery Education. 
The hospital could not run as effectively or efficiently without the dedicated
Midwifery and Nursing staff who have continued to provide such high quality
care despite the many challenges they face. I am indebted to them for their
endless enthusiasm to work in the Rotunda Hospital for and with women, babies
and families. I would like to add a special word of thanks to the Assistant
Directors of Midwifery/Nursing and to Carol and Ger in my office for their loyal
and endless assistance. They continue to meet the ever increasing demands on
their time and talents with patience and enthusiasm.
Ms Margaret Philbin
Director of Midwifery/Nursing 
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1.  PATIENT SERVICES
The RCSI Fetal Medicine Centre continues to provide advanced fetal medicine
services for patients of the Rotunda Hospital, as well as those referred from
throughout Ireland. During the current academic year a total of 3,749 fetal
ultrasound examinations were performed at the Centre. This included a total of 710
first trimester assessments for fetal aneuploidy, based on combined nuchal
translucency and serum screening, as well as 401 non-invasive prenatal testing
(NIPT) cases using free fetal DNA. The RCSI Fetal Medicine Centre operates a one-
stop clinic for assessment of risk of fetal aneuploidy, using the Brahms Kryptor
biochemistry platform and also NIPT.  Management of multiple gestations
contributed a significant workload to the Centre, with 38 twin pregnancies and 3
triplet pregnancies managed through our unit. 
2.  TEACHING SERVICES
Two hundred and four students participated in the RCSI Obstetrics &
Gynaecology and Neonatology clinical rotations. The RCSI Department of
Obstetrics and Gynaecology has a leadership role in providing teaching and
assessment for undergraduates at the Rotunda Hospital, National Maternity
Hospital, Our Lady of Lourdes Hospital Drogheda, Midland Regional Hospital
Mullingar, St. Luke’s Hospital Kilkenny, and Waterford Regional Hospital. 
These students participated as sub-interns on the hospital wards and in clinics,
contributing significantly to the mission and function of the hospital, while
providing increasingly positive feedback on their learning experiences.
3. RESEARCH OUTPUT
a) Research Grants and Awards:
• Health Research Board, Ireland
- HRB Ireland Perinatal Clinical Trials Network
- F. Malone, MD Principal Investigator
- Total support €2,500,000
- 2014 – 2019
• Health Research Board, Ireland
- Haemodynamic Assessment in Pregnancy 
and Neonatal Echocardiography
- A. El-Khuffash, MD, Principal Investigator
- F. Malone, MD, Co-Principal Investigator
- Total support €188,126
- 2014 – 2016
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b) Perinatal Ireland
Perinatal Ireland is a multi-centre, all-Ireland research consortium focussed on
carrying out research into women's and children's health. The consortium, the first
HRB-funded network in the country, links the 7 major academic obstetric hospitals
across the island of Ireland (Rotunda Hospital Dublin, Coombe Women and Infants
University Hospital Dublin, National Maternity Hospital Dublin, Cork University
Maternity Hospital, University College Hospital Galway, Mid-Western Regional
Maternity Hospital Limerick, and Royal Jubilee Maternity Hospital Belfast), as well
as representatives of all 7 medical schools on the island of Ireland (UCD, TCD, RCSI,
UCC, NUIG, University of Limerick, and Queens University Belfast). The network is
headquartered at the RCSI Dept of Obstetrics & Gynaecology at the Rotunda
Hospital and is active in obstetric and paediatric research. 
In addition to its clinical research activities, the Perinatal Ireland network is also
active in other educational activities and methods of advancing clinical care
including: annual teaching conferences for practitioners in critical areas of
obstetric and paediatric health; development of national clinical guidelines to
optimise the management of important obstetric conditions, and contribution to
international guidelines; development of new information technology systems
that underpin obstetric ultrasound equipment based on data developed from
Perinatal Ireland research data.
In December 2014, the Perinatal Ireland Research consortium was joint recipient
(together with the INFANT Centre at UCC) of a HRB Clinical Trials Network Grant
of €2.5 million to fund a five year programme in Perinatal Clinical Trials.  The HRB
Ireland Perinatal Clinical Trials Network (HRB IP-CTN) is a new, exciting and
unique partnership between the two most successful perinatal research entities
currently operational in Ireland, INFANT and Perinatal Ireland. This CTN
represents a critical mass of obstetricians, neonatologists, midwives and allied
professionals from seven of the largest maternity hospitals on the island of
Ireland, which deliver over 55,000 babies per annum (almost three quarters of the
total births on this island). HRB IP-CTN has a balanced and extensive portfolio of
both ‘home-grown’ and international clinical trials of novel interventions and
diagnostics in pregnancy and neonates. The HRB IP-CTN will facilitate greater
national collaboration in the arena of perinatal trials and will ensure that Ireland
maintains our place at the international forefront of this area of clinical research.
4.  RESEARCH PUBLICATIONS
A) Book Chapters:
Malone FD, D’Alton ME. “Multiple Gestation: Clinical Characteristics and
Management” in Maternal-Fetal Medicine, edited by Robert Creasy, Robert Resnik
and Jay Iams, 7th Edition, WB Saunders, Philadelphia, 2014, p 578-596.
B) Papers in Peer-Reviewed Journals:
• Anbazhagan A, Hunter A, Breathnach FM, McAuliffe FM, Geary MP, Daly S,
Higgins JR, Morrison JJ, Burke G, Higgins S, Dicker P, Tully E, Carroll  S, Malone
FD. Comparison of Outcomes of Twins Conceived Spontaneously and by
Artificial Reproductive Therapy.  Journal of Maternal Fetal and Neonatal
Medicine 27:458-462, 2014.
• Blumenfeld YJ, Momirova V, Rouse DJ, Caritis SN, Sciscione A, Peaceman AM,
Reddy UM, Varner MW, Malone FD, Iams JD, Mercer BM, Thorp JM, Sorokin Y,
Carpenter MW, Lo J, Ramin SM, Harper M. Accuracy of Sonographic
Chorionicity Classification in Twin Gestations. Journal of Ultrasound in
Medicine 33:2187-2192, 2014.
• Throughout All Trimesters of Pregnancy Compared with the Nonpregnant
State: A Prospective Study. British Journal of Obstetrics and Gynaecology
121:1580, 2014.
• Corcoran S, Breathnach FM. The early bird catches the worm: Predicting the
onset of gestational diabetes in the first trimester. Journal of Maternal Fetal
and Neonatal Medicine 28:823-824, 2014.
• Flood K, Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM,
O’Donoghue K, Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC, Malone FD.
The Role of Brain-Sparing in the Prediction of Adverse Outcomes in
Intrauterine Growth Restriction: Results of the Multicenter PORTO Study.
American Journal of Obstetrics and Gynecology 211;288-290, 2014.
• Graves SW, Esplin MS, McGee P, Rouse DJ, Leveno KJ, Mercer BM, Iams JD,
Wapner RJ, Sorokin Y, Thorp JM, Ramin SM, Malone FD, O’Sullivan MJ,
Peaceman AM, Hankins GD,
• Dudley DJ, Caritis SN. Association of cord blood digitalis-like factor and
necrotizing Enterocolitis. American Journal of Obstetrics and Gynecology
210:328e1-5, 2014.
• Haddow JE, Craig WY, Neveux LM, Haddow HR, Palomaki GE, Lambert-
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5. INVITED LECTURES
Prof. Fergal Malone
“Monochorionic Twin Gestations – Medical Management and Legal Implications” –
Obstetric and Neonatal Dilemmas Conference, Dublin, Ireland, December 2014
“Prevention of cerebral palsy – The role of magnesium Sulphate” – Obstetric
Anaesthesia Association, Annual Clinical Meeting, Dublin, Ireland, May 2014
“Strategies for preventing cerebral palsy” – Royal College of Paediatrics and Child
Health – British Association of Perinatal Medicine, Annual Conference,
Birmingham, April 2014
“Contemporary management of fetal growth restriction” – Institute of
Obstetricians and Gynaecologists of Ireland, Spring International Meeting,
Dublin, Ireland, March 2014
Dr. Paul Byrne
“The Surgical Management of Urinary Stress Incontinence”. Grand Rounds. Perdana
University-RCSI, Kuala Lumpur, Malaysia. September 2014
“Recent Advances in the Management of Detrusor Overactivity”. Symposium on
Women's  Health, Penang Medical College, Malaysia. October 2014
Dr. Fionnuala Breathnach
“Current Challenges in Twins”. Perinatal Ireland Study Day, Dublin, March 2014
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1.  SERVICES
During 2014, the HARI Unit provided Assisted Reproductive Technology services
which included IVF, ICSI, frozen embryo transfers, natural cycles (IVF and ICSI), follicle
tracking with or without ovarian stimulation (anti-oestrogens, FSH), donor egg
monitoring, testicular biopsy, embryo freezing, oncology stimulation and
subsequent gamete and embryo cryopreservation to couples referred from
throughout Ireland.  In 2014, the Unit had on average 50 staff delivering medical care.
NURSING SERVICES
The Nursing department prides itself on recognizing each individual’s needs and
delivering tailored treatment.  HARI nursing staff provides a high standard of care
to couples attending the Unit whilst maintaining a safe, efficient and friendly
service.  The treatments and services provided range from ultrasound scanning and
hormonal monitoring, patient education and training to scheduling procedures and
intrauterine inseminations.  Nursing staff participates in continuous professional
development through regular meetings at national and international level as well
as training of new staff.  The role of the fertility nurse is unique, delivering
continued care and support for a complex reproductive treatment journey involving
two patients. 
COUNSELLING SERVICES
Our team offers a comprehensive counselling and support service at HARI to our
ART and oncology patients.  The services range from psychological and emotional
support before, during and after treatment to mind/ body medicine, CBT and stress
management services.  Our counselling team comprise of highly skilled individuals
specifically trained in the area of infertility.  They work as an integral part of our
multi disciplinary group. . 
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2. ART DEMOGRAPHICS AND OUTCOMES 
ART Activity
The female age among our IVF/ ICSI patients is a key determinant of the likelihood
of conception.  In 2014 the mean ages were 35.4 years for females and 37.0 years for
males. The mean duration of infertility of those undergoing fresh cycles was 3.0
years. The main indications for IVF or ICSI therapy were male factor (30%), tubal and
endometriosis (23%), unexplained (31%), ovarian (15%) and others (1%).
In these 12 months, 1,108 cycles were undertaken - 357 IVF, 346 ICSI and 405 frozen.
Of the 703 fresh cycles commenced, 586 had oocytes collected (IVF 277, ICSI 309).
Embryos were transferred in 844 cases (IVF 226, ICSI 234 and frozen 384).  A total of
304 clinical pregnancies were achieved,191 after IVF/ ICSI cycles and 113 in frozen
embryo transfer cycles.
TABLE 1. Overall IVF/ ICSI activity (2014)
IVF ICSI FZT
Cycles started 357 346 405
Cycles not completed 80 37 -
Oocyte collections 277 309  -
Embryo transfers 226 234 384
Clinical pregnancies 100 91 113
TABLE 2. Clinical pregnancy rates (2014)
Overall Overall IVF ICSI FZT
(n = 304) (n=191) (n = 100) (n = 91) (n=113)
Per cycle started 28% 27% 28% 26% 28%
Per oocyte recovery N/A 33% 36% 29% N/A
Per embryo transfer 36% 41% 44% 39% 29%
n= total number of patients ()= number of pregnancies
These figures are interpreted as follows: the overall likelihood to have a clinical
pregnancy after IVF/ICSI was 27% per cycle started, 33% per oocyte recovery and
41% per embryo transfer.  The clinical pregnancy rates for patients undergoing
frozen cycle transfers were 28% per thaw and 29% per embryo transfer.
PREGNANCY RATES
Pregnancy rates shown below are clinical pregnancy rates.  All types of fresh
treatments are included, namely: long protocol, antagonist, flare, and natural.
The terms used are defined below:
Clinical Pregnancy = all cases where an intrauterine visible pregnancy sac has
been identified to include ectopic pregnancies (ESHRE definition).
Clinical Pregnancy Rate per Cycle Started = number of clinical pregnancies per
number of patients that commenced therapy.
Clinical Pregnancy Rate per Oocyte Recovery = number of clinical pregnancies
per number of patients that had an oocyte recovery.
Clinical Pregnant Rate per Zygote Transfer = number of clinical pregnancies per
number of patients that had embryos transferred.
Delivery Rate = number of delivery episodes of babies weighing more than 500
grams (per cycle started, per oocyte recovery, per embryo transfer).
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TABLE 3.   CLINICAL (IVF AND ICSI) PREGNANCY RATES ACCORDING TO  
FEMALE AGE (2014)
Age Overall IVF ICSI
(n = 703) (n = 357) (n = 346)
Per Oocyte Recovery
(n=586) ≤ 35 y 35% 38% 33%  
36-39y  27% 41%    32%
≥ 39 y 17% 20% 14%
Per Embryo Transfer
(n=460) ≤ 35 y 48% 50%  48%   
36-39 y 43% 48%     39%
≥ 39 y 21% 24%      18%
A female of under the age of  35 years, undergoing fresh ART treatment had a 35%
chance of a clinical pregnancy per oocyte recovery and 48% per embryo transfer.
Single blastocyst transfer programme
The HARI elective Single Blastocyst Transfer (eSBT) programme continued in
2014.  Details of pregnancy rates after ICSI and IVF are presented in Table 4.
Pregnancy rates are expressed as positive test per eSBT and clinical pregnancy
rate per eSBT.
TABLE 4. Pregnancy rates after elective single blastocyst transfer. (2014)
ICSI eSBT All ages ≤ 35 36-39 ≥ 39
hCG+ve/eSBT 59% 63/106 71% 40/56 49% 22/45 20% 1/5
CPR/eSBT 51% 54/106 61% 34/56 42% 19/45 20% 1/5
IVF eSBT All ages ≤ 35 36-39 ≥ 39
hCG+ve/eSBT 57% 70/123 52% 25/48 63% 40/63 42% 5/12
CPR/eSBT 50% 61/123 48% 23/48 56% 35/63 25% 3/12
TABLE 5. Frozen Embryo Transfers.
Details TOTAL Rates %
Thaws 405
Transfers (ET) 384 (94%)
Embryos thawed 569
Embryos survived 484 (85%)
Embryos transferred 442
Utilisation Rate 442/569 (78%)
Pos hCG/ ET 147 (38%)
CP (Sac) 113 (29%)
Twins 11 (7%)
Pregnancy loss 34 (23%)
eSET 326 (85%)
The introduction of the eSBT was driven by the desire to reduce multiple
pregnancies while maintaining respectable pregnancy rates from one oocyte
recovery. The value in pursuing eSBT lies in the enormous savings to the public
purse in terms of prevention of prematurity-related intensive neonatal care
expenses.  Such savings should be made available for the provision of free IVF to 
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TABLE 5. Multiple pregnancy rates (MPR).
MPR RATES All ages <35 35-39 >39
MPR /Pos hCG
9% 5% 12% 14%
All transfers 20/217 5/91 12/104 3/22
MPR / Pos hCG
1.5% 0% 3% 0%
eSBT 2/133 0/65 2/62 0/6
3. NATIONAL ONCOLOGY CRYOPRESERVATION SERVICES
The activity of the National Oncology Cryopreservation Centre includes
emergency onco-fertility consultations, counselling and gamete/embryo
preservation prior to gonadotoxic intervention, offered to all females and males
diagnosed with cancer referred by a Consultant.  In 2013, 177 male oncology
patients attended HARI and 167 patients had sperm cryopreserved.  The demand
for female cryopreservation services continued, with 88 patients attending, 48
started therapy and 41 reaching either egg or embryo freezing.  New clinical
protocols ensure, in suitable cases, commencement of therapy at presentation,
irrespective if the patient presents in the proliferative or the luteal phase of the
cycle.  This eliminates the need to delay lifesaving oncology treatments in order
to pursue fertility cryopreservation. 
TABLE 8. Oncology cryopreservation data
Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Males attended 114 142 142 158 186 174 163 173 127 155 177
Males with samples 
frozen 102 127 132 141 170 155 149 157 111 140 167
Not suitable / No sample 12 15 10 17 16 19 14 16 16 15 10
Female attendances 5 5 6 14 12 23 25 32 62 82 88
Pursued 
cryopreservation 4 0 1 10 4 7 19 22 32 52 48
Oocyte/ embryo 
cryopreservation 4 0 0 5 3 5 16 22 25 46 41
4. RECOGNITION
Training in Reproductive Medicine (RM)
HARI continued as the main RM teaching centre in Ireland.  In 2014, Dr Srwa Khalid
finished training as a Fellow in Reproductive Medicine and Surgery (RMS) part of
the SpR in Obstetrics and Gynaecology HARI Scheme recognised by the Institute of
Obstetricians and Gynaecologists and RCPI.  
The British Fertility Society continued HARI recognition for medical training in the
following certified special skills modules: Pelvic Ultrasound, Embryo Transfer/IUI,
Management of the Infertile Couple and Assisted Conception.  HARI is also certified
as the only RCOG subspecialty training centre in Reproductive Medicine and 
couples attending ART services that support elective single embryo transfers.  See
table 5 for the multiple pregnancy rates for 2014 in the general population and the
elective single blastocyst transfers (eSBT).
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Surgery in Ireland. Dr Nikhil Purandare continued his Subspecialty Training in
Reproductive Medicine and Surgery,  recognized by the RCOG. 
The unit is similarly recognised for training purposes by the Association of Clinical
Embryologists, UK.  Ms Ciara Hughes is a certified embryology trainer. One
embryologist is currently undergoing the ESHRE training scheme, an andrologist is
undergoing the British Andrology Society training scheme and another trainee
embryologist is completing an MSc in Human Reproduction and Embryology with
IVI in Spain. 
Staff recognition nationally and internationally
Ciara Hughes continued her commitment to Irish Clinical Embryology Society (ICE) and
has represented ICE at the May 2014 consensus meeting of the Alpha Group in Turkey
where she presented on the role and responsibilities of the clinical embryologist. This
document has since been published with all countries being encouraged to adopt the
PACER system developed by Ciara to standardise the roles and responsibilities of
embryologists in their profession. Ciara is also a co-author for the ACE / BFS Update
Guidelines for Elective Single embryo transfer which has been accepted for publication.
Dr Karen Deignan successfully completed a post-graduate diploma in Statistics in
Trinity College and Dr Rob Downer qualified as a senior clinical embryologist with the
European Society for Human Reproduction and Embryology (ESHRE). 
Joan Kelly from the nursing department was asked to represent the HARI Unit and join
the steering committee for Insights, UK’s leading conference which takes place
annually.
Dr. Edgar Mocanu continued as member of Board of Directors of the International
Federation of Fertility Societies (IFFS), Treasurer of the Federation, chair the EUTCD
ESHRE Task Force, member of the Clinical Advisory Group of the Institute of
Obstetricians and Gynaecologists and National Advisor Oncofertility to the National
Cancer Control Programme (NCCP). 
5. QUALITY AND SERVICE IMPROVEMENTS
Our dedicated Quality Department works closely with all staff within the unit to
ensure that the best possible care is provided in an environment of optimal
patient safety. Key to this has been the implementation of an extensive Quality
Management System (QMS). The effectiveness of the QMS is maintained through
teamwork and the commitment of staff. As part of our dedication to continuous
quality improvement all our staff members receive ongoing education on the
importance of their contributions to quality and patient safety and their role as
part of the healthcare team. 
Embryology
The embryology laboratory continues to be at the forefront of developments in
Reproductive technology and the team were delighted to have Dr Lynne O’Shea
a UCD graduate join them as a research assistant. Lynne was awarded a grant of
over ¤90000 as part of the Irish Research council enterprise partner scheme to
work with UCD to develop and optimise the methods for ovarian tissue freezing
to provide an alternative form of fertility preservation for oncology patients.  
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Clinical
The role of the endometrial scratch has been the focus of our clinical team for the
last 12 months.  Based on published studies this procedure was offered to all
couples that wished to avail of it.  A retrospective audit was performed and its
findings showed that the use of the endometrial scratch offered routinely does
not improve pregnancy rates.  The identification of a selective population that
could obtain a marginal benefit from this procedure continues. 
6.        ACADEMIC ACTIVITY
The teaching in Reproductive Medicine of students from Trinity College and the
Royal College of Surgeons in Ireland continued in the Rotunda and the HARI
Unit.  Attendance at infertility clinics, theatre and ward rounds were routine
during the academic year.  The RCSI Consultant Senior Lecturer attended regular
student tutorials in HARI and participated as a final year examiner for RCSI and
TCD students. 
From a scientific point of view, during a very busy and successful year HARI staff
engaged in numerous activities at national, European and international level, as
presented below.  Ciara Hughes has acted as a referee for two journals in
Reproductive Medicine and Dr Mocanu continued as Editorial Board member of
Human Fertility, the official journal of the British Fertility Society and ad-hoc
referee for five other journals in the Reproductive Medicine arena.  
Scientific publications 
Peer reviewed published abstracts 
1. Hughes C, et al. The Alpha Consensus Meeting on the professional status of
the clinical embryologist: proceedings of an expert meeting. RBM Online,
2014, Vol 30 (5): 451-461.
2. Coughlan C, Clarke H, Cutting R, Saxton J, Waite S, Ledger W, Li T, Pacey AA.
Sperm DNA Fragmentation, Recurrent Implantation Failure and Recurrent
Miscarriage. Asian J Androl. 2015 Mar 27. doi: 10.4103/1008-682X.144946.
3. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, Cutting R, Ong K,
Sallam H, Li TC. Recurrent implantation failure: definition and management.
Reprod Biomed Online. 2014 Jan;28(1):14-38. doi: 10.1016/j.rbmo.2013.08.011. 
4. Coughlan, C., Yuan X, Demirol, A, Ledger, W, Li TC. Factors affecting the
outcome of “Endometrial Scratch” in women with recurrent implantation
failure. J Reprod Med. 2014. Jan- Feb; 59 (1-2): 39 – 43.
5. Kupka, M. S., et al. "Assisted reproductive technology in Europe, 2010: results
generated from European registers by ESHRE." Hum Reprod. 2014, Oct (10):
2099-113.
6. Bolster F, Mocanu E, Geoghegan T, Lawler L. Transvaginal oocyte retrieval
complicated by life-threatening obturator artery haemorrhage and managed
by a vessel-preserving technique.  Ulster Med J. 2014; 83(3): 146-148.
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7. Naasan MN, Harrity C, Pentony L, Mocanu E.  Anti-Mullerian hormone
normogram in an Irish subfertile population. Ir J Med Sci. 2014 Febr: (1-6).
8. S Detho, C Harrity, S Afridi, G Emerson, EV Mocanu. First birth following
natural IVF/ICSI treatment in Ireland.  Ir Med J. 2014 Jan;107(1):23-4.
Book chapters
1. Coughlan C. (2014) Reproductive Surgery in Assisted Conception. Local
endometrial trauma: a Treatment Strategy to Improve Implantation Rates.
Springer, New York. In press.
Invited lectures, chairs, media appearances
Chairs
Mocanu EV:
ASRM Annual Meeting, Scientific Program Prize Paper
Abstract Session 2,  October 2014, Honolulu, USA.
3rd International Conference, Bucharest Embryology
Symposium, November 1-2nd, 2014.
Invited lectures:
Hughes C
Hughes C. Preserving Fertility with Cancer- Post Graduate Course, School
of Nursing , UCD, Dublin January 2014
Hughes C. Fertility Preservation: Fertility and the Haematology Patient,
Post Graduate Nursing in Oncology and Haematology,
Beaumont Hospital Haematology Education Programme, St
James Hospital Feb 2014
Hughes C. Preserving Fertility for Breast Cancer Patients, Post Graduate
school of Nursing , Advanced Breast Care Nursing UCD. Feb 2014 
Hughes C. Preserving Fertility for Cancer Patients, Educational Meeting,
Beaumont Hospital, Dublin. December 2014
Hughes C Sessional tutor for RCSI 4th yr Medical students – Introduction
to Embryology 1
Mocanu EV
Mocanu EV Oncofertility. National Medical Oncology and Haemato-
oncology Meeting, 24th January 2014, Farmleigh House, Dublin.
Mocanu EV Onco-cryopreservation in breast cancer patients.
5thSymptomatic Breast Disease Audit, Quality and Risk
Forum, 10th October 2014 Limerick.
Mocanu EV Cross-border reproduction-the EUTCD perspective.  Assisted
Reproduction in Europe: Social, Ethical and Legal Issues,
Thessaloniki, 11-13 December 2014.
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Conference Course Attendance
Brophy M       Sharing Best Practice Nursing Conference. Dublin 2014
Corcoran S Embryoscope Workshop, organised by Parallabs, London Dec
2014 
Deignan K ESHRE Munich 2014
Downer R ICE Annual General and Scientific Meeting, March 2014, Dublin
Downer R ESHRE Munich June 2014
Lowry K        Sharing Best Practice Nursing Conference. Dublin 2014
Finnamore L.  ESHRE  Munich 2014
Hughes C ICE Annual General and Scientific Meeting, March 2014, Dublin
Hughes C Alpha Conference , Antalya, Turkey May 2014
Hughes C Irish Fertility Society Meeting , May Dublin
Hughes C ICE Scientific Meeting, Galway November 2014 
Hughes C Ovarian Tissue Club Meeting, Paris December 2014 
Johnston J Irish Fertility Society Meeting, May 2014, Dublin 
Kelly J           Senior Infertility Group conference.  Aberdeen Feb 2014
Kelly J            Insights Nursing Conference. Manchester. Nov 2014 
Larkin  L ICE Scientific Meeting, Galway November 2014 
O’Reilly F ICE Annual General and Scientific Meeting, March 2014, Dublin
O’Toole R      Insights  conference Oct 2014
O’Toole R      Sharing Best Practice Nursing Conference. Dublin Nov 2014
Rebecca R      Post Graduate Certificate in Fertility Ultrasound. 2014
Sutton F          Post Graduate Certificate in Fertility Ultrasound. 2014
Woods T         Sharing Best Practice Nursing Conference Dublin Nov 2014
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DR FIONNUALA NÍ ÁINLE (DIRECTOR)
MR JOHN O’LOUGHLIN (LABORATORY MANAGER)
INTRODUCTION
The Department of Laboratory Medicine is staffed by dedicated and highly educated
professionals who are committed to providing a service of the highest quality that
is pro-active and responsive to the needs of the users of the service. Quality is of
paramount importance. These high standards are reflected in continuing
accreditation to International Organisation for Standardisation (ISO):15189
requirements across all departments. Individual departments continuously seek
opportunities to improve the care that we provide to our patients, responding to
new challenges and developments particularly in high-risk areas. During 2014, the
microbiology department led the acquisition of a state of the art piece of equipment,
“GeneXpert”, to enable rapid diagnosis of Influenza and other dangerous
microorganisms. It is expected that this rapid testing will commence in early 2015.
The Laboratory Annual Management Review, User Surveys and Users Committee
meetings inform the laboratory management of any concerns regarding the
services provided and also any changes in the requirements of service users. Quality
objectives are in place to ensure that the needs and requirements of users are met;
these quality objectives are reviewed annually.
The overall laboratory workload is reflected in Tables 1 and 2.
*Histology work is numbered by case. Each case can include multiple specimens
and blocks, requiring ≥1 stains of various complexity
D E PA R T M E N T  O F  L A B O R A T O R Y
M E D I C I N E
TABLE 1: TESTS PERFORMED IN-HOUSE IN 2014 
Department Specimens/ Cases*
% Change
over 2013
Tests
/ Blocks*
% Change
over 2013
Haematology 50,358 6.1 79,831 12.5
Blood Group Serology 24,983 5.8 24,983 5.8
Transfusion 9,172 8.3 9,172 8.3
Clinical Microbiology 43,844 -4 81,733 -8.0
Virology / Serology 13,729 3.7 33,150 8.9
Biochemistry 56,603 1.9 254,659 3
Histopathology 6,036 10 16,387 11
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TABLE 2: TESTS REFERRED TO OUTSIDE LABORATORIES IN 2014
Specimens % Changeover 2013 Tests
% Change
over 2013
Haematology 1,589 -3.5 3,870 4.0
Biochemistry* 3,059 -21.6 3,386 -15.9
Microbiology 2,271 -9.8 7,835 7.4
Rubella/VZ/Syphilis 30,228 -9.8 30,515 -7.38
* Serology Confirmation and other specialized tests 
VZ: Varicella Zoster
STAFFING
Consultant posts
Dr Richard Drew was appointed as Consultant Microbiologist
Medical Scientist posts
Grainne Kelleher was appointed as Chief Medical Scientist in Biochemistry
replacing Ann Downey
Jane Halligan retired from her post as Point of Care and IT Coordinator
Mr Haydn Hammerton commenced as Senior Medical Scientist in Microbiology
Fiona Minogue and Lorna Thomas joined Histology team replacing Martin
Fitzpatrick who took up the position of Anatomical Technician.
Miriam Robles replaced Damien Lally in Biochemistry Department 
Tom Murphy joined the Microbiology team.
QUALITY DEPARTMENT: 
Quality Manager: Ms Susan Luke
Deputy Quality Officer Ms Emily Forde*
Training Officer Mr. Ciaran Mooney* 
Health and Safety Officer Ms Aiveen O’Malley*
POCT Co-ordinator Ms Lorna Pentony*
LIMS Officer Ms Jane Halligan 
(*duties carried out in addition to departmental position)
The department of laboratory medicine maintained accreditation across all
disciplines ensuring all processes are compliant with the required standards and
that these standards are continually maintained. The laboratory was assessed
against the newly issued ISO 15189:2012 standard. Of note the Rotunda was the
first public hospital to achieve accreditation against this 2012 standard.  Point of
Care Testing (POCT) was again assessed against ISO 22870. Accreditation was
maintained, POCT is expanding across the hospital and while this is clinically
beneficial it provides challenges to resources both within the laboratory and in
the clinical areas. The INAB assessment process examined the processes within
the laboratory and point of care testing across the clinical and laboratory
environment. INAB assessed the ability of the laboratory to provide governance 
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and a service to facilitate evaluation of new or alternative POCT instruments
/systems. The standard requires that the following must be addressed
procedures and policies are available for purchase, installation, and validation
and running of equipment, maintenance of consumables and reagents,
provision of training and observational auditing  of  POCT operators. A
documented procedure for quality control and quality assurance is in place. Ms
Lorna Pentony replaced Ms Jane Halligan in January 2014 as POCT co-coordinator
upon Ms Halligan’s retirement. The individual departments are responsible for
the technical validation, quality control and maintenance of POCT equipment.
The maintenance of the laboratory quality management system requires a
continuous active program to ensure achievement and compliance with the
required standards and quality of service the laboratory wishes to maintain.
This is achieved through documented procedures both testing, managerial and
day to day running of the laboratory being systematically reviewed. An audit
calendar is drawn up at the beginning of each year. In 2014 the laboratory
performed 96 audits these included audits against the following standards: 
• ISO 15189 2012 Medical Laboratories- Particular Requirements for Quality
and Competence 
• EU Directive 2002/98/EC Article 14 (Traceability) and Article 
15(Notification of Serious Adverse Events and Reactions) 
• RCPath Guidelines for the Retention and Storage of Pathological Records
and Archives 2009
• ISO 22870 Point of Care Testing (POCT) – Requirements for Quality and 
Competence
• WHO Laboratory Manual for the Examination and Processing of Human
Semen, 5th Edition
• INAB Guidance and Mandatory Documents
The laboratory consults users through surveys and user group meetings. In 2014
external users of the Andrology services were surveyed in the final quarter on
their satisfaction of the service provided and the patient experience. This proved
to be a positive action with a number of minor quality improvements being
implemented.
The laboratory met with a number of in house user groups in 2014 and these
meetings allowed open and frank discussion from both sides. It was agreed that
these user meetings and staff contacting the laboratory with difficulties or
suggestions directly provide an improved means of gaining the views of the in
house users of the service rather than by survey. 
The laboratory submitted an Annual Report for Blood Transfusion to the Health
protection Regulatory Agency (HPRA) formally the Irish Medicines Board (IMB).
This report documents the activity for the previous year and reports blood usage
and wastage, status of accreditation and informs of any planned future changes.
The report has been submitted for 2014. 
The QMS is embedded across the laboratory services and is dependant on all
those working in the laboratory. 
We are committed to providing a service of the highest quality and shall be
aware and take consideration of the needs and requirements of the users which
is reflected in our quality policy.
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HISTOPATHOLOGY DEPARTMENT
STAFF
Consultants: Dr. Deirdre Devaney, 
Dr Eibhlis O’Donovan, 
Dr Emma Doyle
Locum Consultant: Dr Sean O’Briain
Registrars: Dr Susan Aherne, Dr. Nairi Tchrakian
Chief Medical Scientist: Colma Barnes
Senior Medical Scientist: Ms Phil Bateson, 
Medical scientists: Ms Sarah Morris, 
Ms Aderanti Morenigbade, 
Mr Michael Smith, 
Ms Tokiko Kumasaka, 
Ms Miriam Hurley
Lorna Thomas
Laboratory Aide Fiona Minogue
Mortuary Manager Bill O Neill
The following Tables indicate the number of autopsies (full, limited, and Coroner’s)
performed in 2014.
This table includes 6 autopsies from infants born in another institution (one of
which was also a LNND) which are not included in the Rotunda figures.
TABLE 3: AUTOPSY WORKLOAD >500GRAMS
Full
Postmortem 
Limited
Postmortem
Coroners
case Total
Stillbirths 20 3 3 26
Early Neonatal deaths 4 2 5 11
Late Neonatal deaths 1 0 0 1
Total 25 5 8 38
Outside cases* 2 0 4 6 
% of Total PMs 25.8% 5.2% 8.2% 39.2%
TABLE 4: AUTOPSY WORKLOAD <500GRAMS
Full
Postmortem
Limited Post
mortem
Coroners
case Total
No. of PMs 51 8 0 59
% of Total PMs 52.6% 8.2% 0 60.8%
TABLE 5: ROTUNDA PERINATAL MORTALITY FIGURES: 2014 (0-7 DAYS)
No
examination
Limited
examination
Full Post
Mortem
Coroners
Cases Total
Stillbirths 20 3 19 3 45
Early Neonatal deaths 18 2 4 1 25
Total 38 5 23 4 70
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PERINATAL PATHOLOGY
The perinatal autopsy service in 2014 was similar to the previous year (97 cases
compared to 101 cases in 2013). Turnaround times (TATs) for these cases remained
in line with previous years in that the majority of cases were reported within the
recommended 8 weeks allowing the clinicians to interface with grieving parents
in a timely fashion. In conjunction with this, there were no organs retained in
2014.
A full autopsy includes external examination, radiology, cytogenetics and
internal examination of all three body cavities (Chest, abdomen and cranium) in
conjunction with placental examination.  Limited autopsy examinations are in
keeping with the wishes of the parents, as expressed on the consent form e.g.
external examination and cytogenetics only or examination of a single body
cavity – as in a case of a known congenital heart disease, the family may only
wish to have the chest cavity opened. We endeavour to examine all placentas
associated with fetal demise, as in a large number of cases the placenta will reveal
a significant pathology which may be the cause of death.
97 cases had some form of autopsy examination in 2014 (38 >500g and 59 <500g)
leading to overall autopsy rate (AR) of 37.6% (38+59=97 / 258 cases through
mortuary) in comparison to 47.2% in 2013 and 45.3% in 2012.The AR (Full, limited
and coroners cases) for >500g was 46.9% (38/81) which is in line with last year
(47.2%). However the AR for the <500g was 33.3% (full and limited – 59/177)
reflecting a reduction in the number of autopsies in this group. However this is
easily explained by the fact that 63/177 cases under 500g weighed 10g or less and
were not suitable for autopsy examination. If we were to exclude cases less than
10g we would have an autopsy rate of 51.7% in the <500g category. Our overall
autopsy ratetakes into account some external transfers and late neonatal deaths.
The AR for the Rotunda cases (perinatal mortality figures) is 45.7% (32/70
cases).This is less than last year (59.5%) and may reflect the continued
improvements in antenatal diagnostic imaging with amniocentesis confirming
congenital malformations (42.8%of congenital malformations had a post mortem
this year in comparison to 45.8% last year).There were 13 limited examinations (5
in the >500g group and 8 in the <500g group).This is in comparison to 2 and 6 last
year respectively. We performed 8 post mortems for the Coroner over the period, 4
of which were for outside cases (i.e. not included in the Rotunda figures). This is
in comparison to 15 last year 
As mentioned above, it is our policy to examine the placenta on all cases of
perinatal deaths.  There were 70> 500g,68 of these cases had placental
examination.In the 2 cases with no placental examination both had known
congenital anomalies.
Tulip Classification of Perinatal Mortality:
This is a Dutch Classification system that separates cause and mechanism of
perinatal mortality for the purposes of counselling and prevention.  The goal of
the system was to identify an unambiguous single cause system aiming to
identify the initial demonstrable pathophysiological entity initiating the chain of
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events that irreversibly led to death based on a combination of clinical findings and
diagnostic tests including pathological findings. The causes of death are stratified
into 6 major categories:
1. Congenital Anomaly
2. Placenta
3. Prematurity / Immaturity
4. Infection
5. Other
6. Unknown
Cause of Death: (perinatal figures Rotunda only  > 500g)
We have used a modified version of the Tulip classification to classify our causes
of death.
Congenital Malformation 29 (41.4%)
Placental causes: 14 (20%)
Cord 8
Parenchyma 6 
Prematurity / Immaturity 5 (7.2%)
Infection 14 (20%)
Other 1 (1.4%)
Unexplained 7 (10%)
The 29 congenital malformations included 14 babies with chromosomal
abnormalities (6 babies had trisomy 21, 5 had trisomy 18, 1 had Trisomy 8, 1 had
monosomy 13 and 1 baby had Triploidy). There were 2 babies with CNS
malformations (1 baby with an encephalocoele and 1 with a duralarteriovenous
malformation). 3 babies were born with congenital heart defects (1 with a
cardiomyopathy, one with a complex malformation and 1 with a hypoplastic left
heart variant). 2 babies were born with renal malformations (one with autosomal
recessive polycystic kidneys and one with probable renal agenesis). 2 babies were
born with skeletal dysplasias (1 with thanatophoric dysplasia and 1 baby with
osteogenesisimperfecta). 1 baby was born with a diaphragmatic hernia with
pulmonary hypoplasia. 2 babies were born with multiple congenital anomalies.  1
baby had a congenital myopathy, 1 baby had Phelan McDiarmaid Syndrome and 1
baby had a respiratory chain defect. 
In the placental category, there were 14 death attributed to placental pathology.
These included  6 cord accidents, 3 cases of placental abruption, 2 cases of villous
maturation defect, 1 chronic villitis, 1 Fetal thrombotic vasculopathy and 1
chorangiomatosis leading to fetal hydrops.
14 deaths were attributed to infection. Of these cases, 7 were stillbirths and 7 were
neonatal deaths. All 14 of these were due to ascending infection. In the stillbirths 5
cultured no organisms. One case cultured Streptococcus pneumoniae and one
cultured Streptococcus viridans. In the Neonatal deaths 6 showed no growth at post
mortem. 1 cultured Staphlococcus Coagulase.   11 babies therefore, had negative
cultures but there was histological evidence of ascending infection with a fetal
response (i.e. umbilical vessel vasculitis +/- a congenital pneumonia). In our use of
the Tulip classification we have modified this category – if we were to adhere to the
strict classification guidelines, these 11 cases would be relegated to the unexplained
category despite the fact there is histological evidence of infection.
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There were 5 neonates who were assigned to the prematurity category.
The miscellaneous category included 1 case of a fetomaternal haemorrhage
leading to fetal demise.
There were 7 cases that had no identifiable cause of death giving an unexplained
rate of 10%( in comparison to 8.8 % last year).Significantly 3 of these 7 cases did
not have any form of post mortem examination and 1 case had a limited post
mortem examination only.
Cause of Death (<500g)
177 cases:
Congenital Malformation: 14 (7.9%)
Placental: 34 (19.2%)
Infection: 33 (18.7%)
Prematurity 6 (3.4%)
Other: 5 (2.8%)
Unexplained: 85 (48.0%)
This cohort shows a much lower rate of congenital malformation with ascending
infection and placental categories as the most prominent cause of death. The high
unexplained rate reflects the fact that a significant number of these cases only
had a placental examination (i.e. did not consent to a full post mortem
examination and also reflects the small size of the foetuses (0.5 grams –
499grams) with 63  (35.6 %) of these cases being 10 grams or less.
Placental Examination:
The placental work load was modified in 2012. During the year we introduced a
triage system for placental examination following The Royal College of Pathologists
Guidelines. A protocol detailing which placentas should be examined is available on
the Labour ward and includes the examination of placentas from babies admitted
to the NICU, from all mothers with pyrexia, PPROM, PET, gestational diabetes
mellitus, multiple gestations and as alluded to earlier,  all cases of stillbirths and
neonatal deaths. These placentas are sent to the laboratory and are then stratified
into two groups. Group One placentas are those that require both gross and
histological examination. Whereas Group Two placentas are those cases that gross
examination only is deemed as sufficient. Should the clinician specifically require a
microscopic examination of these cases, it is available on request.1700 placentas
were referred to the laboratory for examination in 2014.597 (35%) fulfilled the
criteria for gross examination only. The remaining 1103 had both macroscopic and
microscopic examination.  The introduction of this triage system has been very
beneficial in that it has succeeded in reducing the histology workload of placental
examination by approximately one third, affording us extra time to devote to the
cases that require a more detailed examination.  Placental examination continues to
reflect a significant workload for the department.
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TABLE 6:  ANALYSIS OF THE SURGICAL PATHOLOGY WORKLOAD 
FROM 2009-2014
Surgical Pathology:
TABLE 7:  LLETZ & COLPOSCOPIC BIOPSY GRADING 2014
CASES CIN 1 CIN 2 CIN 3 CGIN/AIS/Adenoca
SCC incl
microinvasion
LLETZ 146 111 209 2 12
COLCB 519 211 151 1 2
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BIOCHEMISTRY:
Consultant: Prof Philip D Mayne
Chief Medical Scientist: Ms Ann Downey
Senior Medical Scientist: Ms Sharon Campbell
Medical Scientists: Ms Lorna Pentony
Mr Damian Lally
Clinical Scientist: Ms Aiveen O’Malley
Laboratory Assistants: Mr Paul Reilly
1. General Overview, and developments during 2014
During 2014, the Biochemistry department continued to provide an extensive
repertoire of investigations required for the care of women and infants, with
participation in the relevant External Quality Assessment programmes. 
Gráinne Kelleher was appointed Chief Medical Scientist in March 2014 following
the resignation of Ms Ann Downey. Miriam Blesa was appointed as a medical
scientist in May 2014, following the resignation of Damian Lally.
2. In-house workload 
The total number of Biochemistry tests requested during 2014 remained relatively
stable. A review of the changes in the number of individual tests requested showed
quite a variance with some increasing or decreasing significantly.
A decrease in the number of requests for fasting lipids was noted.   There was a
significant increase in the number of CRP's (43%) requested most likely due to the
increase in the number of septic workups. There was also an increase in the
number of requests for plasma magnesium and SHBG. 
FIGURE 1 : Biochemistry In House Workload for 2014 compared with 2013
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3. Referred workload 
There was a 22% decrease in the number of samples referred to external
laboratories. There was a large increase in the number of GGTs (138%). Due to this
increase in GGT it was decided to repatriate this test in 2015. In addition in order
to improve the turnaround time to result both LDH and CK were also repatriated.
There was a significant increase in the number of tumour markers requested CA
19.9 (35%) and CEA (43%), but due to the constraints on the analyser it is not
possible to repatriate these two tests and therefore they will be continued to be
referred. With the availability of a new assay for AMH this will be evaluated in
early 2015.
4. Point of Care 
The Point of Care Testing (POCT) Committee met on a number of occasions during
the year.   In-house POC training was provided to clinical staff through-out the
year. Additional glucose haemacues were purchased and validated for the
hospital. The POCT committee reviewed methods for near patient testing for
lactate and these will be assessed and validated in 2015
TABLE 8: Referral Workload in 2014 compared with 2013
Test 2014 2013 Difference % Difference
17OH Progesterone (Adult) 10 12 -2 -17
25(OH)Vitamin D 76 92 -16 -17
Acylcarnitine 36 53 -17 -32
Alpha Feto-Protein (Adult) 21 18 3 17
Ammonia 53 90 -37 -41
Androstenedione 49 44 5 11
Anti-Mullerian Hormone 1093 1132 -39 -3
Blood amino acids 68 75 -7 -9
CA 19-9 60 25 35 140
CEA 64 21 43 205
Cortisol (Adult) 24 34 -10 -29
DHEAS 20 17 3 18
Free T3 14 21 -7 -33
GGT 38 16 22 138
Iron and UIBC 21 20 1 5
Lactate 94 87 7 8
Lamotrigine 24 30 -6 -20
Parathyroid Hormone (Adult) 33 41 -8 -20
Phenobarbitone (Paediatric) 44 39 5 13
Primark Test 17 40 -23 -58
PTH (Paediatric) 13 11 2 18
Thyroid Receptor Ab (TRAb) 172 173 -1 -1
Tissue TransglutaminaseAb 13 19 -6 -32
Total Bile Acids 426 414 12 3
Tri-iodoThyronine (T3) 27 17 10 59
Troponin-T 57 47 10 21
Urinary Organic Acids 87 103 -16 -16
Urine Drug Screen 167 153 14 9
Zopiclone (Urine) 27 17 10 59
Total  3385 4318 -933 -22
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5. Accreditation
The Biochemistry laboratory experienced its third INAB inspection in May 2014
for compliance with ISO 15189. No non-conformances were reported by the INAB
assessors. Point of Care Testing was also successfully assessed for compliance
with ISO 22870 and again no non-conformances were reported by INAB
assessors. All staff are to be congratulated on a successful outcome and thanked
for their hard work throughout the year.
3. In-house workload (Table 9)
A recent review of RotundaHospital guidelines for investigation of acquired and
inherited Thrombophilia has resulted in testing being performed in line with
international guidelines and best practice. 
HAEMATOLOGY and BLOOD TRANSFUSION:
Consultant: Dr Fionnuala Ni Ainle (Adult Haematology)
Dr Melanie Cotter (Paediatric Haematology)
Chief Medical Scientist: Ms. Deirdre Murphy 
Senior Medical Scientists: Mr Ciaran Mooney, 
Ms Deirdre O’Neill
Ms Emily Forde
Medical Scientists: Ms Liliana Rasidovic, 
Ms Edel Cussen (commenced a 3 year career 
break December 2013), 
Ms Noreen Brady (returned maternity leave in 
April 2014), 
Ms Deirdre Corcoran (returned from maternity 
leave November 2013), 
Ms Aileen Carr, 
Ms Michelle Burns, 
Ms Elaine O Leary (locum post; 
commenced May 2014)
Laboratory Aide: Ms. Karen Fennelly
1. General Overview, and developments during 2014
The laboratory submits an Annual Report for Blood Transfusion to the Health
Products Regulatory Authority formally the Irish Medicines Board (IMB). This report
documents the activity for the previous year and reports blood usage and wastage,
status of accreditation and informs of any planned future changes. The report has
been submitted for 2014. The annual report for Blood Transfusion for 2014was
submitted to the Irish Medicines Board (IMB). This was satisfactory and no visit was
deemed necessary
2. Training and development initiatives
The department was approached by Dublin Institute of Technology, Kevin Street
in Sept. 2012 to provide in service training for 2012/2013 Degree students.
Provision of Blood Transfusion in service training was also provided in 2014. 
Two staff members successfully completed a master’s degree (MSc) in 2014.   
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Table 9: Haematology in-house workload
Test Name 2014 Change 2013
Full blood count 43,779 +4.8% 41,302
Manual differential 1,886 +33% 1,421
Manual Platelet count 12 - 8
Reticulocyte count 460 +11% 413
Coag Profile 
(PT, APTT, Fibrinogen) 3043 +11% 2,734
Lupus anticoagulant 164 -21% 207
Kleihauer1 477 +31 355
Haemoglobinopathy 2,847 +22% 2,558
Malaria 2 -0.0% 2
Thrombophilia 48 -38 78
Total tests 72,689 -14.1% 84,621
1 Kleihauer tests performed on post-delivery patient samples for confirmation of
flow cytometry results are not included.
DD: D-Dimer; F8: Factor VIII; APCR: Activated Protein C Resistance; PS: Prothrombingene promoter
region mutation G20210A; Y: Y deletions(fertility workup); HPLC:high performance liquid
chromatography (haemoglobinopathy confirmation is sent to external laboratories); Film: blood
films reviewed; LU: Lupus Anticoagulant screening; ACA/B2GP1: anticardiolipin and anti-β2GP1
serology; KLH: Kleihauer test (manual); CG: cytogenetics; HPLCB: newbornhaemoglobinopathy
screen (in house); HPLC: adult haemoglobinopathyscreen (in house); Diff:manual differential; COAG:
prothrombin time (PT), activated partial thromboplastin time (APTT), Fibrinogen;Thromb Screen:
inherited thrombophilia screen (protein C, activated protein C resistance, antithrombin, factor VIII
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TABLE 10: HAEMATOLOGY REFERRED WORKLOAD
% CHANGE
TEST TESTS OVER 2013
Immunology 373 +22.3
Thrombophilia (referred component) 32 -11
Haemoglobinopathy confirmation 143 -6
Lymphocyte subsets 107 +2
Factor Assays 72 +48
Cytogenetics 495 -12
Molecular Genetics 141 -9
YDNA 48 -8
CG by PCR 495 -12
ESR 25 +56
D-Dimer 17 +42
Anti-Xa assay 10 -47
Homocysteine 2 N/A
Haptoglobin 5 N/A
Factor V Leiden 2 N/A
Anti-D  quantitation 103 +24
Anti-C quantitation 6 -60
Total 3870 -3.5%
TABLE 11: BLOOD GROUP SEROLOGY WORKLOAD 
Test Name 2014 Change 2013
ABO Group 26,630 18 22606
Rhesus (Rh) Group 26.630 21 21934
Antibody Screen 18218 0.3 18171
Direct Coomb’s Test 4335 34 3231
Antibody Identification panel 532 -13 610
Genotype 487 -19 600
Rh D antibody screen 1545 87 830
Antibody Titre 103 21 85
Antibody Elution 61 -28 85
Weak/Partial RhD Typing 63 29 49
Flow Cytometry 784 -6.9 842
Total Specimens 24983 5.8% 23616
4. Referred workload (Table 10)
CG: cytogenetics; PCR: polymerase chain reaction; ESR: Erythrocyte
sedimentation rate
5. Blood Group Serology (Tables 11 and 12)
A 17.8% increase in Blood Grouping was observed as a full year consequence of a
change in testing for neonatal blood grouping introduced during August 2013.
The introduction of the two sample rule for issue of group specific blood products
would not account for the significant increase in direct coombs tests and is more
likely to reflect a change in Paediatric policy. 
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TABLE 12: DETAILS OF RED BLOOD CELL ALLOANTIBODIES DETECTED 
Antibody Number Antibody Number
D 17 c 3
E 12 Fya 3
C + D 4 M 28
Cw 6 N 1
c +/- E 10 Jka 3
D +C+E 2 Fya + Cw 1
E+ Jka 1 S 4
D+G +/-C 2 D+C+Jkb 1
e+/-C 3 C+D+E+Jka 1
K 7 Inb 1
Undefined specificity 58 Cr1 related antibody 1
Le a+b 2 Autoagglutinin 3
Lea 23 System Specific 2
Leb 3 Cold agglutinin 2
Cw +E 1 Jka 10
TOTAL 212
TABLE 13: BLOOD TRANSFUSION WORKLOAD 
Test 2014 2013
Group and save 7573 6974
Crossmatch 1599 1492
Patients crossmatched 565 705
Red Cell Units transfused 684 689
Patients Transfused 340 377 
Crossmatch: transfusion ratio 1.7:1 2.1:1
IUT (red cell units) 15 12 
Pedipack units transfused 119 104 
Transfused Components 2014 2013
Plasma (adult) 66 78
Plasma (paediatric) 25 43
Platelets (adult) 18 11
Platelets (paediatric) 39 42
Fibrinogen (adult) 57 68
Fibrinogen (paediatric) 39 35
Novoseven 0 0
Anti-D 2729 2207
Wastage: 2014 2013
Red cell (concentrated) 2.6% 1.8%
Platelets 0% 15.9%
Plasma 18.5% 19.9%
6. Blood transfusion
There has been a modest decrease in the number of patients transfused overall.
A continuing improvement in the cross-match to transfusion ratio was observed
(Table 13), reflecting introduction of new clinical guidelines. Blood wastage
remains low, particularly in 2014 for an uncommonly prescribed product,
platelets. An increase in Anti-D use reflects the full year introduction of the
routine antenatal Anti-D prophylaxis (RAADP) programme since July 2013.
IUT: intrauterine transfusion
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7. Haemovigilance 
The haemovigilance officer (HVO) continues to provide extensive education on
the process of blood transfusion to clinical staff. During 2014, 175 Nurses,
Midwives and Student Midwives and 65 non-consultant hospital doctors
attended Haemovigilance Education.
Once again, a very high standard was maintained in haemovigilance, with 100%
traceability of all blood components issued. The most common indication for
blood transfusion in the obstetric setting remains post-partum haemorrhage.
The RotundaHospitalhaemovigilance department maintains close links with
the National Haemovigilance Office (NHO) with the continuing aim of
maintaining quality of care through regular audit and education. The HVO
reports serious adverse events (SAE) and Serious Adverse Reactions to the NHO.
Two SAEs and Two SARs were reported to the NHO during 2014, there were no
adverse outcomes for patients. Both SAE’s pertained todelayed and inappropriate
administration of Anti-D immunoglobulin. The recently revised clinical pathway
managing patients who require Anti-D for prevention of RhD sensitization
continues to be under review, and specific SAE numbers related to this process
remain low as a consequence, compared with previous years.
As detailed above, implementation of a programme of RAADP administration to
RhD negative women was launched in July 2013. Audit and evaluation of the
system is ongoing through the RotundaHospital multidisciplinary RAADP
committee. In 2014 a total of 1158patients received RAADP - average 22 patients
are receiving Anti-D per week. 
CLINICAL MICROBIOLOGY
Consultant: Microbiologist Dr. Richard Drew   
Specialist Registrar: N/A
Associate Paediatric Specialist in
Infectious Diseases: Dr Wendy Ferguson
Chief Medical Scientist: Mr David Le Blanc 
Senior Medical Scientists: Ms Niamh Cahill
Mr Haydn Hammerton 
Medical Scientists: Ms Ita Cahill (0.5)
Ms Patricia Baynes
Ms Ann Lamont (0.5)
Ms Bernadette Lennon (0.5)
Ms Ellen Lennon (0.5)
Ms Gemma Tyrrell.
Laboratory Aides: Ms Grainne McDonald
Mr Tom Murphy 
Assistant Director of 
Midwifery/Nursing in
Infection Prevention and Control: Ms Marian Brennan
Infection Prevention and 
Control Midwife: Ms Alva Fitzgibbon
Infectious Diseases Liaison Midwife: Ms Mairead Lawless
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TABLE 14: OVERALL MICROBIOLOGY WORKLOAD IN 2014 COMPARED WITH 2013
2014 % Change
Tests Specimens Tests Specimens
Testing in-house
General Microbiology 81733 43844 -7.96 -4.16
Virology/Serology 33150 13729 8.95 3.72
Total tested in-house 114883 57573 -3.65 -2.39
Referred
Rubella 10488 10488 -2.20 -2.20
VZG 9464 9464 -1.09 -1.09
Treponemal tests 10117 9765 -1.04 -1.72
Confirmation and other 
specialist tests referred 
externally 7835 2271 -25.24 -49.80
Total Referred 39418 24390 -7.38 -9.78
GENERAL MICROBIOLOGY WORKLOAD
The activity and complexity of the Microbiology workload and that of the Neonatal
Unit, contributed significantly to continuing high workload (summarised in Table
15 and detailed in Table 18).
However, due to a number of money saving initiatives within the department,
numbers are reduced slightly in a number of areas. Of note, activity was lower in
the hospital in 2014. Swab numbers were reduced by 4.92% and screen numbers
were reduced by a total of 23.22%. This can be attributed to the fact that significant
changes were made in 2014 including screening for resistant Gram-negative bacilli
and MRSA in the NICU. Urines for culture and sensitivity were slightly increased by
0.89% but urines for bacteraemia screening were reduced by 1.02%. Although
pregnancy testing is generally carried out at the patient side, the numbers of
samples sent to the laboratory for pregnancy testing were reduced by 20.39%. CSF
numbers were increased by 1.29% compared to 2014. Bloodculture numbers
continue to rise year on year with a 2.01% rise noted in 2014 compared with 2013.
Specimens referred for Chlamydia trachomatis PCR were reduced (11.53%) which
again reflects hospital activity. A new category of testing was introduced in 2012
termed IQA (Internal Quality Assurance), required for ISO: 15189 accreditation. This
was reduced by 2.14% in 2013, mainly due to improved ordering of stock levels and
less variation in stock types. Overall there was a 4.16% and 7.96% decrease in
clinical Microbiology specimens and clinical tests respectively.
General Microbiology, Serology and Andrology were inspected by INAB in spring of
2014 and continue to enjoy ISO: 15189 Accreditation award in all areas examined.
SURVEILLANCE SCREENING
In line with best practice and in the interests of patient safety, screening for multi-
drug resistant organisms (MDROs) including MRSA, VRE, ESBLs and CRE in
identifiable ‘at risk’ groups in adults and neonates continued in 2014.
2014 saw continued surveillance screening for the entire hospital and improved
reporting of figures to hospital committees. This included figures for adult &
paediatric blood cultures and screening of the NICU for resistant Coliforms, VRE,
pseudomonas and MRSA. All these figures are presented at the NICU and infection
control meetings, which take place quarterly. 
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The Laboratory works as part of a multi-disciplinary team and provides the
surveillance data to the Neonatal Infection Prevention and Control group, which
helped to enable the group to identify changes and practices, which were required
in order to reduce the incidence of contaminated samples and healthcare
associated infection (HCAI). 
The appointment of a new full time Consultant Microbiologist in 2014 greatly
improved the presentation of the surveillance data to hospital committees.
TABLE 15: CLINICAL MICROBIOLOGY WORKLOAD IN 2014 COMPARED WITH 2013
Specimens 2014 % Difference over 2013
Urine 21064 0.13
Swabs 9395 -4.92
CSF 235 1.29
Blood Cultures 2974 3.70
GeneXpert MRSA/BA 22 100
Placenta 173 -20.28
Semen 1931 12.92
Pregnancy Tests 121 -20.39
Screening 4527 -23.22
Chlamydia trachomatis/
N. gonorrhoea PCR 2577 -11.53
IQA 825 -2.14
Total specimens 43844 -4.16
Tests
Urines 34046 0.34
Swabs 18790 -4.92
CSF 756 0.67
Blood Cultures 2974 3.70
Placenta 173 -20.28
MRSA Screen 4214 -20.88
Rectal Screen 7260 -43.86
Semen 4664 10.29
Antimicrobial Cards 2713 33.78
Pregnancy Tests 121 -20.39
Chlamydia trachomatis 2577 -11.53
GC PCR 2576 -9.74
GeneXpert MRSA/BA 44 100
IQA 825 -2.14
Total Tests 81733 -7.96
VIROLOGY/SEROLOGY WORKLOAD
The virology/serology workload for the former HARI Unit continues to be
performed in the virology/serology section of the Microbiology laboratory. Under
the EU Tissue Directive, it is a legal requirement that this testing can be only
performed in a laboratory that is fully accredited to ISO. The laboratory was again
inspected by INAB in 2014, and continues to enjoy ISO:15189 Accreditation.
Antenatal booking samples were unchanged however overall in-house virology
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testing was increased in 2014. There was an 8.95% and 3.72% increase in virology
tests and samples respectively, mainly because the Serology department now
performs virology tests for external laboratories, generating valuable revenue for
the laboratory. The number of specimens and tests referred to external laboratories
was reduced by 9.78% and 7.38% respectively. 
Validation began in late 2014 for Rubella IgG testing on the Abbott Architect and is
expected to be fully operational by January 2015. A tender went out in 2014 for an
analyser to perform Varicella-Zoster IgG testing and the liaison was purchased as
a result, allowing the department to perform in-house testing for VZ. Validation
was performed in late 2014 and is expected to go live in January 2015. Both these
tests will be assessed for ISO:15189 accreditation in April 2015. By performing these
tests in-house the department has managed to reduce the number of blood bottles
taken from 3 to 2 and turn around times have greatly improved. In addition,
Biomerieux provided a free upgrade of the mini-vidas analyser in order to carry out
confirmatory testing for Rubella IgG, VZ IgG and Hep B core. This allows the
department to report all tests in a timely manner and prevents unnecessary and
time-consuming dispatch of confirmatory testing.  The addition of all these tests
in-house is of great benefit to the Hospital and more importantly the patient.  It is
hoped that Syphilis testing would be added to the repertoire of testing in-house in
2015, thus reducing the workload further for unnecessary taking of blood and
dispatch of samples.Virology/Serology testing is represented in Tables 16 &17.
ACCREDITATION WORKLOAD
Batch acceptance (Internal Quality Assurance) of all reagents, media, antibiotics
and kits continues to be an important part of the weekly management of the
department. This is an important part of providing a quality service and although
IQA was down slightly in 2014 from 2013, this does not capture all the work
involved. Accreditation also involves updating standard operating procedures
(SOPs) on a continual basis, in line with international best practice. New media
and/or reagents/kits require validation or verification before they can be
employed.
Continual training for non-microbiology on-call staff and either new staff
members or returning staff members form long-term leave is ongoing. Proficiency
testing and competency testing is an important part of a scientist training log. The
Microbiology department continues to strive towards international excellence and
to this end has ISO: 15189 for nearly 100% of its repertoire of tests.
TABLE 16: VIROLOGY/SEROLOGY WORKLOAD (TESTS), 2014
Tested in-house 2014 % Change over 2013
HIV 11996 6.49
HbsAg 11964 6.17
Hepatitis B Core 2577 34.08
HepC Antibody 5157 16.28
CMV IgG 1452 -4.28
Hep B core - vidas 1 -91.67
VZ IgG - vidas 3 -57.14
Total 33150 8.95
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Tested in-house 2014 % Change over 2013
Specimens Referred 
Referral laboratory 1
TPE 9765 -1.72
RPR 146 21.67
TPEM 59 22.92
TPPA 147 23.53
Total 10117 -1.04
Referral laboratory 2
Rubella 10488 -2.20
VZ IgG - Liaison 9464 -1.09
Parvovirus B19 571 11.96
Confirmation and other specialist 
tests referred externally (MA) 943 -10.36
Other Referred tests (ME) 7835 -25.24
Total referred 39418 -7.38
ANDROLOGY WORKLOAD
Semen analysis for infertility testing and post vasectomy testing continued into
2014. Semen analysis for infertility is by appointment Monday-Wednesday from
9am to 1pm. A medical scientist is specifically assigned to testing.  Because of
accreditation, new forms were designed to facilitate improved reporting, which has
resulted in longer times for analysing these samples. Also, international best
practice would dictate that semen for infertility testing is performed in duplicate in
order to confirm results. Sample numbers for infertility were down slightly in 2014
(2.71%), however overall numbers for semen analysis were up by 12.92%, reflecting
a massive increase in samples for post vasectomy testing. These samples are less
time consuming and do not require immediate testing and therefore can be
batched together allowing better use of the scientist time. All andrology testing
provides valuable income for the laboratory and it is hoped that in 2015 the
repertoire of tests can be increased and the service expanded. 
TABLE 17: SEROLOGY (DETAILED BREAKDOWN OF TESTS PERFORMED)
2014 2013 Differential % change
VZGL 9464 9568 -104 -1.09
VZVR 3 7 -4 -57.14
Total VZ 9467 9575 -108 -1.13
Rubella 10488 10724 -236 -2.20
B19PVG 287 256 31 12.11
B19PVM 284 254 30 11.81
Total Parvovirus (MA) 571 510 61 11.96
Confirmatory & misc tests 943 1052 -109 -10.36
Total NVRL tests (MA) 21466 21854 -388 -1.78
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2014 2013 Differential % change
TPE 9765 9936 -171 -1.72
RPR 146 120 26 21.67
TPPA 147 119 28 23.53
TPEM 59 48 11 22.92
Total TP (SJH) 10117 10223 -106 -1.04
Tested In-House
HIV 11996 11265 731 6.49
Hep B 11964 11269 695 6.17
Hep B core 2577 1922 655 34.08
Hep C 5157 4435 722 16.28
CMV 1452 1517 -65 -4.28
HBCVR 1 12 -11 -91.67
Total  33147 30420 2727 8.96
Total Serology In-House 33150 30427 2723 8.95
Total Samples In-House 13729 13236 493 3.72
Total Tests on MA samples 64733 62504 2229 3.57
Referred Tests (ME) 7835 10480 -2645 -25.24
Referred Specimens (ME) 2271 4524 -2253 -49.80
Total Referred Tests 39418 42557 -3139 -7.38
Total Referred Specimens 24390 27033 -2643 -9.78
Total Tests 72568 72984 -416 -0.57
Total Specimens 38119 40269 -2150 -5.34
CHANGES IN LABORATORY EQUIPMENT AND TESTING PROCEDURES
Changes in agar media
All agar in the department is now sourced from two independent companies.
About 80% of the agar is sourced from LIP Galway, while the remainder is
sourced from Syntec. If one provider fails to deliver, then media can be sourced
from the other. In this way, media should never run out and ordering has greatly
improved through the Exact electronic ordering system.
Mortuary samples 
The number of mortuary samples placed into blood culture bottles for analysis
dropped significantly in 2014, mainly due to a change in practice. This has
eliminated unnecessary Identification of non-significant organisms and
improved the reporting time on these precious samples.
Resistant GNB identification
A new algorithm was introduced in 2014 for Identification and reporting of
RGNB in isolates from both adults and neonates. A new kit was sourced in
helping identify resistant organisms and so improving TATs and eliminating the
need to send isolates to reference laboratories for further work. This, together
with improved management of patients and new guidelines on taking rectal
swabs from the NICU has all helped to reduce the workload and have the added
benefit of cost saving for the department.
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Independent Internal Quality Control
Up to 2014 roughly 1% of all Serology samples were repeated as is recommended
by the Health Protection Agency (HPA) as a means for quality assurance. This
was a costly and time-consuming exercise and has now largely been replaced
with independent internal controls on all analytes. These are now run weekly
and provide valuable data on ‘uncertainty of measurement’ for each test, a
requirement for ISO: 15189. 0.1% of Serology samples are now repeated. This
change has reduced spending for the department while providing added quality
to patient samples.
Blood Culture Reporting times
Blood cultures are now loaded onto the BacT Alert 3D analyser as soon as they
reach the laboratory. It was always the case that blood cultures would be processed
as soon as possible, however now a 4-hour window is ‘ideally’ regarded as best
practice and this is currently been implemented within the department.  Positive
blood cultures are reported 24/7 and a gram result is usually reported within 2
hours to the relevant team. This has been made possible as the Blood Culture
analyser is now linked to the Rees monitoring system, so that positive blood
cultures will alert the scientist within 10 minutes of signalling positive. Our blood
culture analysis enjoys full ISO: 15189 accreditation.
GeneXpert
In 2014 money was sought through the SARI scheme with the intention of
purchasing a GeneXpert for performing Influenza PCR, C. difficile PCR and PCR
on positive blood cultures with Staphylococcus spp. This application was
successful and the analyser arrived in Q4 of 2014. Validation began almost
immediately and it is expected to put these tests forward for ISO: 15189
accreditation in 2015. The introduction of these rapid tests will provide the
hospital with faster turn around times, improve cost-efficiency and improve
patient care.
Mini-Vidas
The mini-vidas was upgraded in 2014 and validated for testing Rubella IgG,
Varicella Zoster IgG and Hepatitis B core. The analyser’s main purpose is as
confirmatory testing for these tests. This will prevent delay in sending out
samples for confirmatory testing to the NVRL and so improve TATs and
unnecessary packaging and dispatch. The analyser will be added to extension to
scope for ISO: 15189 accreditation in 2015.
Liaison
In 2014 a tender was sought for an analyser to perform VZV IgG testing for
Antenatal patients of the Rotunda Hospital. Up until the end of 2014 the NVRL
were performing this test and agreement was sought and given by both the HSE
and NVRL that these tests would form January 2015 be performed in-house by
the Microbiology department. Money for analysing these tests would come from
the HSE. Validation began on the Liaison in Q4 of 2014 and will be added to
extension to scope for ISO: 15189 accreditation in 2015. 
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Medibridge Link with NVRL
In 2013 SARI (Strategy for the Control of Antimicrobial Resistance in Ireland)
provided funding for an electronic link with the NVRL for the upload of requests
and download of results. Work on this began in late 2013 and validation was
completed in March 2014. This has greatly improved TATs for referred tests to the
NVRL and reduces the time needed to report these results. Clerical errors have
been eliminated as reports no longer need to be manually entered.
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TABLE 18: MICROBIOLOGY TESTING
2014                           2013                      Difference               % 
numbers Change
Tests Specimens Tests Specimens Tests Specimens Tests Specimens
MSU
Microscopy’s 12749 12644 105 0.83
MSU Culture 12793 12699 94 0.74
MSU Dipstick 0 4 -4 -100.00
Total MSU 25542 12793 25347 12680 195 113 0.77 0.89
First visit 8504 8271 8583 8356 -79 -85 -0.92 -1.02
Total Urine 34046 21064 33930 21036 116 28 0.34 0.13
Pregnancy
Tests 121 121 152 152 -31 -31 -20.39 -20.39
Blood
Culture (sets) 2974 2974 2868 2868 106 106 3.70 3.70
Placenta 173 173 217 217 -44 -44 -20.28 -20.28
Total Blood
Culture 3147 3147 3085 3085 62 62 2.01 2.01
GeneXpert 
MRSA/SA 44 22 0 0 44 22 100.00 100.00
CSF Culture 235 232
CSF Gram 230 232
CSF Cell Count 233 225
CSF Diff 58 62
Total CSF 756 235 751 232 5 3 0.67 1.29
Semen
Volume 1931 1710 221 12.92
Semen Count 1928 1704 224 13.15
Semen
Motility 789 811 -22 -2.71
Semen
Morphology 16 4 12 100.00
Total Semen 4664 1931 4229 1710 435 221 10.29 12.92
CT PCR 2577 2913 -336 -11.53
NG PCR 2576 2854 -278 -9.74
Total PCR 5153 2577 5767 2913 -614 -336 -10.65 -11.53
IQA 825 825 843 843 -18 -18 -2.14 -2.14
MRSA 4214 2107 5326 2663 -1112 -556 -20.88 -20.88
Rectal 7260 2420 12932 3233 -5672 -813 -43.86 -25.15
Total Screens 11474 4527 18258 5896 -6784 -1369 -37.16 -23.22
Swabs 18790 9395 19762 9881 -972 -486 -4.92 -4.92
Sensitivities 2713 2028 685 33.78
Total 81733 43844 88805 45748 -7072 -1904 -7.96 -4.16
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CLINICAL WORKLOAD
From March 2014, the department has kept a database of all consults seen by the
consultant microbiologist, so that this activity could be captured. Over the 10
months, 327 consults were seen, 245 women and 82 neonates. The most common
diagnosis was recorded and is shown below for the adult and neonatal patients
Consults- Adult 2014 (Mar-Dec)
No sepsis found 42
Pyelonephritis 34
C-section wound infection 24
Blood culture contaminant 21
Chorioamnionitis 19
Endometritis 19
Lower urinary tract infection 13
Lower respiratory tract infection 9
Mastitis 9
Intraabodominal collection 8
Pelvic inflammatory disease 7
Septic miscarriage 7
Wound infection 6
Cellulitis 4
Other 23
Total 245
Consults Neonates 2014 (Mar-Dec)
No sepsis found 20
GBS related 11
Blood culture contaminant 9
Infection control issue 7
Meningitis 6
Culture negative sepsis 5
Necrotising enterocolitis 5
Other 19
Total 82
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SUMMARY OF KEY ACHIEVEMENTS DURING 2014
There were no episodes of MRSA Bacteraemia
There were no episodes of Clostridium Difficile Infection in the hospital.
There was one outbreak of a resistant e coli  in the NICU. Four infants were colonised
with the same resistant organism  but none were infected. There were no adverse
events as a result.
The IPC Team have reviewed the HIQA standards for prevention and control of
healthcare associated infections and incorporated quality improvement plans into
their service plan to help achieve compliance.
The IPC Team continues to work with the neonatal team  to reduce infection
The role of the IPC Link midwife/nurse has been reviewed with greater emphasis on
their role as providers of local training and education and local auditors.
The IPC Team have worked with the Quality Manager, Support Services Manager and
Household Manager to monitor standards of cleanliness throughout the hospital
The IPC Team have significantly supported major capital developments that have
improved patient experience.
The IPC team have incorporated new national guidance on IV Cannulation and
MDRO Screening into IPC Policy.
SERVICE OVERVIEW
The vision of this service is to provide an environment in which our patients can receive
safe and effective care, in the knowledge that appropriate measures have been put in
place to minimise the risk of healthcare associated infections (HCAIs). We aim to put the
woman, her child and their family at the centre of everything that we do. We can put
this in place by ensuring that:
• The facilities in which care is received are kept in a manner to prevent HCAIs
• Staff are educated with respect to key elements of infection control practice 
• A robust and effective Infection Prevention and Control team (IPCT)  is in place
to assist staff in managing and preventing HCAIs
• The Health Information and Quality Authority (HIQA) National Standards for
the Prevention and Control of Health Care Associated Infections 2009 are
embedded into the culture of the organisation and act as a structure on which
to base our continual improvement in IPC. 
I N F E C T I O N  P R E V E N T I O N  A N D  C O N T R O L
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The Team
During 2014 the Infection prevention and Control Team (IPCT) has undergone
further change as Dr Richard Drew Consultant Microbiologist took up position on
1st March. In December Ms Carol Gogan retired from the Hospital leaving vacant the
0.2 WTE position of Decontamination Coordinator.
The IPCT is represented at the following Hospital Committees
• Hygiene Committee
• Quality and Safety 
• Procurement
• Neonatal Infection Prevention and Control Group
• All Departmental Patient Safety Meetings
• Clinical Midwife Managers
• Drugs and Therapeutics
• Building Planning
Role of the Infection Prevention and Control Team
The following roles are undertaken by the IPC Team:-
➢ Education
➢ Surveillance of hospital infection
➢ Investigation and control of outbreaks
➢ Development of Infection Prevention and Control policies
➢ Implementation and monitoring of Infection Prevention and Control policies
➢ Audit
➢ Assessment of new items of equipment
➢ Assessment and input into service development and buildings / estate works
➢ Reference source for hospital personnel
QUALITY INITIATIVES
HIQA Standards 
The HIQA PCHAI standards were reviewed and form the basis of the Service Plan
and the reports for the Infection Prevention and Control Committee.
The IPCT took part in the Hospital self assessment against Standard 1 of the HIQA
National Standards for Safer Better Healthcare. The IPCT also contributed to the
gap analysis against compliance with recommendations following the
publication of the Patient Safety Investigation Report into the Services at
University Hospital Galway.
In October 2014 an unannounced inspection by HIQA was undertaken on the
Gynaecology Ward and Neonatal Unit. This focused on Standard 3 –Environment
and Standard 6 Hand Hygiene. The IPC team assisted in developing the Quality
Improvement Plan to address non conformances identified.
Education
The IPCT has provided 34 general training sessions plus 3 hand hygiene
awareness days with training for all staff. During the last quarter of 2014 there
were 3 educational sessions regarding correct procedures for donning and doffing
Personal Protective Equipment for Ebola cases.
Monthly in service education programmes for midwifery and nursing staff were
undertaken by the IPCT in collaboration with others including the Occupational
Health Nurse and the Infectious Diseases Liaison Midwife. 
This includes presentations on hand hygiene and all the standard and
transmission based precaution
The IPCT also give education to all staff at induction.
Mandatory training every two years in hand hygiene is a requirement for all staff.
Although the majority of this education is given directly by the Infection
Prevention and Control Midwives a limited number of link staff also provide this
training in their own departments. Staff are also encouraged to use the HSELanD
hand hygiene e learning tool and the SureWash machine.
Reports of staff who have received hand hygiene education are returned to the
HSE monthly. 
• % of new healthcare staff that have received mandatory induction hand 
hygiene training.
• % of existing healthcare staff that have received mandatory hand hygiene
training within the last two years. 
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Guidelines
The IPCT team have incorporated new national guidance on IV Cannulation, MDRO
Screening and Ebola management into IPC Policy.  New clinical care pathways for
pyelonephritis, intrapartum fever and breast abscess were introduced by the IPCT.
Other policies and guidelines (8 in total) due for renewal were reviewed and updated
by the Team
Environmental and Hand Hygiene Audits
The IPCT with the link midwife/nurses carried out 55 audits on the decontamination
of medical equipment. The average score ranged from 84% to 98%. The target is 90%.
Hand Hygiene audits were carried out in all areas. In total 30 audits were recorded.
Audits done in May and October were returned to the HSE and published as part of
the National Hand Hygiene Audit. The results of these audits continue to improve on
previous years and achieved the HSE target.
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SERVICE DEVELOPMENTS
Infection Prevention and Control Committee
The IPC Committee meets quarterly and is chaired by the Master of the Rotunda.
Terms of reference of the committee were reviewed. The Committee receives regular
reports on infection prevention and control activities from clinical and non-clinical
departments.
The IPCT report quarterly to IPCC 
Throughout the year many changes in practice have been initiated, facilitated,
supported or demanded through the work of the IPCT and IPCC.
The following detail some of the changes facilitated throughout the year.
• A procedure for performing root cause analyses into serious adverse events
when they occur
o Adults
• Hospital acquired bacteraemia
• Major outbreaks of disease
o Neonates
• Late-onset sepsis
• Necrotising enterocolitis
• Outbreaks of disease (Reported within 30 days of 
closure of outbreak)
• Progressions of the introducing of sharps free/needle safe devices in areas of
the hospital where it is practicable to do so.
• Production of surveillance reports and identifying trends
• Review of patient information leaflets and making them available on 
hospital Intranet for staff to provide to patients in a timely manner. 
• Production of a revised screening policy  which incorporates national 
guidelines 
PRIORITIES FOR 2015
• Revision of the water policy
• Production of antimicrobial consumption at a sufficient frequency to inform 
clinical practice
• Incorporate new national guidelines on hand hygiene into local policy
CONSULTANTS:
DR. CAROLE BARRY PROF. FERGAL MALONE
DR. FIONNUALA BREATHNACH DR. SHARON COOLEY
DR. RONAN GLEESON DR. BARRY GAUGHAN
DR. JENNIFER DONNELLY DR. KAREN FLOOD  
MATERNAL FETAL MEDICINE FELLOW:
DR. ETAOIN KENT DR. JENNY WALSH
MIDWIFE SONOGRAPHERS:
IRENE TWOMEY CMS DEIRDRE NOLAN CMS
GEMMA OWENS CMS (PENDING) ALLYSON LAWLESS
HILDA O’KEEFFE (Perinatal Ireland Research Sonographer)
RADIOGRAPHERS:
MABEL BOGERABATYO
FIONA CODY (Perinatal Ireland Research Sonographer)
FETAL MEDICINE MIDWIVES:
NOLLAIG KELLIHER CMM2 JANE DALRYMPLE CMS
JOAN O’BEIRNES S/M LAURA MCBRIDE S/M
MARY DEERING CMM3  Antenatal Inpatients, Day Services, Incorp. Fetal Medicine
MEDICAL SOCIAL WORKER:
DEIRDRE KEEGAN SINEAD DEVITT
ADMINISTRATION
ANITA O’REILLY SUZANNE LARKIN MARY MAGUIRE
2014 was another busy year in the Ultrasound, Fetal Assessment (FAU) and
Prenatal Diagnosis (PND) clinics. 
The core ultrasound services in The Rotunda Hospital in 2014 were provided by
midwife sonographers Irene Twomey, Deirdre Nolan, Gemma Owens, Allyson
Lawless, Hilda O’Keeffe and radiographers Mabel Bogerabatyo, and Fiona Cody.
S/M Laura McBride commenced additional training as a sonographer on a part-
time basis. Once again their dedication, hard work and commitment are
recognised and appreciated. All patients are offered a departmental fetal anatomic
survey at 20 weeks. Serial scanning services were provided for patients attending
the Diabetes, Twin and Medical Clinics. Non routine or emergency ultrasound
requisitions are accommodated in addition to the scheduled workload.  
Fiona Cody and Hilda O’Keeffe of Perinatal Ireland contributed enormously to
the FAU this year. 
U LT R A S O U N D, F E TA L  A S S E S S M E N T  &
P R E N ATA L D I AG N O S I S  C L I N I C S
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DEVELOPMENTS IN 2014
• CMS Irene Twomey and Radiographer Mabel Bogerabatyo completed their 
Masters in Ultrasound.
• Sonographer Allyson Lawless joined us from Castlebar.
• Non-Invasive Prenatal Testing was introduced for fetal screening.
NUMBER OF OBSTETRIC SCANS
20 Week Scan Fetal Anatomic Survey 8,838
Growth Scan 8,711
Echocardiogram  215   
Others 1,433
NUMBER OF GYNAECOLOGICAL SCANS 1,588
Total 20,785  
PRENATAL DIAGNOSIS CLINIC
In 2014 1,429 new patients attended for Prenatal Diagnosis.  Drs. Barry, Breathnach,
Cooley, Donnelly, Flood and Prof. Malone with CMS Jane Dalrymple, CMM2 Nollaig
Kelliher, S/M Joan O’Beirnes and S/M Laura McBride operated 7 clinics per week.
There were 3,390 attendances as some patients were followed longitudinally. All
patients had an ultrasound scan.  In addition the following tests were performed:
Combined First Trimester Screening 547
Second Trimester Screening (Intmark) 15
Non Invasive Prenatal Testing (Cell Free Fetal DNA) 375
Amniocentesis 144
Chorionic Villus Sampling 80
Of the 224 diagnostic procedures performed, there were 77 abnormal results
representing 34.5% of invasive tests. Notably since the introduction of NIPT the number
of invasive procedures has fallen but the proportion of positive results has increased.
Abnormality CVS Amnio Total
Trisomy 21 11 19 30
Trisomy 18 8 13 21
Trisomy 13 2 4 6
45X 3 1 4
Triploidy 2 2 4
Mosaic 1 0 1
Translocation 1 0 1
Deletion 0 2 2
Di George 0 1 1
Sickle Cell 1 1 2
Klinefelter 1 1 2
Roberts Syndrome 1 0 1
Inversion 1 1 2
Total 32 45 77
Failed Culture 0 2 2
33 invasive procedures other than amniocentesis or CVS were performed. These
included: 
Fetal Bladder Shunts 1
Cordocentesis 6
Intrauteine Transfusion 11
Laser Ablation (see Note Below) 15
Total 33
Dublin Fetal Surgery Group:
Since 2010, the fetal surgical teams at the National Maternity Hospital Dublin, and
the Rotunda Hospital Dublin have collaborated jointly for the management of all
cases of twin-to-twin transfusion syndrome referred to either centre. This has
resulted in a single team approach to all such cases, regardless of which of the two
hospital locations at which such patients are seen. Professor Fergal Malone, Professor
Fionnuala McAuliffe and Dr Stephen Carroll jointly perform all such procedures.
During 2014, a total of 15 cases of severe TTTS were managed by the Dublin Fetal
Surgery Group by means of fetoscopic laser ablation of placental vessels. By the
end of 2014, our group had completed 117 cases of laser surgery for severe TTTS,
with at least one survivor occurring in 82% of cases (97 /117). These results are in
line with international published experience for this complex condition and our
results have been recently published (Outcome following selective fetoscopic
laser ablation for twin to twin transfusion syndrome: an eight year national
collaborative experience. Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:125-9).
This approach to a complex, but relatively rare, fetal problem is an excellent
example of a joint collaborative management strategy that successfully
optimises care for these patients. Patients are currently referred from obstetric
units throughout Ireland for fetoscopic laser ablation and, where appropriate
expertise is available, patients are referred back to their original obstetric centre
for subsequent fetal surveillance and delivery. It is hoped that, as referral
pathways become more established, the number of cases of fetoscopic laser
ablation will increase further.
Major Fetal Structural Abnormality:
Excluding soft markers and chromosomal abnormalities, 188 cases of major
structural abnormalities were detected and followed.  These include:-
Abnormalities detected based on RCOG/RCR Classification
CNS (excluding choroid plexus cyst) 30
Head & Neck  (including hygromata) 22
Cardiovascular system (excluding echogenic foci and 
untreated arrhythmias) 36
Renal (excluding pelvic dilatation of<10mm) 49
Abdominal contents  (Including anterior abdominal 
wall defects and excluding echogenic bowel) 7
Skeletal 15
Thoracic (excluding cardiac abnormalities) 8
Others 21
Total 188158
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Targeted fetal echocardiograms were performed in women deemed high risk
according to a specific departmental protocol or where a routine structural scan
was suspicious for a cardiac abnormality.  Dr Fionnuala Breathnach performed the
majority of fetal echocardiograms. A total of 215 targeted fetal echocardiograms
were performed within the Department in 2014, 
Where fetal congenital heart disease was identified or suspected, women were
seen at our Combined Fetal Cardiology clinic based at the Coombe Hospital, staffed
by Consultant Paediatric Cardiologist Dr. Orla Franklin and by consultants in
Maternal Fetal Medicine Prof. Sean Daly and Dr. Fionnuala Breathnach.  
Established in 2009, this collaborative clinic offers a seamless transition from
prenatal to neonatal care for infants diagnosed in-utero with congenital heart
disease.  This approach allows for individualized care, to include prenatal
counseling and formulation of delivery and perinatal care plans. This clinic
continues to expand, and caters for referrals from all maternity units in Ireland.
In 2014, the cases of fetal cardiac abnormality co-managed through this clinic were
classified as follows: (For comparative purposes, 2013 data is also presented)
Lesion 2013 2014
HLHD 14 19
HRHD 6 14
cAVSD 15 12
VSD 23 21
Outlet Lesions AS 2 4
Isomeric Lesions (Single Ventricle) 5 3
Coarctation 5 5
Cardiac Tumours 1 1
Truncus Arteriosus 3 2
Tetralogy of Fallot 8 8
Cardiomyopathy 1 5
Ebsteins Anomaly 1 1
TGA 5 4
Bilateral SVC (Isolated) 1 1
Primum ASD - 2
Interrrupted Aortic Arch 1 1
TOTAL 93 103
Arrhythmia 2013 2014
Congenital Complete Heart Block 2 0
SVT 3 3
Atrial Ectopics 6 8
TOTAL 11 11
We estimate that two-thirds of infants born with single-ventricle physiology in
Ireland attend our combined service for prenatal consultation.
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Multiple Pregnancy:
Dr Ronan Gleeson runs the weekly twin clinic which is conducted as part of the
Team D antenatal clinic. Both mono and dichorionic twins are managed in this
antenatal clinic. Twins that are considered to be higher risk –eg. monochorionic
twins that develop complications are usually referred for management to the
Fetal Medicine Unit. There were 183 sets of twins (365 babies >500g) delivered
in the hospital in 2014. Higher order multiples are usually managed in the FAU.  
Eighty six multiple pregnancies were referred to the Prenatal Diagnosis Clinic
in particular high risk circumstances.  These included:
Multiple Pregnancy
Monoamniotic Twins 7
MCDA Twins 51
TTTS 9/51
Discordant growth 17/51 
Structural anomaly 1/51
Normal Outcome 24/51
Dichorionic Twins
Discordant growth 9
Structural Anomaly 6
Normal Outcome 1
MCTA Triplets 1
DCTA Triplets 
Discordant Growth 2
Structural Abnormality 3
Normal Outcome 2
TCTA Triplets 
Structural Abnormality 1
Normal Outcome 1
Quads 2
Total 86
Excludes women undergoing laser therapy for TTTS In the Dublin Fetal Surgery Group
MCDA = Monochorionic Diamniotic;  MCTA = Monochorionic Triamniotic;  
DCTA = Dichorionic Triamniotic;                TCTA = Trichorionic Triamniotic
Additional Cases Followed in Prenatal Diagnosis Clinic:
PPROM 1st & 2nd Trimester 10
IUGR (Severe 2nd trimester) 46
Polyhydramnios 10
Oligohydramnios/Anhydramnios 2
Rhesus Sensitization 5
Antibodies 20
CMV 2
Toxoplasmosis 1
Parvovirus 2
Soft Marker Normal Outcome 27
High Risk Screen Normal Outcome 37
Total 162
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DR GERALDINE CONNOLLY
DEBORAH BROWN RM
Antenatal care is provided to all teenage pregnant mothers up to age 17 in the
Rotunda hospital in the teenage pregnancy clinic.  Girls who are older and
deemed vulnerable, such as those with special needs, also attend the clinic as we
feel they may benefit from continuity of care. Comparative figures for the past 8
years for the clinic are presented.
Number booked
2007 120
2008 132
2009 145
2010 116
2011 124
2012 110
2013 112
2014 119
Primiparous Multiparous
2007 113 7
2008 123 9
2009 131 6
2010 109 7
2011 115 9
2012 100 10
2013 98 14
Two patients were expecting their third baby.
Onset of Labour
Spontaneous % Induction %
2007 72 26
2008 70 30
2009 68 30
2010 69 27
2011 66 24
2012 68 31
2013 66 33
Mode of Delivery %
SVD Instrumental C Section C section 
Emergency No labour
2007 64.7 20.7 12 2.6
2008 59.8 28.8 11.4 0
2009 64.2 23.3 10.9 1.6
2010 58.4 19.7 17.9 3.7
2011 63.6 20 10.9 5.5
2012 61.1 21.3 15.5 1.9
2013 62 23 15 1
T E E N A G E  P R E G N A N C Y  C L I N I C
Epidural rates %
2007 78.5
2008 71
2009 74.4
2010 66.3
2011 68
2012 66
2013 72
Premature delivery % low birth wt %
2007 5.8 3.3
2008 7.8 6.8
2009 7.6 6.5
2010 4.7 2.8
2011 7.3 9.1
2012 2.9 4.8
2013 2 3
Chlamydia positive (%) Third degree tear (n)
2007 15 1
2008 6.4 1
2009 16 3
2010 12.2 3
2011 9.6 3
2012 14.1 2
2013 9.6 4.8
Adverse baby outcome (n)
intrauterine neonatal
2007 0 1
2008 1 0
2009 2 2
2010 0 1
2011 0 2
2012 0 1
2013 0 0
Attendance at
Antenatal Classes % Postnatal Clinic (%)
2007 52 50
2008 66 67
2009 55 37
2010 48 48
2011 54 41
2012 45 55
2013 40 49
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Comment
The caesarean section rate in the teenage population is 16% which is
significantly lower that the overall hospital population.  Two patients attended
the pre-natal diagnosis clinic. One had transposition of the great vessels and was
delivered liveborn at 37 weeks.  The other had non-specific abnormalities noted
at the anatomy scan with a normal amniocentesis.  She spontaneously laboured
at 22 weeks and declined post mortem.  
Attendance at the postnatal clinic was less this year and we hope to improve
this. We inserted a mirena IUS into 24% of those who attended.  Breast feeding
was initiated in 32%.   Chlamydia positive rate was 9.6% somewhat less than last
year. Two percent had premature deliveries. Three babies weighed above 4.5Kg
and 3 babies had IUGR at term.
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DR. JOHN SHEEHAN, Consultant in Perinatal Psychiatry
MS. KATHLEEN O’DONOHOE, Mental Health Support Midwife
MS. LOUISE RAFFERTY, Mental Health Support Midwife
MS. URSULA NAGLE, Mental Health Support Midwife
The mental health service at the Rotunda is a multidisciplinary service
run by a part-time consultant psychiatrist and 1.5 WTE support midwives.
Pre-pregnancy counselling is offered as well as assessment and
management of perinatal mental health problems. As well as their
clinical duties, the midwives act as a resource for information and advice
and offer a telephone consultation service mainly to mothers, GP’s and
Public Health Nurses.  
In 2014, 132 new patients were seen by Dr. Sheehan as well as 175
review/follow-up patients.  The Support Midwives saw 310 new patients
in the Health Promotion Clinic and 183 patients for follow-up.  On the
wards, the support midwives saw 1333 mothers and saw 213 for follow-up.    
In February, Ms. Louise Rafffery left the service to start a Masters in TCD.
She contributed significantly to the mental health service during her four
years as part of the team.  She brought great enthusiasm, good humour,
energy and intelligence to her job.  Our loss was Trinity’s gain.
In March, a Perinatal Mental Health Study day was held in the Rotunda.
Organised by Ms. Kathleen O’Donohoe and Ms. Louise Rafferty, it was
very successful with over 30 midwives attending.  Dr. Sheehan was one of
the speakers giving an overview of perinatal mental health and Dr. Anne
Marie Waldron, Consultant Child Psychiatrist, gave an excellent lecture
on Attachment in infants. 
In May, Ms. Ursula Nagle commenced work as a support midwife.  She is
trained as both a general nurse and as a midwife.  Having works as the
CNM I in the Labour ward, she brings considerable expertise and
experience to her role as a support midwife. 
In July, Dr. Yvette Giblin, SpR in Psychiatry, started a special interest
session with Dr. Sheehan in order to gain experience in perinatal
psychiatry. 
Regarding education, lectures were provided to UCD medical students
and midwifery students and the weekly educational Continuing
Professional Development meetings continued. 
M E N T A L  H E A L T H  S E R V I C E S
165
DR FIONNUALA BREATHNACH Consultant Obstetrician, 
Maternal-Fetal Medicine Specialist
DR MARIA BYRNE Consultant Endocrinologist
DR SIOBHAN BACON Specialist Registrar, Endocrinology
DR NAJIA SIDDIQUE Research Registrar, Endocrinology
DR SIOBHAN CORCORAN Research Registrar, Obstetrics & 
Gynaecology
MS JACKIE EDWARDS CMM Specialist Diabetes Midwife
MS AILEEN FLEMING Specialist Diabetes Midwife
MS CLAIRE KEARNEY Specialist Diabetes Midwife
MS LAURA HARRINGTON Senior Dietician
MS AILBHE MCCARTHY CNM1 Research
INTRODUCTION:
The Combined Obstetric Endocrine service for care of women with Diabetes
Mellitus continues to represent one of the highest-risk areas of clinical care in
this hospital. The population with pregestational type II diabetes now exceeds
that with type I disease, and the extent to which each subgroup with diabetes
(type I, type II and gestational diabetes) contributes to the population whose
prenatal care is conducted through this clinic is illustrated in Figure 1:
FIGURE 1: Women with pregnancies complicated by Diabetes 
at the Rotunda 2007 - 2014
C O M B I N E D  O B S T E T R I C - E N D O C R I N E
S E R V I C E  F O R  D I A B E T E S  M E L L I T U S
The most striking observation for 2014 is the exponential increase in our
Gestational Diabetes population. This phenomenon is a reflection of the
transition in February 2014 from the 100g 3-hour screening test to the IADPSG-
endorsed 75g 2-hour Oral Glucose tolerance test with its accompanying lower
thresholds for GDM diagnosis. The International Association of Diabetes in 
Pregnancy Study Group (IADPSG) does not apply the term Impaired Glucose
Tolerance (IGT) in pregnancy, and thus any deviation from threshold norms
constitutes a diagnosis of GDM. Therefore, an IGT category is not considered to
represent a distinct entity for this year’s report.
Our model of care for women with GDM involves monitoring and surveillance
for diet-controlled GDM in a midwifery-led service, with obstetric care for these
women being provided through routine antenatal clinics. Attendance at the
Combined Obstetric Endocrine clinic is only required for women with
pregestational diabetes (type I or type II) or with gestational diabetes who
require therapy beyond diet. Women with a history of gestational diabetes in a
prior pregnancy attend the midwifery-led unit for regular surveillance from the
first trimester of pregnancy; again with transfer to the Combined Obstetric
Endocrine service only in the event that gestational diabetes is confirmed and is
not adequately responding to dietary therapy.
TREATMENT FOR GESTATIONAL DIABETES:
We are hopeful in the future that resources may be provided to allow the women
with more minor degrees of carbohydrate intolerance to avail of tailored
specialist dietetic consultation and self-glucose monitoring in pregnancy, which
is widely recognised as representing the optimal standard in pursuit of
glycaemic control. Unfortunately in 2013 the HSE withdrew temporary long-term
illness card coverage for the diagnosis of gestational diabetes, such that women
who develop GDM and require insulin must now self-fund insulin, glucometers
and glucose-strips. These costs render the condition unaffordable for a large
proportion of our patient population.  This team is advocating strongly for the
HSE to reverse this decision and invest in maternal-fetal health for substantial
long-term gain.
TABLE 1: Pregestational Diabetes: Maternal Characteristics
TYPE 1 TYPE II
N 16 37
Age 30.9 ± 6.5 34.1 ± 4.4
DM duration (yrs) 17.9 ± 10.0 4.8 ± 3.2
DM Complications: (Expressed in ongoing viable pregnancies)
• Chronic hypertension 3/16 (19%) 1/35 (3%)
• Retinopathy 4/16 (25%) 0/35 (0%)
• Nephropathy 3/16 (19%) 0/35 (0%)
• Neuropathy 0/16 (0%) 0
Preeclampsia 2/16 (13%) 2/35 (6%)
Gestation at booking 6.1 ± 2.1 8.3 ± 5.7
HbA1c at booking/IFCC 67 ± 22 50 ± 17
HbA1c at delivery/IFCC 51 ± 20 40 ± 6
Fructosamine at booking 378 ± 73 266 ± 59
Fructosamine at delivery 260 ± 63 227 ± 24
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TABLE 2: Pregestational Diabetes: Perinatal Outcome
TYPE 1 TYPE II
N 16 37
Spontaneous Fetal Loss (<24 weeks) 0/16 (0%) 2/37 (5%)
Preterm delivery 24+0 – 36+6 weeks 6/16 (38%) 5/35 (14%)
Liveborn 16/16 (100%) 34/35 (97%) 
Stillbirth 0 1#
Neonatal death 0 0
Delivered Elsewhere 0 0 
Caesarean Delivery 12/16* (75%) 15/35* (43%)
Gestational age at delivery 36.0 ± 3.4 37.2 ± 3.7
Birthweight (g) 3900 ± 1000 3300 ± 1100
Macrosomia ≥99th centile for 
gestational age 1/16 (6%) 4/35 (11%)
Shoulder dystocia 1/16 (6%) 1/16 (6%)
Major congenital anomaly 0/16 (0%) 1/16 (6%) (Mar 
chromosome 
aberration; 
marked 
kyphoscoliosis)
*Ongoing viable pregnancies delivered at the Rotunda
TABLE 3: Gestational Diabetes (GDM):
Diet-controlled GDM GDM ONINSULIN
N 495 149
Age 32.7 ± 5.4 33.2 ± 5.1
Gestational age at delivery 38.7 ± 1.9 38.6 ± 1.3
Birthweight (g) 2650 ± 1270 3400 ± 500
Caesarean delivery 196/495 (39.6%) 63/149 (42%)
Stillbirth 5/495 (1%) # 0
Spontaneous fetal loss <24 weeks N/A N/A
Delivered Elsewhere 0 1/149 (0.7%)
Preeclampsia 11/495 (2%) 0
Macrosomia ≥99th centile 
for gestation 0 7
Major congenital anomaly 1 (Trisomy 21) 2: (Trisomy 21;
Diaphragmatic 
hernia)
#CASE STUDIES : Please refer to Perinatal Mortality section of this 
report for further detail 
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RESEARCH:
In 2014 Dr Siobhan Corcoran commenced her MD thesis on Prediction of
Gestational Diabetes in the First Trimester, under the supervision of Dr
Fionnuala Breathnach. This study involves the prospective recruitment of
women at risk for gestational diabetes, with first trimester analysis of a panel of
biomarkers aimed at exploring the potential to refine the screening process for
GDM. The thesis is on target for completion in late 2015, with anticipated
presentation of results at the Society for Maternal Fetal Medicine Annual
Congress in Atlanta in February 2016.
Citations from Obstetric Diabetes Service in 2014:
Corcoran S, Breathnach FM. The early bird catches the worm: Predicting the onset
of gestational diabetes in the first trimester. J Matern Fetal Neonatal Med 2014
Jul 11:1-2. PMID: 24920284 IF:1.311
Khalifeh A, Breathnach FM, Coulter Smith S, Robson M, Fitzpatrick C, Malone F.
Changing trends in Diabetes Mellitus in pregnancy. J Obstet Gynecol Feb 2014;
34:135-7. IF 0.6 
Ryan H, Morrison JJ, Breathnach FM et al. The influence of maternal body mass
index on fetal weight estimation in twin pregnancy. Am J Obstet Gynecol 2014
Apr;210(4):350e1-6. PMID:24215852. IF 3.973
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LAURA HARRINGTON, RD, MINDI- SENIOR DIETITIAN
In 2014 the dietitian saw a total of 1056 new patients and 408 follow-up visits.
This is a 35% increase in activity from 2013 and reflects the increase in the
number of patients diagnosed with gestational diabetes (GDM). The types of
patients cared for can be classified in the tables below:
Referring Service New Patient Follow-up Total Percentage
(in- Patient Patient of Total
and visits Encounters Patient
outpatients) (in-and Activity
outpatients)
Antenatal 182 67 17 %
Diabetes 833 280 76 %
Gynaecology 10 4 1 %
Paediatrics 24 51 5 %
Postnatal 7 6 1 %
TOTAL 1056 408 1464
Group Patient Education Classes
Class Patient Numbers Attending
Antenatal Parent Education Class 1426
Gestational Diabetes Lifestyle Intervention Class 533
The majority of dietetic referrals are for the following conditions:
. Antenatal: Overweight or obesity, underweight, poor weight gain, 
hyperemesis, multifoetal gestation, anaemia, eating disorders, Crohn’s
• Diabetes: Gestational diabetes, type 1 and 2 diabetes in pregnancy 
• Gynaecology: Polycystic ovary syndrome, poor wound 
healing/postoperative infection and infertility linked to 
overweight/obesity or underweight
• Neonatology/Paeds: Poor weight gain, faltering growth, food 
intolerances and allergy
• Postnatal:  Poor wound healing, infection, underweight, constipation, 
IBS and incontinence
C L I N I C A L  N U T R I T I O N
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Diabetes referrals continue to dominate the dietetic service. There was an
increase of over 86% in the number of new patients with diabetes, all types
combined. To manage this increased demand, the majority of patients newly
diagnosed with GDM or, with a history of GDM in a previous pregnancy, are seen
in multi-disciplinary group education sessions. Over 66% of patients with GDM
were seen in the class, with the remaining 34% seen by the dietitian individually.
Services to gynaecology, postnatal and paediatric patients had to be limited in
order to prioritise high risk diabetic patients. The current level of activity in the
department does not reflect the true demand for dietetic services. However, the
dietitian endeavours to provide a quality service within the confines of limited
staffing resources.
The dietitian also gives presentations to midwifery and nursing staff in diabetes
study days yearly. Links are maintained with the dietitians in maternity services
nationwide to contribute to the National Clinical Guidelines, create and share
cost of patient education materials and facilitate continuing professional
education.
DR MARY HOLOHAN
At the Epilepsy Clinic in 2014 there were 119 patients seen.  For all of the patients
a delivery plan was determined and if on treatment, medication optimised in
conjunction with the Clinical Nurse Specialist - Epilepsy.  Monitoring of the
therapeutic drug levels in each trimester has significantly assisted in patient care.  
During 2014, 80 of these patients delivered in the Rotunda Hospital with 2
patients transferring care to other unit in late pregnancy. 34 had not required
anti-convulsant treatment for some time before pregnancy and 32 patients
needed anti-epilepsy drug treatment for the duration of the pregnancy.  A patient
on Sodium Valproate for mood enhancement discontinued the treatment in early
pregnancy. 8 patients had discontinued treatment shortly before this index
pregnancy. One of these women had a recurrence of myoclonic jerks and
recommenced Lamotrigine. One patient had neurology review due to absence
seizure after mid trimester pregnancy loss. Seizure activity in 5 patients were
associated with use of Benzodiazepines in the context of substance abuse.
There was 8 complications in the group of 34 patients not on treatment. One
patient had intra-uterine fetal death at term and a patient had mid - trimester
pregnancy loss. There were 3 deliveries at 31 - 34 weeks. There was 1 case of
significant fetal growth restriction.  APH requiring emergency delivery at term
occurred in two cases.
Of the 32 patients on anti-epilepsy treatment regimes throughout pregnancy - 25
were on mono-therapy, 5 required 2 medications, 1 needed 3 anti-epileptic drugs
and 1 patient was on 4 medications.  2 of the patients had monotherapy with
Sodium Valproate and one patient was on a combination of Valproate and
Levetiracetam.  2 patients using Sodium Valproate changed to Levetiracetam.
There were 5 pregnancy complications in patients using anti-epilepsy
medications
- Early pregnancy loss on Valproate 
- Early pregnancy loss on Levetiracetam
- Intra-uterine growth restriction on Carbimazepine 
- Intra-uterine growth restriction on Levetiracetam and Carbimazepine
- Placental Abruption at 33 weeks on Topiramate
The patient who required 4 medications for her epilepsy had not achieved
complete seizure control before pregnancy and had a number of seizures in
pregnancy, a single seizure in labour and seizures in the post natal period.
There were 3 pregnancy complications in the 5 patients whose seizures related to
Benzodiazepine use - one early pregnancy loss and in 2 patients preterm delivery
due to haemorrhage and intra-uterine growth restriction.
E P I L E P S Y  C L I N I C
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Provision of standardised care for Women with Epilepsy has been further enabled
and enhanced with the development of the National Clinical Programme on
Epilepsy under the direction of Dr. C. Doherty (National Clinical Lead). Throughout
2014, the national Standard Operating Procedure was developed such that
integrated care pathways were improved for maternity patients with epilepsy. It
is planned to finalise this initiative with Clinical Care Programme on Obstetrics
and Gynaecology early in 2015.
The Irish Epilepsy Association Nurse Specialist, Sinéad Murphy, attends the
Epilepsy Clinic on alternate weeks and has an individual consultation with each
of the patients on anti-epilepsy medications. Changing from Sodium Valproate is
actively encouraged even after first trimester in view of the developmental
challenges now linked to treatment with Valproate. The support, advice and care
plans offered in the clinic have been enhanced by the appropriate  access by the
Specialist Nurse to the electronic patient record of patients attending Beaumont.
The record is updated at patient visits and a printed summary placed in antenatal
notes.
I am very grateful to the neurology service in the Dublin hospitals for their
support in assisting with the care of the patients attending this clinic and in
particular to Professor Norman Delanty and Clinical Nurse Specialist Sinéad
Murphy.
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MS CINNY CUSACK, PHYSIOTHERAPY MANAGER
The Physiotherapy Department’s mission is to provide patient centred,
innovative and evidenced based care in the management and treatment of
obstetric (pre and post natal), gynaecology and Neonatal/ paediatric conditions. 
STAFFING
Our current staff compliment is 4 WTE. This year we upgraded a basic grade post
to senior grade. This has enabled one senior post to have responsibility for
service development in paediatrics and the other senior post for service
developments in women’s health is currently job shared.
The current staff is: Cinny Cusack, Anna Hamill, Anne Duignan, Brona Fagan
and Niamh Kenny
ANTENATAL  CLASSES
Health promotion and ante natal education forms a key part of our women’s
health service. This empowers women to take an active role in their preparation
for parenthood, management of pregnancy related musculoskeletal conditions,
incontinence and promotes participation in a healthy exercise programme not
just for during pregnancy but for motherhood and beyond. We continue to
advise mothers about the role of exercises in managing gestational diabetes
through multidisciplinary patient education sessions.
Preparation for parenthood classes are jointly run with the Parent education
midwife. The physiotherapy department gives 3 of the 6 classes.  Approximately
20% of first time mothers attend these classes. This year a total of 1,508 attended
the first class and were given appointments for the subsequent 5 classes. We
would like to see more mothers avail of these classes but numbers are limited by
physical space and staff availability. 
Early attendance for the class is recommended and any special needs are catered
for on an individual basis. Refresher classes are provided for multigravida
mums.  Partners are welcome to attend classes 2 to 6.
INPATIENT PHYSIOTHERAPY
7,735 face to face contacts were made to 7,378 post natal mothers for advice,
pelvic floor and abdominal exercises, treatment of pelvic girdle pain and
mobility issues.  Our focus is on the high risk mothers who have obstetric anal
sphincter tears, , an instrumental delivery , caesarean section ,have a baby over
4kg or who have any incontinence. Mothers are encouraged to attend the
postnatal class in the first 6-8 weeks post partum.
Pelvic girdle pain affects approximately 20% of mothers and during 2014, 92
prenatal in patients were treated for pain and difficulty mobilising. 
P H Y S I O T H E R A P Y
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183 Gynae In patients were seen following major surgery for advice, pelvic floor
and abdominal exercises, management of reducing risk of future prolapse and
how to safely return to exercise. 
Patients requiring chest physiotherapy are also referred. There were 43 patients
requiring 51 treatments. 
Babies are referred as inpatients to physiotherapy for the following conditions,
Torticollis, Talipes, Erbs and Plagiocephaly. 74 babies were reviewed requiring 93
treatments. 
NICU: Since September 2014, the senior physiotherapist attends the NICU ward
round and is involved in providing advice regarding the positioning and
handling of babies and meeting the parents to give advice as part of the
discharge planning. However, due to significant restraints on available time,
there are only 2 hours per week available to provide this service. This is an area
that the Physiotherapy department would like to see further resourced. 
OUTPATIENT PHYSIOTHERAPY
In 2014, there were 2,074 new patients seen in the physiotherapy department
requiring 4,381 attendances. 
The post natal class runs weekly and is open to all postnatal patients up to 8
weeks postpartum. It is an opt in service and 281 patients plus babies attended
the classes held during 2014. The aim of the class is to provide an opportunity for
questions, support and advice. We review the pelvic floor exercises and assess for
a diastasis rectus abdominus so that exercises can be progressed safely to enable
the mother return to fitness and so reduce the risk of future back pain and
incontinence.
Patients suffering from post partum urinary and faecal incontinence can self
refer for physiotherapy during the first 6 months post partum.  By using a
variety of manual therapy techniques for scar release, abdominal breathing for
pelvic floor release and down training, physiotherapy can have a significant
positive impact on pelvic floor dysfunction which may lead to dyspareunia and
pelvic pain.
Obstetric anal sphincter injuries. (OASI): 164 patients were who sustained an
OASI were given a 2 week and 6 week postnatal physiotherapy follow up
appointment in accordance with the HSE guideline on Management of OASI. 35
patients who had had previous tears were also followed up during their
subsequent pregnancy for advice and sphincter exercises. The physiotherapy
department works closely with the perineal clinic to provide an integrated care
pathway for patients with ongoing issues.
Urinary incontinence: 279
Faecal incontinence: 19  
Prolapse: 52
Carpal tunnel syndrome: 48
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PELVIC GIRDLE PAIN (PGP)CLASS
1,206 patients suffering with pelvic girdle pain or low back pain were referred to
physiotherapy. The referrals are triaged based on their gestation and pelvic girdle
questionnaire score. Patients are then given an appointment for the pelvic girdle
class (577 patients) or an individual appointment (629). The aim is to give an
appointment within 2-3 weeks of referral. Significantly urgent patients may be
seen sooner. The class provides advice on ergonomics, management of activities of
daily living, pacing and specific stabilising abdominal and pelvic floor exercises.
Patients who may require further treatment are triaged through this class and
assessed for use of pelvic support s and walking aids.
PAEDIATRIC PATIENTS
370 babies were referred as outpatients requiring 853 attendances for the
following conditions: 
Plagiocephaly and Torticollis: 112
Brachial plexus injury and upper limb: 20
Talipes and lower limb: 82 
Developmental delay: 156
To facilitate links with paediatric outpatients and liaison with paediatric staff, we
now run a physiotherapy clinic once a week in paediatric outpatients. 
The Continence promotion Clinic is led by Dr. Mary Holohan and Cinny Cusack
Physiotherapy Manager. This clinic is aimed at providing specialised conservative
management to women suffering from urinary incontinence. The clinic offers a
comprehensive assessment and treatment programme including referral for
physiotherapy, medication, use of pessaries and life style advice. Approximately
80% of patients can be successfully managed by the clinic with only a small
percentage needing consideration for surgery.
Clinical audit Urinary retention
During 2014, there has been continued focus on improving the early recognition
and management of urinary retention in the ante natal, post natal and
gynaecological patients. In May 2014 a clinical education study day was organised
by Mary O’Reilly, Practice Development and Cinny Cusack Physiotherapy
Manager. Minor changes were made to the Urinary retention guideline which was
republished in July 2014. A Urinary retention re audit was completed during 2014.
This was presented at the Research meeting in January 2015 and won 3rd prize.
The audit highlighted the importance of fluid balance documentation on the
delivery transfer sheet and the first two voids post delivery. Staff has received
training in the teaching of self intermittent catheterisation for patients with
ongoing issues following urinary retention.
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DEPARTMENT ACTIVITY
Physiotherapy students
This year, the Physiotherapy department has taken undergraduate students
from RCSI School of Physiotherapy. 3 placements were offered for 2 final year
students and one observational placement for a first year. The placements were
successful with all key learning objectives from the placement achieved to a
high standard. 
A post graduate placement for the final practical assessment was also given to a
student from Bradford University completing the Post graduate Physiotherapy
Diploma in Continence. 
Clinical research
The physiotherapy department with Deirdre Daly of the MAMMI (Maternal
health and Maternal Morbidity in Ireland) are currently researching  Women’s
knowledge and practice of Pelvic Floor Muscle Exercises (PFME) and their
opinions of PFME education at the Rotunda Hospital. 570 questionnaires were
completed and returned by ante and post natal patients.
Clinical audit: Poster presentation on Physiotherapy management of 3rd and
4th degree tears was presented at St James Hospital research seminar in May
2014 and at the ISCP conference in October 2014
Continuous professional development (CPD)
The department actively engages in regular CPD in the form of journal club and
joint treatment sessions.
Post graduate short courses attended. 
• Physiotherapy management of neonatal graduates in the community. 
• Physiotherapy for babies with CP and developmental delay (5 day course
in CRC)
• The Rotunda Physiotherapy Department also hosted a post graduate 
course ‘Managing dysfunction in the pregnant and post partum pelvis.
The physiotherapy department have actively participated in the 
• Rotunda and RCSI Leadership Development programme.
• Pressure to Zero collaborative which successfully maintained the 
incidences of pressure sores at zero.
• Epidural study days
• Manual handling training programme
I would like to acknowledge the hard work, enthusiasm and dedication that the
Physiotherapy staff has put in over the past year. The smooth running of this
extremely busy department could not happen without the significant
contribution of the physiotherapy secretary Karen Chillingworth Filan. 
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DR MAEVE EOGAN
Introduction
The Rotunda SATU is one of 6 HSE supported SATUs around the country, with units
established in Cork, Waterford, Mullingar, Galway and Letterkenny. Each unit
provides responsive patient centred care underpinned by national interagency
guidelines. This ensures that all men and women who seek care after sexual crime
receive the same standard of care regardless of which SATU they present to. In 2014
the SATU at the Rotunda Hospital provided care for 286 men and women after rape
or sexual assault, a decrease of 24 patients (7%) from 2013. While we hope that this
reduction in attendances is due to a reduction in sexual crime, it may actually
result from the increased awareness of and attendance at the SATU at Midlands
Regional Hospital, Mullingar.
Most patients (80%) presented within 7 days of an incident of sexual assault, with
2 patients disclosing long-term abuse.  Early presentation is optimal in terms of
provision of appropriate care as well as collection of forensic evidence. In 13 cases,
the incident had occurred outside of Ireland. Of the cases where the incident was
reported to have taken place in the Republic of Ireland, 214 (80%) of these took place
in Dublin city or county. 14 other counties were also represented in the figures.
March and May were the busiest months and Tuesday was the busiest day for the
unit. While 79% of attendees reported that the incident took place between 9pm
and 9am, the majority of patients (183, 64%) actually attended for care within
daytime hours (9am-9pm). Nevertheless a not inconsiderable proportion of
patients, 36%, were seen between the hours of 9pm and 8.59am, which emphasises
the continued need for a round-the-clock service.  
The age and gender profiles of all patients is shown in Figure 2, the age range was
from 12 to 94 years. Although the remit for the Adult SATU services is for patients
over 14 years, in 2014 the unit provided care for 8 female patients less than 14 years.
These were instances where acute care in a paediatric service could not be
arranged. Considerable developments in paediatric services are anticipated which
will mean that such patients can be appropriately accommodated in the future. 
S E X UA L  A S S AU LT  T R E AT M E N T  U N I T
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112 (39%) patients were students, 82 (29%) were in employment and 87 (30%) were
unemployed. The majority of patients (253, 88%) were single. 221 (77%) patients
reported a single assailant, and 107 (38%) patients reported that the assailant was a
stranger. In 24 cases the alleged assailant was reported to be an intimate (or ex-
intimate) partner, and in an additional 5 cases reported to be a family member. 204
patients (71%) disclosed that they had consumed alcohol in the 12 hours precedding
the assault, 7.5 units of alcohol being the mean number of units ingested. That being
said, many patients had an imprecise recall of the amount of alcohol ingested. 38
patients were unsure if a sexual assault had taken place, in 33 of these patients this
lack of recall was due to memory loss associated with alcohol ingestion. 
Emergency contraception (EC) was given to 123 of 188 women seen with 72 hours
of an incident. There were a range of reasons (including previous effective
contraception, hysterectomy) why the remaining patients did not require EC.  All
SATU attendees were offered follow-up screening for sexually transmitted
infections. 256 men and women accepted this offer, and 180 actually attended for
screening. Such low return rates are not uncommon, both nationally and
internationally, and have encouraged continued provision of routine prophylaxis
for Chlamydia at the time of the patient’s initial attendance. The rates of
identification of Chlamydia have fallen precipitously since the introduction of
routine prophylaxis. All patients are also offered a course of Hepatitis B
Vaccination. This policy was introduced in 2009 and I would like to acknowledge
the ongoing support of the ID Services at the Mater University Hospital. Since
2009 we have also been in a position to offer HIV prophylaxis on-site if required.
In 2014 27 patients also received post-exposure prophylaxis for HIV. 
Since 2009 we have been providing care for men and women who have
experienced sexual violence but who preferred not to report the incident to An
Garda Síochána. Of the 286 patients that attended the SATU, 75 (26%) patients
attended without reporting the incident to An Garda Síochána. It is a welcome
development that patients seek care and attention following an incident which
will hopefully have a positive impact on their recovery. In 2015, all SATUs aim to
begin to provide a facility for safe storage of forensic evidence. This will enable us
to store forensic samples for a defined period for people who are uncertain as to
whether or not they wish to report an incident to An Garda Síochána. Forensic
evidence deteriorates quickly so appropriate and safe storage will preserve
evidence and allow patients to consider reporting options.
A postgraduate certificate in Sexual Assault Forensic Examination was run by
UCD for doctors aspiring to work in the adult and paediatric SATU services. This
course provided training in care provision, and educational components were
delivered by many Rotunda SATU staff. In the latter part of 2014 a higher
diploma programme in Sexual Assault Forensic Examination for nursing and
midwifery staff commenced at RCSI. All SATUs now depend greatly on clinical
nurse/midwife specialists, and we look forward to all the trainee nurse/midwife
specialists joining the SATU workforce on completion of the programme. We
also welcome Noelle Farrell who has taken up the role of CMM at the Rotunda
SATU, this role had been vacant for a period of time, and Noelle’s arrival has
already had a very positive impact on the service. We hope she will continue to
enjoy her new role with all its inherent challenges and we look forward to
working with her for many years to come. 
SATU staff are actively involved in outreach education within Emergency
Departments & General Practice, Mental Health Services, Prison Services, An
Garda Síochána, and Dublin Rape Crisis Centre to raise awareness and increase
understanding and recognition and to equip people better to respond to
incidents of sexual violence. The strong Interagency Links that have
traditionally existed, particularly with An Garda Síochána, Forensic Science
Laboratory and Rape Crisis Centre were maintained over this year.  The SATU
Liaison group met quarterly during the year.  These meetings are a valuable
opportunity to discuss relevant issues pertaining to SATU facilities and care and
ensure that all staff from the various agencies are aware of changes and
developments, and indeed challenges, as they arise.  SATU staff are also
committed to education in a range of settings including schools and universities.
At a national level, the 6 SATUs are a vibrant and motivated community of
practitioners, who work with each other and our partner agencies to progress
our services to provide the optimum response at a time when our patients are in
crisis. 2014 saw the launch of the 3rd Edition of our National Interagency
Guidelines. These guidelines ensure that all patients receive the highest level of
responsive care regardless of where or to whom they disclose an incident of
sexual violence. 
A definite highlight of 2014 was the SATU’s transition to a new physical space
within the School of Midwifery. We now have a large bright unit, with
appropriate waiting areas and clinical infrastructure as well as facilities for
administrative support and document storage. We acknowledge all our
‘neighbours’ in that area, who put up with relocation as well as significant
disruption as the unit was being developed. Furthermore, we acknowledge
greatly the support of the hospital board and the executive management team
in facilitating this development. Unfortunately in 2014 we began to experience
challenges staffing our assisting nurse/midwife rota. This meant that there
were occasions when we were unable to provide an out-of-hours service which
is not ideal. A recruitment drive has been initiated and hopefully this imbalance
will be reversed over the course of 2015.  
At this time every year I acknowledge the assistance of all SATU staff, and this
year is no different.  Maintenance of a responsive service is only possible due to
the dedication of the unit staff. All staff are extremely committed to providing 
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exemplary care at all times and but for them the SATU of the Rotunda Hospital
would not be a centre of excellence. This report highlights the significant
amount of work done by a small but highly committed team, and their
continued availability to provide holistic care to patients at a time of crisis is
acknowledged. 
Publications:
Richardson D, Eogan M. Care for Male Victims of Sexual Assault. Modern
Medicine 2014;44(1):27-28. 
Audits:
An Audit of STI Prophylaxis, Screening and Follow-up in SATU. Dr Killian Bates. 
Re-audit of attendance rates following referral from the Sexual Assault
Treatment Unit to Infectious Diseases Clinic for HIV prophylactic treatment and
completion of follow-up treatment from 2012 to 2014. Aideen Walsh
Media:
In October 2014 the Rotunda SATU was involved in a ‘Doors Open’ piece for the
RTE programme Morning Edition with Keelin Shanley. The team were filmed in
the unit, explaining a patient’s pathway within the SATU and Aideen Walsh
attended RTE for a formal interview and panel discussion. This was a
worthwhile experience for all, and hopefully highlighted SATU services in a
positive way. 
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INTRODUCTION
In 2014, the Rotunda’s team of social workers continued to provide a comprehensive
social work service to patients, their partners and their families.  Those who used
the service had a broad range of needs and issues of concern.  These included:
bereavement, domestic violence, addiction, relationship issues, mental health
issues, underage pregnancy, the birth of a baby with special needs, child protection
issues, concealed pregnancy, crisis pregnancy and intellectual disability.
The Rotunda’s social work service is extremely proactive and broad in its remit.  It
operates from the rationale that addressing problems in a timely manner can
prevent their escalation and can serve to minimise the distress experienced by
patients.  To exploit the potential of preventative interventions, there is a social
worker attached to each of the hospital’s four obstetric teams and to all the larger
specialist clinics and units.  Patients are typically met during pregnancy so that
issues of concern can be identified and alleviated.
FINANCIAL ADVERSITY
Throughout 2014, the economic crisis continued to impact significantly on patients
and their families.  In 2014, the President of St Vincent de Paul (SVP), Geoff Meagher
pointed out that, although economic recovery has begun and the numbers at work
have risen, the gap is widening between those who are benefiting from the upturn
and those who have yet to do so.  One indication that austerity continues to impact
the less well-off is the increase in SVP sending to provide help for people struggling
financially in Ireland.  Since 2008, the society’s spending has risen by more than 50
per cent to 82 million euro annually.  
In 2014, food banks were set up by charities across the country in an attempt to feed
the estimated 600,000 people suffering from food poverty.  It has been well
documented that poverty is strongly associated with the risks of neglect and abuse,
and the number of children at risk of poverty has been steadily increasing since the
financial crisis hit.
HOUSING
In 2014, almost 20,000 applications for housing have been made to Dublin City
Council, an increase of 3,000 from 2013.  The actual number of people seeking
accommodation is unclear as applications may be made by families containing a
number of children as well as individuals.  The Rotunda is located within the area of
greatest need on the northside.  Of the 133,005 local authority housing units across
the State, 3,668 are empty.  Of these, just 770, or 21 per cent are available for letting.  
Every application on the housing list has been established by the county council as
having a housing need.  While applicants wait a number of years to be housed by
the county council, the majority are dependent on the private rented sector and
rent supplement.     
M E D I C A L  S O C I A L  W O R K
Some 29,000 Dubliners are in receipt of rent supplement, which provides support
to people in the private rented sector who can’t pay full rent.  Approximately 77,000
people nationwide benefit from this scheme, which cost the government 344
million euro in 2014.  Unfortunately, rising rents, housing shortages and home
repossessions have resulted in discrimination against social welfare tenants.  There
were fewer than 27,000 properties listed to rent in Dublin in the first 9 months of
2014, compared to more than 47,000 in the same period in 2011.  Rents in Dublin
have risen more than 11 per cent in the past 12 months.  This is also concerning as it
is estimated that Dublin’s population is growing by 10,000 households a year. 
Patients of the Rotunda have reported having to look for private rented
accommodation far away from their communities, family and friends in an
attempt avoid homelessness.  If they are successful in securing accommodation
in a different location, they can find themselves isolated from their familiar
environment and supports, at a time when they need them the most.  If someone
is vulnerable to post-natal depression, this can have a negative impact on them
at a very sensitive time. 
Patients who do not find private rented accommodation before their baby is born
are becoming homeless.  The Dublin Simon Community reported that the crisis
was spiralling out of control as the use of hostels, hotels and B&Bs to house
people is becoming the long term solution. 
In May 2014, it was estimated that there were 180 families with child dependents
in emergency accommodation in Dublin.  Since January 2014, according to Focus
Ireland, 128 Dublin families with 321 children have moved into hotel rooms.  This
year the MSWs have worked with women who have been living with their
children in hotels and B&Bs.  These women are facing the difficulty of trying to
get their children to school, feed a family in a hotel room and prepare for the
birth of a new baby. 
In 2014, Barnardos highlighted how children are the ‘hidden victims’ in the
worsening housing crisis, which campaigner Fr Peter McVerry has described as a
“tsunami of homelessness” and the worst crisis he has ever witnessed. 
CHILDREN 
The 1st of January 2014 was the first official day of the new Child and Family
Agency.  The agency absorbs the child-protection and welfare services previously
carried out by the Health Service Executive (HSE).  It comes in the wake of the
passing of the Children’s Rights amendment to the Constitution, which intends
to make children’s rights explicit and their voices heard.  The ambitious aim of
this agency is to improve the lot of children and families by focusing on
prevention rather than crisis-driven intervention.
In April 2014, the Government published the Children First Bill which, if made
into law, will make it mandatory for professionals to report possible incidents of
abuse.  The legislation was recommended in the 2009 Ryan Report
Implementation Plan.  Guidelines and policies in the Rotunda Hospital are
already consistent with the principles of the Children First Guidelines, which
were first published in 2009. The Bill also hopes to clarify the situation about
reporting underage non-abusive sexual activity where young people between
the ages of 15 and 17 years become pregnant. 182
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In Ireland, the age of consent has been 17 years of age since the Criminal Law
Amendment Act 1935.  Ireland has one of the highest ages of consent in the EU.
Sweden, Denmark, Poland, France and Greece have all set the age of consent at 15
– the most common in the Union.  The Germans and Italians have opted for a
year lower at 14 while the British, Dutch, Portuguese and Belgians have set the
age at 16.  While ministers have discussed lowering the age of consent from 17 to
16 in Ireland, in recognition that people are having sex at a younger age, it has
been argued that the age of consent permits the State to continue to intervene in
a way that is suitable for a teenage child. 
The Growing Up in Ireland survey confirms that a significant proportion of
children are growing up in diverse family types.  The survey indicated that 14 per
cent of the infants sampled are living with lone parents.  Equally, the number of
children living in cohabiting households is rapidly increasing, rising by 41 per
cent between 2006 and 2011.  In Ireland, births outside marriage account for
approximately 35 per cent of all births.  In 2014, 41 per cent of births in the
Rotunda were to parent who weren’t married.  The Children and Family
Relationships Bill 2014 is proposed as the legislative response to many of the
issues raised by the changing composition of Irish families.  
DOMESTIC VIOLENCE
In 2014, the staff in the Rotunda Hospital continued to routinely enquire about
domestic violence in keeping with best national and international
recommendations.  Domestic violence in pregnancy is more common than
gestational diabetes and hypertension and can actually begin or increase during
pregnancy. It may lead to miscarriage, pre-term labour, low birth weight, fetal
injury and can pose a significant health risk for both the woman and her baby. 
Routinely asking all women during the ante-natal period if they are
experiencing domestic violence is a model that supports women to disclose
abuse and seek support.  It also serves to reduce the stigma associated with
domestic violence and has the value of highlighting the prevalence of this issue
to women.  Research shows that many women were asked about domestic
violence 11-12 times before disclosing.  Women are asked about domestic violence
without their partner present to ensure their safety is not compromised. 
The medical social work team prioritise all domestic violence referrals.  It is
important to explore with the woman where she is at in the domestic violence
cycle. She could be only defining what is happening to her as an abuse or may be
at the point of leaving a relationship.  The medical social worker can assist a
woman explore her options, such as, a referral to a refuge or Woman’s Aid and a
safety plan can be discussed.  Not all domestic conflicts warrant the involvement
of statutory child protection services.  The level of risk to children is assessed by
the medical social worker with the patient.  A woman, in the majority of the
cases, is the best judge of her family’s safety.  The medical social work team will
audit the documentation of domestic violence enquiry in patient’s charts in 2015
to ensure there is appropriate medical social work follow up.
The social, legal and economic changes which have taken place in Ireland over
this year have given rise to many challenges for patients attending the hospital.
This has led to an increase in the number of referrals to the social work
department and has rendered the nature of our work more complex and varied.  
The following reports of social work involvement in the hospital’s specialist
clinics and units during 2014 provide a summary of the services offered by the
department.
TEENAGE PREGNANCY CLINIC
In 2014, there were 119 teenagers booked into the Teenage Clinic.  There were 20
teenagers who were 16 years of age at booking and 11 who were 15 years of age.  One
teenager was 14 years of age at booking.  In these cases, a referral is always sent by
the medical social worker to the appropriate office of the Child and Family Agency
(CFA).  Underage consensual non-abusive sexual activity continues to be
investigated by the CFA in conjunction with An Garda Siochana to satisfy relevant
legal requirements.  New measures contained in the Child First legislation should
clarify this situation.   Teenagers aged 18 and 19 years can also attend the teenage
clinic if required and can be referred by the MSW and midwifery staff if they
require the extra support the clinic provides young mothers.  
For many young people, their pregnancy is unplanned and the medical social
worker provides support and counselling to the young person to assist them to
come to terms with the news and to provide ongoing support and assistance
throughout the pregnancy.  Becoming a mother at any age can be a daunting
experience and young people, in particular, can feel overwhelmed about
becoming parents.  Attendance and participation in the antenatal classes is also
encouraged. The Teen Parents’ Support Programmes in the young person’s local
area offer continued support for the mother and baby following delivery.
The medical social worker attached to the Teenage Clinic works closely with the
Clinic’s specialist midwife in order to provide a holistic and consistent service. 
BEREAVEMENT SOCIAL WORKER
In 2014 the bereavement social worker offered a service to all women who had
experienced the loss of a baby through miscarriage, ectopic pregnancy, stillbirth
or neonatal death. The role of the bereavement social worker was to visit these
patients and their partners while they were in hospital or to contact them when
they went home. The number of babies for burial in 2014 was 259. The
bereavement social worker met with 214 of these patients in the hospital and
made written contact with the remaining 45 patients. A service was also
provided to the Early Pregnancy Unit and the Recurrent Miscarriage Clinic.
Patients and their partners were offered emotional and practical support,
counselling, advice on explaining the death of a baby to children, and follow-up
care. They were also offered counselling and support during subsequent
pregnancies and after the birth of their new baby. This follow-up care was
offered both in the Rotunda Hospital and on home visits if requested. The
bereavement social worker met with 119 patients for follow up care after their
discharge from hospital and carried out 278 hours of face to face counselling
sessions in 2014. She provided 28 hours of counselling over the phone. She
continued to develop educational information for parents and staff regarding
children and loss. She met with 8 children for bereavement counselling
following the loss of a sibling.184
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FETAL ASSESSMENT AND PRENATAL DIAGNOSIS CLINICS
2014 was another very busy year for these Clinics, where care is provided for
women with high-risk pregnancies, as well as the diagnosis of chromosomal and
major structural abnormalities. Fetal Medicine Midwives, Nollaig Kelleher, Jane
Dalrymple and Joan O’Beirnes work closely with the Medical Social Worker in
identifying patients who have been given difficult news about their baby and
may need additional emotional and practical support at the time of a diagnosis
and in the weeks and months that follow. 
There was an increase in the number of referrals to the medical social worker in
2014. Part of the reason for this may be attributed to the increase in the uptake
of prenatal screening and prenatal diagnostic testing. This has meant that a
greater number of anomalies are being detected during pregnancy than
previously seen and consequently that women being given difficult news about
their baby need more specialised counselling support around this time. 
Getting the news that an expected baby may have a problem changes everything
for parents. As part of the team caring for and supporting parents during this
difficult time, the Medical Social Worker offers a confidential counselling and
support service to all patients attending the Fetal Assessment & Prenatal
Diagnosis Clinics. Meeting with the Medical Social Worker allows patients to
identify another source of support available to them when they are trying to
come to terms with a diagnosis.
Continued emotional support is provided by the whole multidisciplinary team
during the remainder of the pregnancy.  Patients report how comforting it is for
them to meet with the same midwives and doctors at each visit, as well as it
being invaluable to have a quiet space to meet with the Medical Social Worker
and explore their feelings in confidence.
The role of the Medical Social Worker in providing practical support regarding
financial assistance, continued to be very important in 2014, when so many
families were experiencing financial difficulties. Patients, who have been given
difficult news about their baby can feel embarrassed or guilty asking questions
about financial assistance at this time. However, it can represent an additional
significant burden for families, during what is already a very anxious and stressful
time and it is important for patients to know that this support is available. 
Grateful appreciation is expressed to Midwives Nollaig Kelleher, Jane Dalrymple
and Joan O’Beirnes for their invaluable support and assistance throughout the year.
SUBSTANCE MISUSE
2014 2013 2012 2011
Deliveries to Substance Using Women 68 73 81 71
Number of Referrals to CFA 52 (76%) 50 (68%) 64 (79%) 41 (57.7%)
Discharge Meeting 19 11 19 21
Child Protection Case Conferences 19 21 19 8
Voluntary Care 7 1 6 4
Care – Court Orders 4 12 4 1
Mothers returned home under 
supervision of a non-drug using relative 7 11 17 14
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In 2014, the medical social worker attached to the DOVE team continued to provide
emotional and practical support to all women attending this specialist clinic.  From
an addiction perspective, this included all women who were on a methadone
maintenance programme, or using illicit substances during pregnancy. 
Referrals can be received from external agencies, such as community social work
departments, or any department within the hospital.  The highest percentage of
referrals received in 2014 was from the Drug Liaison Midwife (DLM).  The DLM
introduces the Social Work Department to the women attending - this in turn
assists in reducing women’s fears and anxiety about meeting a social worker.
The DOVE medical social worker carried out psycho-social assessments with women
attending the clinic and their partners, focusing on the environmental, social,
emotional and physical factors in their lives.  A special emphasis is placed on drug
use in pregnancy and the risk this carries for a newborn baby.  There is a known
increase in the potential risk for harm and neglect to children whose parents misuse
substances. Therefore, the medical social worker endeavours to establish whether
there is a need to refer pregnancies to the Child and Family Agency.
The Child and Family Agency (CFA) is the statutory body responsible for
improving wellbeing and outcomes for children.  In 2014 the medical social
worker referred 52 pregnancies to the Child and Family Agency – in some cases
families were already known to this agency and the medical social worker liaised
with their social workers during and after the birth of the baby.  
The social worker attached to the CFA may convene meetings prior to the birth or
discharge of a baby from the hospital, which the medical social worker is obliged
to attend. The drug liaison midwife and medical social worker attended 19 Child
Protection Conferences during 2014 – this conference is an interagency meeting
and involves facilitating the sharing and evaluation of information between
professionals and parents.  The medical social worker also attended 19 other
professional meetings to discuss the care of the baby after birth. 
11 babies did not return home with their biological parents immediately after
discharge – 7 babies went into foster care under voluntary care orders, 3 babies
went into care under interim care orders and 1 baby went into care under a
private family arrangement.   The number of babies going into voluntary care has
risen by 70 per cent this year.  However, the overall number of babies received into
foster care has decreased by 2 compared with figures in 2013.  This does not reflect
the trend reported by the CFA, who saw a 23 per cent increase in children in the
care of the state since 2007.  The Rotunda Hospital is situated within the within
an area which has the highest proportion of children in care in the country.
NEONATAL UNIT
The role of the medical social worker attached to the Neonatal Unit is to help
families cope with the stressful experience of having a premature or sick baby.
The social worker provides emotional support, information and practical
assistance to parents while their baby is in the hospital and also after their baby
has been discharged home.  In addition, bereavement support is offered to
parents if their baby dies while in neonatal care.
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The role of the medical social worker attached to the Neonatal Unit is to help
families cope with the stressful experience of having a premature or sick baby.  The
social worker provides emotional support, information and practical assistance to
parents while their baby is in the hospital and also after their baby has been
discharged home.  In addition, bereavement support is offered to parents if their
baby dies while in neonatal care.
The social worker liaises closely with medical and nursing colleagues to ensure
that parents receive holistic family-centred care.  There is particularly close
collaboration with the NICU Discharge Co-ordinator and with public health nurses
and community-based support services to ensure continuity of care from the
hospital to the home environment.
At a time when many families are experiencing financial difficulties, the social
worker is involved in informing parents of their welfare entitlements and in
enabling them to secure financial assistance with medical and other expenses.
Grateful appreciation is expressed to community welfare officers for their support
of parents and to the HSE Client Registration Office for their assistance in
processing medical cards for babies who require equipment and medication on
discharge.
During 2014, there continued to be an increase in the number of babies transferred
from hospitals outside Dublin to the Neonatal Unit in the Rotunda.  These families
had to cope with the practical and emotional difficulty of commuting long
distances or of finding somewhere to stay in Dublin.  The lack of accommodation
for parents, the high cost of car-parking in the city centre and the absence of
adequate financial supports for such families constitute major problems.  For some
parents, the transfer of their babies to Dublin means that they are unable to
provide their babies with expressed breast milk or visit them on a regular basis
because they can’t afford the travel costs.
A positive development over the past year was the refurbishment of the Parents’
Room attached to the Neonatal Unit.  This room provides parents with the
opportunity to spend some time away from the Unit in a comfortable
environment.  Another positive development was the publication of a new edition
of A Parent’s Guide to the Neonatal Unit.  This booklet aims to support parents of
babies who have been admitted into neonatal care.
TRAINING - STAFF
Professional Development
S. Devitt, Leadership and Development Programme - 2014, RCSI
S. Devitt attended Children First: National Guidance for the Protection and Welfare
of Children 2011 HSE Training – 1 day
D. Kirk, Bereavement Social Worker attended The Complicated Greif Treatment
Advanced Training Day, Irish Hospice Foundation, 11/01/14
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D. Kirk, Bereavement Social Worker attended The Annual Conference of the
Childhood Bereavement Network, 4/10/14
D. Kirk, Bereavement Social Worker, continued to attend quarterly meetings of the
Irish Association of Paediatric Palliative Care in 2014
D. Kirk, Bereavement Social Worker attended The Maternity and Neonatal Hospice
Friendly Hospital Network meetings in 2014
TRAINING
Domestic Violence Routine Enquiry Training – private clinic – 05/03/14 
S.Devitt 
Specialist Midwifery services sessions for PHN students – MSW role/ Children
First – 05/06/14
S. Devitt
Midwifery Journal Club – Children First – 29/05/14
S.Devitt
Training for Midwifery Students on Miscarriage, Stillbirth and Neonatal Loss –
08/04/14
D. Kirk
Infectious Disease & Substance Misuse in Pregnancy Study Day – Child
protection in a Maternity Setting – 15/05/14
H.Lydon
Training Day on Stillbirth and Neonatal Loss, Centre of Midwifery Education –
04/06/14 
D. Kirk
Training for Student Public Health Nurses on Medical social Work Services –
09/10/2014
H. Lydon
In-service Training for Midwifery Staff on Miscarriage, Stillbirth and Neonatal
Loss – 28/11/14
D. Kirk
Presented at National Clinical Programme for Obstetrics and Gynaecology Early
Pregnancy Loss Forum, Early Pregnancy Loss and Social Support, RCPI, 03/12/14
D. Kirk
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The Early Pregnancy Assessment Unit (EPAU) is an essential component of the
Rotunda with the provision of specialized care to women in early pregnancy. In
2014, this compromised 4,446 new, return and reassurance appointments in the
EPAU.  Continued improvements including a streamlined referral pathway,
efficient appointment scheduling and staff training allow the delivery of a
dedicated service that manages patients in a safe, timely and supportive
manner. Further achievements in 2014 include:
• Development of a separate reassurance scan list dedicated to patients 
with a history of previous miscarriages, ectopic pregnancy or gestational 
trophoblastic disease. The main benefit of this new sub-clinic is the 
increased availability of emergency appointments for symptomatic 
patients. It also serves as a focussed ultrasound list for training of junior 
NCHDs under direct supervision. 
• Development of a system to identify and provide early antenatal booking 
appointments for patients with previous poor obstetric history (491 
patients).
• Provision of support documentation for patients (also available on hospital 
intranet).
• Continued provision of Registrar training in Viewpoint® and early 
pregnancy undertaken by Dr Karen Flood and Dr. Jennifer Donnelly.
E a r l y  P r e g n a n c y
A s s e s s m e n t  U n i t
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• Continued provision of Senior House Officer training in basic ultrasound in
conjunction with the Royal College of Physicians Basic Specialist Training 
by Dr Fionnuala Breathnach.
• Participation in regular clinical auditing of early pregnancy key 
performance indicators.
Clinical activity:
2014 (%) 2013 (%) 2012 (%) 2011 (%)
Total number of patients seen 4106 4191 3106 3116
Repeat EPAU reviews 3067 (75) 2587 (62) 2315 (80) 2214 (71)
Failure to attend for first 
appointments 63 (6) 145 (4) 200 (7) 114       (4)
Failure to attend for follow-up 
appointment 277 (9) 270 (10) 144 (6) 178 (8)
Miscarriages 1260 1661 1551 605       
Surgical management of 
miscarriage 545 (43) 531 (32) 590 (38) 247 (41)
Expectant or medical management 715 (57) 1130 (68) 961 (62) 358 (59)
Ectopic pregnancy or pregnancy 
of unknown location 187 192 123 51         
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CONSULTANTS: Dr Karen Flood
MIDWIFE: Patricia Fletcher
The recurrent pregnancy loss clinic was initially developed to provide thorough
investigation and follow-up of couples with three or more consecutive
miscarriage. As continuity of care is very important in this setting, this service
has undergone significant expansion over the last number of years with the
provision of dedicated early pregnancy support with frequent ultrasound
monitoring and counselling. Patients are then followed from their booking
appointment until delivery. Also, all patients with histological confirmation of
gestational trophoblastic disease following a miscarriage attend this clinic for
counselling and close serum βhCG monitoring with rapid access for review if
complications arise.
2014 % 2013 (%) 2012 (%)
Total number of patient visits 667 499 376
Return visits 510 (83) 390 (78) 292 (78)
Failure to attend for first 21 (19) 26 (24) 18 (21)
appointments
Failure to attend for follow-up 47 (8) 45 (12) 39 (13)
appointment
Total number of pregnant women seen 65 62 55
Livebirth rate 44 (67) 39 (63) 43 (78)
R e c u r r e n t  p r e g n a n c y  
l o s s  s e r v i c e
193
MS CLAIRE O’MAHONY, CLINICAL RISK & CLAIMS MANAGER
NATIONAL INCIDENT MANAGEMENT SYSTEM
The Rotunda, as the selected pilot site for the National Incident Management
System, commenced as early adopters of the live system in September 2014. 14
staff members were trained on the inputting of incidents into the new system,
six existing from the Clinical Risk/Health & Safety Teams. Eight additional
piloters came on board to representing various departments within the Rotunda
with a view to consideration of roll out of the electronic system to local areas and
give feedback on the user friendliness of the system and the suitability of the
incident categories.
Representatives from the Delivery Suite, NICU, Haemovigilance, Private Clinic,
Bereavement Services, Laboratory Quality and Patient services participated in
the early adoption of the electronic NIMS system.  Feedback was provided to the
Clinical Indemnity Scheme with mixed reviews in respect of the user
friendliness of the system and with recommendations for improvement in
respect of the incident categories and highlighted the need for further
consultation with multidisciplinary groups in order to ensure that the categories
fit the local needs of healthcare organisations. IT challenges also presented
relating to the IT network in place and these were reported to the IT department
for investigation and resolution. 
INCIDENT REPORTING
Intense efforts were put into the investigation of incidents and sharing of reports
with families through 2014 with an objective of ensuring that existing outstanding
reviews were completed as well as new reviews.
There are two types of system analysis investigations in use in the Rotunda. The
first is the comprehensive style of investigation called a Full Adverse Incident
Review (FAIR). The second is a follow up analysis or concise systems analysis
investigation. Continued work was put into examining external documents to try
to improve the quality of our incident investigations during the year. This included
consideration of the Portlaoise Report and also the National Safety Incident
Management Policy which was introduced in May 2014. A continual gap analysis
was monitored at the Clinical Risk Committee every two months to ensure
progress in aligning the Rotunda’s incident investigation practices with those
outlined in the National Policy and significant changes were made in this regard.
Investigations completed in 2014 are outlined below.
FAIR INVESTIGATIONS 
Four FAIR investigations were completed during the year and shared with the
patient/family; a maternal death, a case of massive obstetric haemorrhage and two
cases of neonatal death. 
Clinical  Risk Management &
Claims Department Activity
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RECOMMENDATIONS
The following actions were recommended and implemented out of FAIR and
concise investigations in 2014:
➢ Education update to NCHDs in respect of best practice ultrasound 
diagnostics.
➢ Addendum to RHOET training in respect of importance of carrying bleeps
➢ Continued education in respect of the Early Warning Score
➢ Introduction of Neonatal Resuscitation form for improved documentation
in emergency resuscitation
➢ All ectopic samples for processing to be flagged as urgent.
➢ Ectopic related histology results are now sent to the Gynaecology ward for
daily medical review.
➢ Additional drills on use of bleep system and daily check of the bleep 
system. 
➢ Continued education in respect of compliance with Management of Early
Pregnancy Guidelines
➢ Education re the importance of documentation and accurate transcription
➢ Introduction of ready mixed Magnesium Sulphate bags for safety 
purposes
➢ Ongoing education on use of the SBAR communication tool
➢ Further education and drills on the Categorisation of Caesarean Section
➢ Introduction of a repeat back for verification of patient id by telephone
➢ Review of process to ensure timely communication process with 
patient/families in respect of a Serious Incident.
The following recommendations were in progress or outstanding in December
2014:
➢ Introduction of the named obstetric consultant system has been 
recommended and adopted as part of the Hospital Strategic Plan
➢ Introduction of electronic laboratory result reporting has been 
recommended
➢ Written Patient Identification Policy
➢ Written transfer policy
12 Follow Up (concise) investigations were completed in 2014 and the findings were
shared with the patient/family in each case:
Follow up reviews (12)
Late diagnosis of ectopic
Neonatal Death x 2
Misdiagnosis of miscarriage  x 2
Partial salpingectomy for ectopic with late follow up of results x 1
Patient identification & feeding issue x 2
Retained wick x 1
Medication incident x 2
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➢ It was noted that midwifery Staffing ratios are being looked at nationally
and that there is a distinct need for this review given the issue of staffing
and resources as a contributory factor to some serious incidents.
➢ The review of allocation of babies for septic work up in the NICU
➢ A medication self assessment is in process which incorporates plans for 
review of the process for prescribing and medication administration.
➢ Multidisciplinary prelabour rupture of membranes guideline to be made 
available & audit to be undertaken.
TRAINING ON INCIDENT REPORTING AND RISK MANAGEMENT
Over 156 staff members were trained in risk management and documentation in
2014, along with additional attendances at specific training or feedback sessions.
A training day was facilitated by the CIS for high grade staff on incident
investigation methodology in May 2014 which was well attended by senior
clinicians.  The joint risk/legal study day at CME continued in 2014 with good
attendance and favourable feedback from staff.
The high volume of activity and associated staffing levels continued to feature as
a concern in incident trends in 2014. Information was gathered from the incident
reporting process and was shared on regular occasions with the HSE
highlighting the hospital’s evidenced concerns in this regard. Activity along
with other risks continued to be a priority risk on departmental risk registers
across the hospital and on the corporate risk register during the year.
Ms Claire O’Mahony,
Clinical Risk & Claims Manager
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DR. JOANNA GRIFFIN Director of Research and Academic Affairs
COLIN KIRKHAM Research Officer
DR. JONATHAN COWMAN Postdoctoral Researcher
LUCY SHIRREN Research Assistant
ROBIN GEORGE Research Assistant
The Rotunda strongly embraces the concept of conducting high quality
fundamental and translational research with a view to improving patient care.
The establishment of a dedicated department is testament to the commitment of
the Rotunda to research. 
The Rotunda research community has grown considerably in 2014 with the
appointment of a six month postdoctoral fellow and two research assistants.
Although we face an increasingly difficult clinical and research environment, the
productivity from many of the Rotunda staff continued to grow in 2014, both in
quality and volume, reflecting the commitment, determination and expertise of
our staff. A total of 37 applications were reviewed by the hospitals Research Ethics
Committee and the Research Advisory group reviewed 13 applications.
RESEARCH STRATEGY AND INFRASTRUCTURE
In 2013, the Irish Government announced a major re-structuring of public hospitals
into regions with a view to enhancing the delivery of health services. The Rotunda
is affiliated with the newly formed hospital group, RCSI Hospitals, and includes
Beaumont Hospital, Connolly Hospital, Our Lady of Lourdes Hospital (Drogheda),
Louth County Hospital (Dundalk),  and Cavan/Monaghan General Hospital with
RCSI as an academic partner. Research is a key priority and will be incorporated
within the group’s strategic aims and objectives.
It is imperative that The Rotunda’s research strategy is aligned to the research
strategy of the hospital group as well as the shifting funding landscape in Ireland.
It must identify ways to promote and support new and existing research projects
that can attract industry interest and support. In particular, considerable
opportunity exists for the Hospital to enhance links with industry, academia and
other hospitals
Research infrastructure is of paramount importance in order to grow the
department. Designated research space within the school of midwifery has been
identified to house the department offices and a small research laboratory.
STRATEGIC COLLABORATIONS
An important function of the Research Department is  forming key strategic
collaborations with academic centres, other hospitals and industry. 2014 saw the
signing of a Morandum of Understanding  (MOU) with RCSI with regard to
research. This allows for the appointment of Rotunda staff to Honorary Research 
Department of Research
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positions at RCSI. Together RCSI and The Rotunda have developed an agreed
framework for the provision of support and conditions associated with the
administration and management of research funding. We also aim to co-operate in
establishing closer research and clinical links.
Research projects have been initiated with DIT and the development of a MOU
with DIT is underway in the area of analytical research. On an international scale,
a team from the Rotunda visited Alder Hey hospital in Liverpool with a view to
develop a partnership fostering collaborative research projects. 
CURRENT PROJECTS
An increasingly large volume of high impact research is being undertaken at the
Rotunda. In 2014 we saw greater initiation of research projects by Rotunda
clinicians (HANDLE, IRELAND, MINT) and recuitment of the hospital to large-scale,
multicentre clinical studies (GENESIS, HiP, ANSeR). These studies include both
clinical trials of medicinal products (TEST, IRELAND, HiP, MINT) and research on
medical devices(ANSeR, HANDLE). Our infectious disease research group saw the
initiation of it’s first Group B Streptococcus project: Pilot Study assessing Feasibility
and Impact of Maternal Group B Streptococcus Screening at Onset of Labour.  In
addition, as the home of the  Perinatal Ireland research consortium, the Rotunda
has been involved in many high profile studies such as PORTO and ESPRIT. This
range of research engagement at the Rotunda is helping to build a reputation for
excellence in conducting clinical trials with great potential for further growth. Key
to our current success is our proven ability to recruit patients to clinical studies (eg
GENESIS 650 patients, HANDLE 80 patients, TEST 50 patients to end of 2014),as well
as effectively communicating with other centres as part of multicentre trials.
STATISTICAL SUPPORT
Colin Kirkham, research officer continues to provide statistical support to hospital
staff. For seven consecutive weeks from September 30th to November 11th, a course
titled “An Introduction to Research Methodology” was presented and was open to
both Rotunda staff and interested individuals from outside institutions. External
participants paid a small fee that went to the ‘Friends of the Rotunda’ Charity and
thanks must go the Sheila Thompson for her assistance in organising the course.
Jointly presented by Colin Kirkham and Dr. Afif El-Khuffash, the topics covered
during the 90 minute sessions were:
• ‘The concept of causality and Experimental Design’
• ‘Non-Experimental study design and data sampling methods’
• ‘Quantitative data types’
• ‘Bias and Confounding’
• ‘Measurement, Correlation & Regression’
• ‘Introduction to Biostatistics’
On the final evening, a tutorial covering many useful features of MS Excel was
held. The event was approved for 12 external CPD credits by the RCPI.The intention
is to run the course again in 2015. 
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FUNDING
The level of existing funding remains reasonable and the output continues to
exceed expectations in terms of peer-reviewed publications in high quality
medical and scientific journals. New research funding from the EU, The Wellcome
Trust and partners inthe Pharmaceutical Industry will  be targeted to further drive
growth in clinical and translational research.
FUTURE DIRECTION
In a research environment where major amounts of funding go towards the
development and support of large-scale research centres, The Rotunda must
promote the establishment of large multidisciplinary research networks and
programmes that are innovative, sustainable and aligned to national and
European research funding opportunities. 
THE FRIENDS OF THE ROTUNDA
The Friends of the Rotunda are generous supporters of research and researchers in
the Rotunda. They continue to provide financial and other supports to researchers
whose projects fit within the hospital’s research ambition. The Friends of The
Rotunda are committed to providing seed funding for projects with a view to
funding start-ups that may then progress to applications for larger grants from
outside agencies.
4
Friends of
the Rotunda
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THE FRIENDS OF THE ROTUNDA is the official fundraising arm of the Rotunda
Hospital and a Registered Charity (CHY20091). It was formed in 1971 and
incorporated as a Limited Company by Guarantee and Not Having a Share
Capital. 
The Charity has a firm commitment to transparency, accountability and an
adherence to best practice and performance. It publishes annual audited
accounts that have been approved by KSi Faulkner Orr Auditors and submitted
to the Revenue Commissioners.  It is registered with the Charities Regulatory
Authority (CRA), and was granted Tax Exemption effective from 4th October
2014, for the purpose of the Charitable Donation Scheme.
The Main Objective of the Charity is to provide a sustainable funding base for:-
➢ Research into aspects of Maternal and Child Health; 
➢ Additional and vital equipment and support services for the Hospital’s
Specialist Units, Services and Clinics; and 
➢ Improved amenities for patients, their families and hospital staff.
The Friends’ of the Rotunda awarded €300,000 in grant awards during the year
to provide seed funding in support of Rotunda Research.
➢HRB / Medical Research Charities Group (MRCG) - Joint Funding Scheme
The HANDLE Study: Hemodynamic Assessment in Pregnancy and 
Neonatal Echocardiography Assessment. RCSI Rotunda Hospital, 
Principal Investigator: Professor Fergal Malone.
A study identifying abnormal hemodynamic profiles in pregnancy as a 
predictor of adverse obstetric outcome and characterisation of neonatal 
myocardial performance in infants.
➢ Additional Funding for a 1 YR Registrar Post to assist with all 
enrolment aspects of the HANDLE Trial.
➢ The Use of Targeted Neonatal Echocardiography to Predict Short Term
Clinical Sequelae Associated with a Patient Ductus Arteriosus.
➢ The MAMMI Study: Maternal Health and Maternal Morbidity in 
Ireland – Mental Health Strand, 2 year period, under supervision of 
Professor Agnes Higgins, Professor Cecily Begley and Deirdre Daly, 
Trinity College Dublin.
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Dr. Afif EL-Khuffash, Consultant
Neonatologist & Paediatrician,
Rotunda Hospital and Children’s
University Hospital, Temple Street
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➢ Thrombinoscope Machine funded by the Friends has been used to study in
great detail how blood clots in tiny babies. The CRISP Research Study is led
by Dr. Fionnuala Ní Áinle and her team and is providing critical
information that has the potential to change neonatology practice
worldwide. This equipment is also being used in other associated research
collaborations with the Mater Misericordiae Hospital. Dr. Ní Áinle reported
that “patients with liver disease (Cirrhosis) have complicated
abnormalities in their blood clotting systems. We have demonstrated,
using a state of the art blood coagulation assay (funded by the Friends of
the Rotunda) that subtle abnormalities in blood clotting evolve well before
standard laboratory tests become abnormal. These findings may act as a
marker of future decompensation or serve as a future therapeutic target.”
➢ PREDICT Study: Prenatal Diagnosis of Complicated Twins
Principal Investigators: Dr. Karen Flood, Consultant in
Obstetrics/Gynaecology, Rotunda Hospital and Dr. Niamh Murphy,
Registrar in Obstetrics/Gynaecology, Rotunda Hospital.
➢ A Six Week Course on the Introduction to Research Methodology was
organised by Dr. Afif El-Khuffash, Colin Kirkham and the Friends, free of
charge to Rotunda Staff. (Awarded 12 CPD Credits). 
➢ Cranial Ultrasound Course – A one day programme designed to give
participants introduction to cranial ultrasound and provide practical
hands-on experience for neonatal / paediatric trainees. (Awarded 6 CPD
Credits).
The Friends’ Board (‘The Council’) is committed to adopt the Principles of Good
Governance as outlined in The Governance Code - A Code of Practice for
Good Governance of Community, Voluntary and Charitable Organisations
in Ireland.
• Directors: Marie Malone (Secretary), Sylvia Graham, Andrew Wortley.
The Management Executive is run by Sheila Thompson who is responsible
for the administration, marketing and development of the organisation.
The Friends of the Rotunda Charity is a member of The Medical Research
Charities Group (MRCG), Fundraising Ireland, Philanthropy Ireland,
MyCharity.ie, ICTR and the Wheel. In January 2014, the Charity was
accepted as a Host Institution by the Health Research Board.
Karl Egan, Postdoctoral Scientist.
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FUNDRAISING & EVENTS:
The Charity does not receive any State funding and generates revenue each year
by actively encouraging Rotunda staff, patients, their families and friends, to
participate in fundraising activity:-
• Rotunda Golf Classic – The Masters’ Cup
• The River Erne Kayaking Challenge
• Supermarket Bag Packing
• Christening Party Fundraisers
• Coffee Morning Fundraisers
• Birthday Party Fundraisers
• Sponsored Charity Walks/Runs/Cycles
• Vhi Women’s Mini Marathon to Fundraise for Rotunda Neonatal Unit
• Dublin City Marathon
• NY City Marathon
• Sale of Easter Eggs
• Coin Box Collections and Raffles
• Sale of Publications gifted to Rotunda Hospital by Artists / Authors
• Sale of Football Shirts in aid of Rotunda Research Fund 
• Sale of Christmas Cards
• Sale of Art illustrating the Rotunda Hospital
• Sale of Designer Silver Jewellery Collection
• Sale of  Memorabilia of the Rotunda Hospital
• Tango Fiesta Charity Fundraiser
• Young European Strings Chamber Orchestra Performance 
in the Pillar Room
• Christmas Swim Fundraiser
• Sky Dive Fundraisers
• Raffles
• Friends of the Rotunda Annual Membership Subscriptions
• Charity Collaboration with ‘Ride out for Prems’ – Irish Premature 
Babies Organisation
• Charity Collaboration with Feileacain
• Charity Collaboration with Park Rite Parnell Street Car Park
• Charity Collaboration with local businesses
www.MyCharity.ie hosts the Friends of the Rotunda Charity registration on its
website. Fundraisers can set up a Fundraising Page with links to mobile and
social media platforms.
DONOR GIVING:
Provides designated funding for additional vital equipment for the Neonatal
Intensive Care Unit and provides funding that would otherwise not be provided
for by the State to improve amenities throughout the Hospital. 
How we used some of your donations:
➢ The Rotunda’s refurbished Neonatal Unit’s Parent’s Room – a tranquil 
space for our NICU parents to relax in.
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➢ TCM Combi Monitor for NICU
The condition of an infant or child can take a turn for
the worse in a matter of minutes. By continuously
monitoring ventilation and oxygenation, the NICU
team can detect and quickly react to these changes,
avoiding adverse patient outcomes. The TCM Combi monitor gives a
valuable trending tool in monitoring tcpCO2 and tcpO2 levels in the
incubator or at the bedside. Parents, who wish to remain anonymous,
provided funding to purchase this state of the art new equipment for
NICU together with a year’s supply of consumables to support 40+ babies.
➢ ‘Ride Out For Prems Committee’ supporting Premature Babies presented
the Friends of the Rotunda with a donation of €20,000 towards the
purchase of a new state of the art Echocardiography Machine for the
Rotunda’s Neonatal Intensive Care Unit.
➢ Parnell Street Community Fund awarded the Friends of the Charity with
a donation of €350 in aid of the Rotunda Research
Programme.
➢ Planting for the Rotunda’s Mortuary Chapel is provided for from
donations received to the Bereavement Support Services Fund.
➢ Ten Recliner Armchairs were purchased from the Bereavement Support
Services Fund to improve amenities and to provide additional comfort to
distressed parents and family members.
➢ Donations of Cuddle Cots to the Rotunda and the Feileacain Charity from
families that have suffered the loss of a baby. Their generous donation
gifts are their way of helping other families who also have had to endure
the difficult journey of losing a child.
➢ Lasting Memories - These bags were
commissioned following feedback from
bereaved parents and paid for from donations
received to the Bereavement Support Services
Fund. They are given to bereaved parents so that
they can carefully transport baby’s precious
possessions and belongings home when leaving
hospital. 
Tea & Coffee Facilities. Five Leather Armchairs.
Wall-paper Furnishings.
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Donors can give directly to their designated fund which is managed by the
Friends of the Rotunda Charity, by using our On-line payments facility for
Donations on (www.friendsoftherotunda.ie ). Revenue has since been collected
to support each of the following areas:
• Neonatal Intensive Care Unit
• Bereavement Support Services 
• The Delivery Suite
• The Early Pregnancy Unit
• Rotunda Families in Need
• Fetal Assessment Unit
• Maternity Day Care Unit
• Physiotherapy Department
• Rotunda Research Programme
• Sexual Assault Treatment Unit
• Additional Essential Equipment 
• Lactation Unit
The Rotunda Knitters continue to supply the Friends of the Rotunda Charity
with their amazing hand crafted knitwear for newborn and premature babies
born at the Rotunda. Complimentary Gift Packs are frequently distributed to
new parents in celebration of memorable events such as World Prematurity Day,
National Breastfeeding Week, St Patricks Day, Spring Awakening, Summer Joy,
Winter Warmth and Merry Christmas!
Donations Appeal for Mothers & Baby – supports the Rotunda’s Medical Social
Work Team who each year, need to provide support to pregnant Mothers who
find themselves in a crisis situation with little or no money to care for their new
born infants. The Friends of the Rotunda Donations Appeal asks for new or
nearly new items of clothing and/or general overnight toiletries for both Mother
and baby.
CAFÉ ROTUNDA
The Hospital Shop is located within the main reception of the Hospital and
provides a café and retail service to all in the Hospital. Annual rental income
from the Shop provides extra revenue to the Friends’ Charity to run its
administration costs. 
THE HIRE OF THE PILLAR ROOM
Another substantial source of revenue in aid of Rotunda Research is generated
each year through the hire of The Pillar Room Complex as a facility for private
and corporate functions. It is also used by the Hospital as a teaching &
examinations / conference centre. Bookings are managed by the Friends of the
Rotunda office on 01 872 2377 or email friends@rotunda.ie.
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Pictured above is the striking contemporary bar facility within the Pillar Room
Complex. The Venue offers Conferencing and Catering facilities and is equipped
with a modern PA Sound System and Wi-Fi.
The Council of the Friends of the Rotunda wishes to extend its gratitude to all
those who organised and supported fundraising activities during 2014.
Sheila Thompson
Friends of the Rotunda 
www.friendsoftherotunda.ie
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Clinical Audit
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Clinical Audit Team:
DR SHARON COOLEY Clinical Audit Lead
MARY WHELAN Clinical Audit Facilitator
VALERIE JACKSON Surveillance Scientist
COLIN KIRKHAM Statistician
The Rotunda Hospital Clinical Audit Department was established in June 2011
under the quality and safety initiative of the Rotunda’s Strategic Plan 2011-2013.
Clinical audit offers a structured approach to evaluating our care against local,
national and international standards.
The Clinical Audit Department functions include:
• Education and support at all stages of the clinical audit pathway. This 
includes topic selection, researching standards, the application process, audit
tool design, data analysis and report writing.
• Assistance in maintaining clinical audit experience which is an essential 
element of professional competence. 
• Monitor all clinical audit activity within the hospital and routinely report on
same.
• Monitor local and national audit standards and appraise hospital 
performance against these standards where appropriate. 
• Promote a high standard of practice amongst clinical staff and all healthcare
workers undertaking clinical audit.
• Provide a forum for the sharing and dissemination of clinical audit work in 
the Rotunda, which is facilitated by the use of the clinical audit database, the
Biannual Rotunda Audit and Research Day and quarterly audit results 
meetings.
• Encourage presentation of audit results at inter-hospital meetings e.g. JOGS, 
SJH Annual Audit Day and TSH Biannual Audit Day.
• Forge professional links with other clinical audit units nationally.
Clinical Audit Group Weekly Meeting
The core group within the Clinical Audit Department meet weekly to discuss and
approve audit applications.
Clinical Audit Steering Group
The Clinical Audit Steering Group meets quarterly. Membership of the steering group
includes the executive management team, clinical risk department, departmental
patient safety representatives, heads of departments and allied health professionals. 
Other Internal Meetings
Clinical audit activity reports are submitted to the Quarterly meeting of the Board
of Governors, the Patient Safety Meetings and the Monthly Quality and Safety
Committee meeting. These reports include details of new audits, completed audits
and any immediate actions arising from audits. In addition, any clinical audit with
a plan that requires immediate action is highlighted to the Executive Management
Team.
C L I N I C A L  A U D I T
D E PA R T M E N T
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Clinical Audit Database
The database of clinical audit activity in the hospital facilitates the production of
weekly and quarterly reports on topics audited; departments and clinicians
involved, action plans and dates for re-audit. All clinical audits conducted in the
hospital are registered on the database. All health professionals who participate
in completed clinical audits that have been registered with the hospital receive
a certificate of participation in conjunction with their supervisors. 
In total 70 clinical audits were registered in 2014 (39 first audits, 24 re-audits
and 7 continuous audits). 
Clinical Audit Training
The clinical audit team regularly delivers educational sessions in-house on the
clinical audit cycle across all disciplines. In 2014 there were 8 information
sessions held and a total of 53 staff members attended with representatives from
all clinical areas. In addition, external sessions are delivered to midwifery
students at Trinity College Dublin.
Clinical Audit Intranet Page
The department has developed a designated page on the hospital intranet where
the application forms, excel tool template, guide to clinical audit, key steps to
audit success, draft action plan and report template are available to download.
Annual and Monthly clinical audit reports are also available to download.
Audit and Research Day
Two successful audit and research days were held within the hospital during the
year and kindly sponsored by AbbVie. The Rotunda Medals were awarded to
Professor Brain Cleary for his research on the association between methadone
use and Pierre Robin sequence and Dr Catherine Finnegan for her audit into the
use of methotrexate in the management of ectopic pregnancy. Congratulations
also to all our other winners and to all who took presented and took part.
Presentations at External Meetings
• “Audit of Blood Group and Crossmatch” was present by Dr Kim Caulfield on
behalf of the anaesthetics and laboratory departments at the International
meeting of the Obstetrics Anaesthetist Association.
• “Audit Of Early Pregnancy Attendances And Referrals” was presented by Dr.
Jennifer Hogan (moderated poster) at St James’s Hospital 7th Annual Multi
Disciplinary Research, Clinical Audit & Quality Improvement Seminar 15th
May 2014
• “Review of physiotherapy management of 3rd and 4th degree tears” was
presented by Cinny Cusack (poster) at St James’s Hospital 7th Annual Multi
Disciplinary Research, Clinical Audit & Quality Improvement Seminar 15th
May 2014
• “An audit of inotrope administration in hypotensive babies of less than 1500
grams” was presented by Dr Attia Kalim (poster) at the Irish Perinatal Society
Meeting 2014 
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• “An Audit of Risk Status of Teenagers at the Booking Visit and throughout
Pregnancy” was presented by Debbie Brown at the Nursing & Midwifery
Clinical Research Conference in Dublin City University on 12th June 2014  as
part of the Nursing & Midwifery REACH (Research Excellence Across Clinical
Healthcare) Project
• “An Audit of Risk Status of Teenagers at the Booking Visit and throughout
Pregnancy” was presented by Debbie Brown at the at Royal College of
Surgeons Symposium of Nursing Initiatives RCSI North Dublin Hospitals
Group on 26th November 2014
• “ Creation of a Clinical Audit department and Database” was presented by
Clinical Audit Department staff at the at Royal College of Surgeons
Symposium of Nursing Initiatives RCSI North Dublin Hospitals Group on 26th
November 2014
• “Audit of LLETZ Procedures. Are we meeting NCSS Audit Standards?” was
presented by Rebecca Horgan at the Royal College of Surgeons in Ireland
Undergraduate Research Meeting
• Clinical Audit Department Staff also attended Clinical Audit Study days in the
Adelaide and Meath Hospital, St James Hospital and St Vincent’s Hospital
over the course of the year. We look forward to developing links with other
Clinical Audit Departments with hospitals in our group and nationwide.
New Initiatives in 2014
• We effected a change in Clinical Audit Policy to facilitate timely completion of
audits. All audits given grace period of 3 months beyond the proposed
completion date to complete, after which the audit was marked as abandoned
unless an extension request was received
• Audits undertaken by the Health and Safety Department and the Support
Services Department are now recorded on the Clinical Audit database to
enable a complete repository of audit activity within the hospital.
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TABLE OF CLINICAL AUDITS REGISTERED IN 2014
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